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ABSTRACT
Membrane bioreactors (MBRs) can effectively remove a wide range of trace
organic contaminants (TrOCs), yet their fate and recalcitrant contaminant removal
during MBR treatment is uncertain. This study focused on revealing the fate and
removal of TrOCs during MBR treatment, membrane distillation (MD) and novel
membrane distillation bioreactor hybrid treatment (MDBR). It also aimed to
elucidate the effect of physicochemical properties (namely, molecular structure, log
D, and volatility) on the fate and removal of TrOCs during MBR, MD and MDBR
treatment.
The effect of molecular properties on the fate of trace organic contaminants
in the aqueous and solid phases during wastewater treatment by MBR was
comprehensively examined. A set of 29 TrOCs was selected to represent
pharmaceuticals, steroid hormones, phytoestrogens, UV-filters and pesticides that
occur

ubiquitously

in

domestic

wastewater.

Both

adsorption

and

biodegradation/transformation were found to be responsible for the removal of
TrOCs by MBR treatment. Molecular structure had an important effect on the
biodegradability of a compound while adsorption was the dominant removal
mechanism for hydrophobic (log D >3.2) compounds. Compounds with high log D
(log D >3.2) but which were readily biodegradable did not accumulate in sludge. By
contrast, recalcitrant compounds with a moderate hydrophobicity, such as
carbamazepine, accumulated significantly in the solid phase. The results provided a
framework to predict the removal and fate of TrOCs by MBR treatment.
This study also investigated the fate of eight N-nitrosamines during MBR
treatment. The results suggest that biodegradation is mainly responsible for the
iii

removal of N-nitrosamines during MBR treatment. Other removal mechanisms (e.g.
adsorption to sludge, photolysis and volatilization) were insignificant. N-nitrosamine
removal efficiencies were found to be from 24 to 94%, depending on their molecular
properties.

High

removal

efficiencies

of

N-nitrosamines

such

as

N-

nitrosodimethylamine and N-nitrosodiethylamine could be explained by the presence
of strong electron donating functional groups (EDG) in their structure. In contrast, Nnitrosomorpholine possessing the weak EDG morpholine was persistent to
biodegradation. The removal efficiency of N-nitrosomorpholine was the lowest
amongst all N-nitrosamines investigated.
The feasibility of MD for removing a set of common TrOCs was then
examined. The results suggest that the rejection and fate of TrOC during MD are
governed by compound volatility and, to a lesser extent, hydrophobicity. All TrOCs
with pKH> 9 (which can be classified as non-volatile) were well removed by MD.
Among the 29 TrOCs investigated, three compounds (i.e. 4-tert-octylphenol, 4-tertbutylphenol and benzophenone) possess moderate volatility (pKH< 9) and therefore
had the lowest rejection efficiencies of 54, 73 and 66%, respectively. In addition, the
fate and transport of the TrOCs during the MD process was also investigated.
Hydrophilic TrOCs having negligible volatility were concentrated in the feed, while
compounds that are hydrophobic or moderately volatile were substantially lost
through adsorption or evaporation. When MD treatment was integrated with a
thermophilic MBR, near complete removal (>95%) of all 29 TrOCs investigated was
achieved despite their diverse physicochemical properties (i.e. hydrophobicity,
persistency and volatility). The results suggest that MD could be a promising posttreatment used in conjunction with thermophilic MBR for TrOC removal.
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The removal of TrOCs by a novel membrane distillation - thermophilic
bioreactor (MDBR) system was then examined. Salinity build-up and the
thermophilic conditions to some extent adversely affected the performance of the
bioreactor, particularly the removal of total nitrogen and recalcitrant TrOCs. While
most TrOCs were effectively removed by the thermophilic bioreactor, compounds
containing electron withdrawing functional groups were resistant to biological
treatment and their removal efficiency by the thermophilic bioreactor was low (0 to
53%). However, the overall performance of the novel MDBR system with respect to
the removal of total organic carbon, total nitrogen, and TrOCs was high and was not
significantly affected by the salinity build-up and thermophilic conditions of the
bioreactor. All TrOCs investigated were highly removed (>95%) by the MDBR
system. Biodegradation, sludge adsorption, and rejection by MD contribute to the
removal of TrOCs by MDBR treatment.
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Chapter 1: Introduction

CHAPTER 1
INTRODUCTION
1.1

Trace organic contaminants
Water reclamation is a pragmatic approach to address the scarcity of water

supplies in urban areas due to population growth and irregular climate patterns [1].
Through water reclamation, municipal wastewater can be a reliable alternative source
for clean water. However, development of advanced treatment processes is necessary
to ensure the adequate removal of common contaminants (e.g., organics, nutrients,
minerals) and especially trace organic contaminants (TrOCs) that occur in municipal
wastewater. A large number of TrOCs have been detected in raw sewage, treated
effluent and withdrawn sludge as well as sewage-affected water bodies all over the
world. These include steroid hormones, pharmaceuticals, personal care products,
surfactants, pesticides, and disinfection by products [2-5]. In recent years, several
studies have also highlighted the frequent occurrence of UV ﬁlters and
phytoestrogens in municipal wastewater as a potential concern [6-8], although little
is known about their fate during wastewater treatment. N-nitrosamines also are an
emerging class of TrOCs of signiﬁcant health concern, which have been widely
detected at trace levels in several environmental matrices including raw sewage,
secondary treated effluent, and even drinking water [9-11]. TrOCs can enter the
environment via industrial wastewater, domestic wastewater and livestock
wastewater. Chloramination or chlorination of drinking water can also contribute to
the elevated N-nitrosamines concentration in municipal wastewater [11, 12].
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The presence of TrOCs in the aquatic environment is of signiﬁcant concern to
public health and the ecosystem because of the potential adverse impact on living
organisms caused by TrOCs. This can include a range of oestrogenic, mutagenic,
endocrine disrupting and genotoxic effects, which have been observed even at low
levels of several nanograms per litre (ng/L) [3, 4, 7]. Moreover, most N-nitrosamines
have been classified as probable human carcinogens by the US Environmental
Protection Agency [13]. As a result, the removal of TrOCs during wastewater
treatment has been the subject of many recent publications.
1.2

Membrane bioreactors for trace organic contaminants removal
Membrane bioreactors (MBRs) have recently emerged as an efficient

technology for water reclamation, capable of treating wastewater to a high effluent
quality suitable for water reuse. [14]. Appreciable removal of certain TrOCs such as
natural steroid hormones and phenolic compounds by aerobic MBR treatment has
been widely reported in the literature [15-25]. MBR is usually operated with a long
solid retention time (SRT) which can improve the removal of some TrOCs via
adsorption onto the sludge and subsequent biodegradation. A long SRT can also
favour the proliferation of slowly growing bacteria (such as nitrifying bacteria), thus
improving the microbial diversity in the reactor and achieving better biodegradation
of TrOCs [19, 26-30]. However, given the number of TrOCs and the diversity in
their molecular properties, the efﬁciency of aerobic MBRs as a barrier for some
TrOCs and their removal mechanisms is still poorly understood. In addition, previous
studies have focussed mostly on the removal of TrOCs in the aqueous phase and
little is known about their accumulation in sludge. The current understanding on
TrOC removal under oxic conditions of the sludge phase in particular is still limited.
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N-nitrosamines appear to be biodegradable under both aerobic and anaerobic
conditions. A number of studies have investigated their biodegradability in soils,
groundwater, river bed sludge and isolated microbial cultures [31-34]. Notably, only
a few studies have reported the removal of N-nitrosamines from either industrial or
domestic wastewaters by conventional activated sludge (CAS) treatment [11, 12, 35,
36]. However, very little is known about N-nitrosamines removal efficiency and
removal mechanism during MBR treatment.
1.3

Fate and transport of trace organic contaminants during membrane
bioreactor treatment
It is noteworthy that the presence of TrOCs in sludge is of concern especially

in terms of agricultural applications. Agricultural usage accounts for 50% of the
biosolids production in Europe. As a result, the European Union regulates these
organic compounds in sludge to secure the safety of agriculture and soil [7]. There is
a limited number of studies on removal mechanisms of TrOCs in MBR. Adsorption
of TrOCs onto sludge is an important removal mechanism during MBR treatment.
MBR, yielding higher biodegradation rate due to the application of a prolonged SRT,
could reduce the TrOC load in sludge [29]. Compared to the conventional activated
sludge treatment, MBR treatment results in enhanced biodegradation of certain trace
organic contaminants [26-28]. Therefore, it is crucial to understand the removal of
TrOCs from both aqueous and solid phases in MBR treatment.
Given the diverse range of emerging TrOCs, elucidation of the removal
mechanisms and subsequent development of predictive tools for the extent of the
removal of specific TrOCs groups is vital to avoid continuous and expensive
monitoring of the fate of each individual TrOC.
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1.4

Membrane distillation for trace organic contaminant removal
MBRs can effectively remove TrOCs that are hydrophobic and/or readily

biodegradable [24, 27, 37, 38]; however, recent studies have highlighted the
challenge of removing recalcitrant TrOCs (e.g. carbamazepine and diclofenac) by
biological treatment processes, including MBRs [27, 29, 37, 39]. Given the resistant
nature of some TrOCs to biodegradation, the use of post-treatment processes to
specifically target these resistant TrOCs has also been explored (e.g reverse osmosis,
activated carbon adsorption and ultraviolet oxidation) [40-42]. MD is a low
temperature distillation process. MD offers complete rejection of all non-volatile
solutes because mass transfer occurs in the gas phase [43]. Nevertheless, limited
data is available on removal and fate of TrOCs during MD. Also, MD as a post
treatment for MBR to enhance TrOC removal is poorly studied.
1.5

Membrane distillation bioreactor for trace organic contaminant removal
High retention MBR represents the integration of a high retention membrane

process such as nanofiltration [44], forward osmosis [45-47], or membrane
distillation (MD) [48-51] with a bioreactor, and can be an efficient means to achieve
high removal of pollutants. Membrane distillation bioreactor (MDBR) is a high
retention MBR process where the MD membrane can act as a barrier to the
permeation of low molecular weight compounds and recalcitrant compounds. In the
MDBR process, the biological reactor can be operated under thermophilic conditions
to facilitate the integration of biological treatment with MD.
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1.6

Research objectives

The overall goal of this research was to evaluate the removal and fate of TrOCs
during high retention MDBR treatment. Specific objectives were to,
1. Evaluate the fate of TrOCs during MBR treatment and examine the effects of
hydrophobicity and molecular structure of the compound.
2. Elucidate the removal and fate of TrOCs during MD
3. Investigate the biological stability of MDBR and removal and fate of TrOCs
during MDBR treatment.
1.7

Thesis outline
This thesis contains eight chapters (Figure 1.1). Chapter 2 discusses the

occurrence and fate of TrOCs in the environment, available knowledge on TrOC
removal during MBR process and high retention MDBR treatment. Chapter 3 details
the materials and methods used. Chapter 4 to Chapter 7 discusses the findings of four
experiments which were carried out to achieve the research objectives. Chapter 4
provides a detailed understanding on the fate of TrOCs during MBR treatment using
aqueous phase and solid phase removal of 29 contaminants representing several
groups of TrOCs and possessing diverse physicochemical properties. In Chapter 5,
removal and fate of N-nitrosamines during aerobic MBR treatment were examined.
In Chapter 6 the rejection and fate of a broad range of TrOCs during MD and the
potential application of MD as a post treatment for thermophilic MBR to enhance
TrOC removal were examined. Chapter 7 provides an insight into the biological
stability and the removal of a wide range of TrOCs during MDBR treatment.
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Figure 1.1: Outline of the thesis
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CHAPTER 2
LITERATURE REVIEW
2.1

Introduction
A large number of trace organic contaminants (TrOCs) have been detected in

municipal sewage, treated effluent, digested sludge from wastewater, and sewageaffected water bodies. These include steroid hormones, pharmaceuticals, personal
care products, surfactants, pesticides, and disinfection by products. In recent years,
several studies have also highlighted the ubiquitous occurrence of UV filters,
phytoestrogens and N-nitrosamines in domestic wastewater as being a potential
concern. The occurrence of TrOCs in the aquatic environment is of significant
concern because of the potential adverse impact on living organisms caused by
TrOCs. Given the adverse effects associated with human and environmental
exposure to TrOCs, it is important to achieve adequate removal and understand their
fate during the treatment process. In particular, knowledge about the removal of Nnitrosamines, UV filters and phytoestrogens during domestic wastewater treatment is
still very limited.
Membrane bioreactors (MBRs) have recently emerged as an efficient
technology for TrOC removal from municipal wastewater. Nevertheless, given the
number of TrOCs and the diversity in their molecular properties, the efficiency of
MBR as a barrier for some TrOCs and their removal mechanisms need to be
comprehensively investigated. There is limited data and studies on high retention
membrane processes such as membrane distillation (MD) as a post treatment for
MBR. Integration of membrane distillation with a bioreactor, membrane distillation
7
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bioreactor (MDBR), constitutes the so called High Retention MBR, which can be an
efficient means to achieve high removal of low molecular weight and recalcitrant
TrOCs.
This chapter provides a comprehensive review of types, health and
environmental effects, occurrence and fate of emerging TrOCs within the aquatic
environment. This chapter also examines the available knowledge on the removal of
TrOCs during MBR treatment and removal mechanisms. Finally, a comprehensive
discussion on membrane distillation technology and high retention MDBR is also
presented.
2.2
2.2.1

Trace organic contaminants
Types, health and environmental effects
TrOCs consist a wide range and expanding collection of anthropogenic as

well as naturally occurring compounds. TrOCs can be classified according to their
origin, usage, potential health effects and physicochemical properties. According to
the usage and origin, TrOCs are categorized into many different groups such as
pharmaceutically active compounds (PhACs), steroid hormones, industrial
chemicals, pesticides, UV-filters, phytoestrogens and N-nitrosamines. Most TrOCs
are of anthropogenic origin. They also contain naturally occurring compounds such
as steroid hormones and phytoestrogens. Endocrine disrupting compounds (EDCs),
carcinogenic and genotoxic compounds are known to have specific health effects on
human and wildlife. EDCs are a diverse collection of compounds including steroid
hormones (e.g. estrone, estradiol and 17β-estradiol), UV filters (e.g. benzophenone-3
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and benzophenone -4), phytoestrogens (e.g. enterolactone) and industrial chemicals
(e.g. Bisphenol A).
2.2.1.1 Pharmaceutically active compounds
Compounds that are pharmaceutically active include prescription and nonprescription medication, beautification products, personal hygiene products and
preservatives used by human beings and domesticated animals. There are a wide
range of pharmaceutical compounds with a variety of therapeutic groups and
physicochemical properties such as non-steroid anti-inflammatory drugs, antibiotics,
anticonvulsants, lipid regulators, beta-blockers, antidepressants and vasodilators [3,
19]. Personal care products include microbial disinfectants, preservatives and
sunscreen agents, and their metabolites. Examples of common and environmentally
concern PhACs are ibuprofen, carbamazepine, ketoprofen, salicylic acid, naproxen,
diclofenac, primidone, triclosan and parabens. Eleven PhACs representing different
therapeutic groups and physicochemical properties are to be studied in this research.
Pharmaceuticals are produced and used in large volumes worldwide, and a
number of new chemicals are introduced to the market every year. Pharmaceuticals
are intended to have biological active properties, hence bioaccumulation in human,
animal and plant tissues and detrimental effects in human and ecosystems could be
expected [3, 4, 7].
Detrimental effects of pharmaceuticals on aquatic and terrestrial species have
been reported. Potential toxicity can be due to the combined and synergistic effects
of parent compound and metabolites present in the environment [52]. A diverse
range of health impacts on aquatic species have been identified, for example,
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histopathological changes in kidney and liver of the rainbow trout even at low
exposure level (1-5 µg/L) of diclofenac [53], bioaccumulation of diclofenac,
ibuprofen and gemfibrozil in fish blood and plasma leading to estrogenic/mutagenic
activity and genotoxicity [3, 54]. Adverse effects also have been observed in the
higher levels of the food chain. As an example, the extraordinarily high mortality of
oriental white-backed vultures in India and Pakistan during 2000-2003 [55] due to
renal failure and visceral gout was found to be due to diclofenac residue
accumulation [56, 57]. Also, extensive antibiotic usage could increase the
development of antibiotic resistant bacteria in the environment [58]. Endocrine
disrupting activity of triclosan even at low level of exposure has been identified, for
example, in alterations in thyroid hormone receptors in frogs [59, 60]. Triclosan and
its transformation bi-product (methyl-triclosan) can bioaccumulate in algae, snails
and fish [3]. Being a moderately persistent compound, the triclosan concentration can
be magnified in the ecological food chain. Indeed, a triclosan concentration of
several nanograms per gram of body weight (ng/g) has been detected in the plasma
of dolphins [3].
2.2.1.2 Steroid hormones
Steroid hormones include a variety of both natural and synthetic compounds.
Environmentally important natural steroid hormones such as estrone, estriol and 17βestradiol are largely found in human and mammalian urine. Environmentally
significant

synthetic

hormones

include

ethinylestradiol

and

mestranol.

Ethinylestradiol is widely used as the active ingredient of the contraceptive pill.
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Steroid hormones are also of concern due to their endocrine disrupting
activity. Steroid hormones have been demonstrated to have higher endocrine
disrupting activity compared to other TrOCs [61]. The estrogenic potency of
common steroid hormones is listed in Table 2.1. Steroid hormones, even at low
detection levels, can cause feminization of aquatic and terrestrial species such as
frogs, turtles and mice [3]. For example, ethinylestradiol at a concentration of 4 ng/L
prevented development of secondary sexual characteristics of male fathead minnows
[62]. In addition, expression of vitellogenin was induced in rainbow trout by a few
nanograms of estradiol [63] and in frog and turtles at 1 µg/g of estriol [64].
Carcinogenic effects in female mice at 5-90 µg/kg.d dose of ethinylestradiol [65]
have been observed, whilst prostate cancer development associated with estrogen
[66] and a correlation of estriol with breast cancers/endometriosis risk in humans
[67] have been identified.
Table 2.1: Physicochemical properties and estrogenic potency of selected steroid
hormones
Molecular
Weight
(g/mol)
270.4

Water
solubility
(mg/L)
30

17β-estradiol

272.4

Estriol
Ethinylestradiol

Compound
Estrone

Log
Kow

Estrogenic Potency
YES

E-screen

3.13

0.38,1

0.01

3.6

4.01

1

1

288.4

441

2.45

0.001-0.024

0.03

296.4

116

3.67

1.19-1.5

1.25

Note: Estrogenic potency was determined by yeast estrogen screen (YES) and E-Screen methods
[68].

2.2.1.3 Pesticides
According to the US-EPA, pesticides are defined as “any substance or
mixture of substances intended for preventing, destroying, repelling or mitigating
11

Chapter 2: Literature review
any pest”. Pesticide contamination in the aquatic environment has been extensively
studied due to their wide usage, high persistency and high toxicity. Several classes of
chemicals are included in this category, such as insecticides, fungicides and
herbicides. Amongst these, based on the environmental and health effects,
organochlorine and organophosphoric pesticides are two important classes. Examples
include pentachlorophenol, atrazine, aldrin, dieldrin, hexachlorocyclohexane,
hexachlorobenzene, lindane, methyl parathion and chlorpyrifos.
The increased and uncontrolled use of pesticides in agriculture has led to
significant environmental contamination. Persistent pesticides are abundant in
polluted areas due to their wide occurrence and indiscriminate usage in the past. In
this study, five persistent pesticides, including clofibric acid, fenoprop, propoxur,
pentachlorophenol and atrazine are to be studied. Clofibric acid is an herbicide and it
is also a metabolite of lipid lowering pharmaceutical medicine clofibrate. Clofibric
acid reduces plant growth by action on the plant hormone system. Fenoprop is also
an herbicide which disrupts plant growth and life cycle. Propoxur is a carbamate
insecticide, has both acute and chronic residual effects on insects and is widely used
in agricultural and livestock pest control. Pentachlorophenol is an organochlorine
compound used as a pesticide and a disinfectant while atrazine is an herbicide.
Adverse effects of pesticides are thought to be due to both the parent
compound and its metabolites. Metabolites have been shown to have higher toxicity
than the parent compound in several studies [69, 70]. Organochlorines are classified
as highly to moderate toxic to aquatic species (e.g. aldrin, dieldrin –high toxic and
lindane- moderate toxic) [71]. Organophosphoric and organochlorine pesticides have
been recognized for their neurotoxic and endocrine disruptive effects on living
12
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organisms, including humans [72]. Interaction of organophosphoric with DNA and
resultant chromate exchange in human lymphocytes has been observed [73, 74].
Furthermore, the adverse effects of these pesticides on reproductive systems for
example, human sperm DNA damage due to several organophosphoric pesticides,
have been demonstrated [70].
2.2.1.4 Industrial chemicals
Compounds investigated in this category are bisphenol A, 4-tert octylphenol
and 4-tert butylphenol. Bisphenol A is one of the highest volume chemicals produced
worldwide. It is commonly used in manufacturing polycarbamate plastic products
such as water bottles, baby bottles, sports equipment, CDs, DVDs, medical and
dental devices, household electronics and eyeglass lenses. Bisphenol is also used in
epoxy resin coatings on inside of food and beverage cans. Bisphenol is toxic to
aquatic and terrestrial organisms probably due to its interaction with protein and it
has been identified as an endocrine disruptor [75]. 4-tert-octylphenol and 4-tertbutylphenol are widely used to manufacture alkylphenol ethoxylates, surfactants
used in detergents, industrial cleaners, and emulsifiers, and are frequently detected in
wastewater and freshwater bodies. In particular the toxic effect of these compounds
on reproductive systems of living organisms has been demonstrated [76].
2.2.1.5 Ultraviolet filters
Ultraviolet (UV) filters are widely used as sunscreen agents to absorb and
dissipate UV radiation from the sun. Their use has rapidly increased with the
increasing awareness of skin cancers, sun burn and photo aging effects of UV
radiation [77, 78]. They are used as UV stabilizers in clothes, pharmaceuticals,
13
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personal care products (hair sprays, shampoos, shower gel and beauty cream),
agricultural chemicals [77, 79] and food packaging [80, 81]. UV filters are also used
as an indirect food additive [79]. Examples of common UV filters are octocrylene,
benzophenone, benzophenone-3 (oxybenzone), and benzoic acid [79].
Most UV filters including oxybenzone and benzophenone are classified as
endocrine disruptors [79]. UV filters can be absorbed through human skin and
ingested from the contaminated food through plastic packaging [81, 82]. The parent
compound and the metabolites of most of the UV filters are highly lipophilic [77]. As
a result they can accumulate in tissues of wildlife and also in humans [79, 83].
2.2.1.6 Phytoestrogens
Phytoestrogens are natural plant-based compounds which have both inherent
estrogenic and androgenic properties. They can be found in a wide variety of plants
such as soybeans, cabbages, fruits and nuts [84]. Two of the most common classes of
phytoestrogens are isoflavones and lignans [85]. A variety of phytoestrogens and
their mammalian metabolic products have been identified in human body fluids.
Habitual consumption of phytoestrogens has been shown to be beneficial to human
health related to cardiovascular diseases, cancer, osteoporosis and menopausal
symptoms [85]. However, recently, there has been an increasing awareness of
endocrine disruptive activity of phytoestrogens on humans and animals [86, 87].
Phytoestrogens are structurally or functionally similar to ovarian and placental
estrogens and their metabolites [8]. They also possess endogenic activity and
genotoxic effects [8]. The significance of phytoestrogens as environmental
contaminants has been mostly neglected. In this study, therefore, two common
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phytoestrogens, namely formononetin and enterolactone belonging to isoflavone and
lignin groups, respectively were selected.
2.2.1.7 N-nitrosamines
N-nitrosamines can be generated as by-products from a range of industries
where amines are in contact with nitrite, nitrous acid and nitrogen oxides. Examples
include tanneries, circuit board manufacturing, dye manufacturing, metal casting,
rubber manufacturing, metal working and food processing [88]. They may also be
present in commercial products such as antifreezes, pesticides, detergents, processed
meats, beverages, cigarette ﬁlters and cosmetics [12]. In addition, N-nitrosamines
can be produced as a result of metabolism of amines and nitrate rich food.
Furthermore, N-nitrosamines are also generated during chloramination or
chlorination of drinking water [11, 12].
N-nitrosamines of concern to environmental authorities include Nnitrosodimethylamine (NDMA), N-nitrosomorpholine (NMOR), N-nitrosomethylethylamine
(NMEA),

N-nitrosopyrrolidine

(NPYR),

N-nitrosodiethylamine

(NDEA),

N-

nitrosodipropylamine (NDPA), N-nitrosopiperidine (NPIP), and N-nitrosodi-n-butylamine
(NDBA). Most N-nitrosamines have been classified as probable human carcinogens

by the US-EPA and many other international agencies [13]. Their carcinogenic
effects have been detected even at sub-nanogram per litre (ng/L) levels [35, 89].
Dietary intake of N-nitrosamines incurs a risk of stomach, oesophageal and
nasopharyngeal and brain cancers [90, 91]. NDEA in drinking water at low
concentrations (0.2 ng/L) could result in an increased lifetime cancer risk of 1 in 10 6
[90]. As a result, N-nitrosamines have been regulated in both drinking water and
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recycling water guidelines in several countries. In California, where high
groundwater levels of N-nitrosamines are observed, authorities have set a limit of
NDMA in drinking water of 3 ng/L [13]. The Australian Guidelines for Water
Recycling sets the maximum value for N-nitrosodimethylamine (NDMA) and Nnitrosomorpholine (NMOR) at 10 and 1 ng/L, respectively [92].
2.2.2

Occurrence in aquatic environment
TrOCs are released into the environment in different ways, including

domestic

wastewater

(DWW),

industrial

wastewater,

hospital

wastewater,

aquaculture wastewater, agricultural runoff, landfill leachate, and livestock
wastewater (Figure 2.1). Domestic wastewater is a major source of most of the
TrOCs found in the environment [93].

Octocrylene

Diclofenac

Estriol

Hospital
wastewater

Aquatic
Environment

N-nitrosodimethylamine

Formononetin

Triclosan

Agricultural wastewater
Bisphenol A

Figure 2.1: Environmental contaminations pathways of TrOCs
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A large amount of PhACs and synthetic steroid hormones are used each year
worldwide. Annual per capita consumption of PhACs is 15 g and it is three to ten
times higher in developed countries [93]. After ingestion in humans a percentage of
PhACs and their metabolites are excreted through urine and faeces and enters the
environment with domestic wastewater [3]. Phytoestrogens which are present in most
edible plants that are commonly consumed by human and livestock are also partly
recovered in urine or faeces [84]. UV filters are extensively used as sunscreen agents
in cosmetic products and ended up in domestic wastewater. The occurrence of Nnitrosamines in domestic wastewater can be attributed to the consumption of amines
and nitrate rich food, cosmetics as well as household detergents. In addition,
chloramination or chlorination of drinking water can also contribute to the elevated
N-nitrosamines concentration in domestic wastewater [11, 12]. Wastewater treatment
plants are not designed for the specific treatment of these contaminants. Wastewater
treatment plant effluents are discharged to surface water bodies, applied to ground
water recharge and biosolids are used in agriculture with these contaminants. Other
than that, uncontrolled disposal of unused or expired drugs into landfill also is a
major contamination source.
Moreover, direct and indirect uses of PhACs in aquaculture and farmland
application of pesticides are also important environmental sources of TrOCs. Farm
runoff is also a key exposure pathway of phytoestrogens [6]. In addition, industrial
spillages and wastewater also are significant contamination sources of all types of
TrOCs.
A wide range of TrOCs are detected in aquatic environmental matrices,
including wastewater treatment plant influent, secondary effluent, surface water,
17
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ground water and drinking water. Their occurrence level is dependent on a range of
factors including the annual consumption, excretion rate, climate and efficiency of
the treatment process [94]. Orally ingested TrOCs are metabolized in the human
body and excreted via urine and faeces. Compounds such as erythromycin,
carbamazepine, diclofenac, gemfibrozil, and trimethoprim are discharged as parent
compounds in 5, 28, 65, 70, and 80%, respectively, while the rest is metabolized in
the liver and discharged to the environment as partially degraded products [3].
Environmental levels of selected TrOCs are summarized in Table 2.2. PhACs
are the most abundant TrOCs in DWW [2, 94-96]. PhACs such as non-steroid antiinflammatory drugs and antibiotics have frequently been found in raw sewage at
concentrations reaching mg/L level [96, 97]. Ibuprofen is the most abundant PhAC
found in raw sewage followed by the gemfibrozil, naproxen, salicylic acid and
ketoprofen, possibly because of their excessive usage. About 160 different
pharmaceuticals and their metabolites have been identified in domestic wastewater
treatment plants, surface water and ground water in Northern Europe [98]. Because
of high usage possibly triggered by health effect at cold climates and the readily
access to medical treatment, high concentrations of antibiotics, analgesic and nonsteroidal

anti-inflammatory

contaminants

(e.g.

trimethoprim,

ciprofloxacin,

sulfamethoxazole, ibuprofen, naproxen, ketoprofen, diclofenac salicylic acid and
acetaminophen) have been reported in raw sewage and wastewater treatment plant
effluent in Europe and North America [93]. For example, concentrations of 5000
ng/L, 2000 ng/L and 20, 000 ng/L of trimethoprim, ciprofloxacin and ibuprofen,
respectively have been detected in hospital wastewater and high concentration of
sulfamethoxazole (794 ng/L) has been detected in raw sewage in USA [93].
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Concentration level of these contaminants in Asia and Australia is relatively low
[93]. Excessive concentrations of estrogenic contaminants have also been detected in
hospital effluent, DWW and surface waters in USA, Europe and Southeast Asia
mainly attributed to the animal husbandry and excessive usage of contraceptives. As
an example, remarkably high concentration of estriol (>4600 ng/L) reported in
hospital effluent in Taiwan [93].
UV filters and phytoestrogens are also detected in raw sewage at relatively
high concentrations. Oxybenzone is the most abundant UV filter detected in DWW.
Enterolactone and daidzein are two widely occurred phytoestrogens in DWW. The
occurrence level of enterolactone and daidzein is of one to two folds higher than that
of formononetin (Table 2.2). Formononetin can be converted to daidzein and
genistein presumably due to the faecal bacteria [6]. N-nitrosamines concentration in
raw sewage is reported to be low (< 100 ng/L), where NDMA being the only
exception. Few µg/L concentration of NDMA has been reported in raw sewage
presumably through industrial spillage.
Surface water recharge using the treated effluent has been the main cause for
the presence of TrOCs in surface water bodies [94, 99]. Notably, ibuprofen,
carbamazepine, triclosan, sulfamethoxazole, ciprofloxacin, and pentachlorophenol
were detected at alarmingly high levels with concentration at several µg/L. TrOCs
are subjected to dilution, sorption onto suspended solids and sediments, photolysis
and biodegradation after discharge to the surface water. Occurrence level of TrOCs
in surface water depends on the abundance and the persistency of the compound.
Ibuprofen is an easily biodegradable compound, but is the most abundant in raw
sewage also detected in surface water at high concentration. Triclosan,
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carbamazepine, sulfamethoxazole and pentachlorophenol are persistent compounds,
present in raw sewage at high levels, and also abundant in surface water. In contrast,
steroid hormones, phytoestrogens and N-nitrosamines are detected at low
concentrations in surface water either due to low level in raw sewage and efficient
removal during treatment. Phytoestrogens as plant derivatives are consistently
detected in surface water at low concentration (Table 2.2).
Pollution of NDMA in the surface water and ground water near rocket engine
testing facility areas in California USA are very high. For example, 100-400 µg/L of
NDMA has been detected in ground water where NDMA is produced as a
biodegradation

product

of

rocket

engine

fuel

containing

unsymmetrical

dimethylhydrazine [9]. Extremely high level of NDMA in both onsite (400,000 ng/L)
and offsite (20,000 ng/L) ground water has been reported [9]. High levels of NDMA
contamination is attributed to N, N-dimethylhydrazine based rocket fuel used in
rocket testing where NDMA is produced as a biodegradation by-product. In addition,
N-nitrosodimethylamine (NDMA) frequently detected in water resources in the USA
and Canada, which could be mainly attributed to the use of chlorine or chloramine
for the disinfection of drinking water or wastewater [9, 12]. In contrast effluent
impaired drinking water contamination of NDMA is low in countries like
Switzerland and Germany, where wastewater treatment plant effluents are not
disinfected using chlorine and no chloramine and hardly any chlorine is used for
drinking water disinfection. In addition, Switzerland and Germany enforced stringent
water quality standards in terms of free chlorine residual for finished drinking water,
where it restricted to <0.1 mg/L and <0.3 mg/L in Switzerland and Germany,
respectively.
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In comparison to the surface water, ground water contamination is found to
be low. Landfill leachate and artificial recharge using treated wastewater have been a
significant cause for TrOC contamination in ground water. TrOC polarity is a vital
factor for their occurrence in ground water. Polar compounds have less affinity for
subsoil and are likely to infiltrate through soil and contaminate the ground water.
Polar compounds such as NDMA and NDEA are detected at ground water in similar
concentrations as in surface water [12, 90, 100]. NDMA and NDEA (log Kow are 0.640 and 0.34, respectively), are highly soluble in water (solubility at pH 8 & 20 °C
1000 and 147 g/L, respectively), high leaching potential from surface water to
ground water [9, 13]. High levels of these compounds have also been detected in
surface water and ground water all over the world. Most pharmaceutical compounds
are polar (e.g. clofibric acid, carbamazepine, diclofenac and primidone), and under
recharge conditions, can leach through the subsoil and contaminate the groundwater
[101]. Clofibric acid, which is used as a blood lipid regulatory drug is found in
groundwater at significantly high concentration (4000 ng/L) in Berlin Germany from
a former sewage irrigation field [95]. High level of clofibric acid also has detected in
Berlin drinking water samples [95]. Phytoestrogens which are plant derivatives are
present in ground water at substantial levels (100 ng/L). UV filters have hardly been
studied in environmental matrices and limited evidence of their presence in the
ground water exists to date.
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Table 2.2: Concentration of TrOCs in aquatic environment

Compound

Raw
sewage

Level of contamination (ng/L)
Treatment
Surface
Ground
plant
water
water
effluent

Reference

Pharmaceutically active compounds
Ibuprofen

100056500
86-1000

20-48240

< 5044

< 200

[96, 97, 101-105]

8.8-5450

1.1- 568

< 380

Carbamazepine

1000-2000

73-2100

< 1075

< 10.4

Gemfibrozil
Trimethoprim

1090-8500
4000

< 4000
<7900

1.8-790
< 2-710

< 340
1.4- 11

Triclosan

180-4400

12- 9300

35-2300

NA

[93, 97, 101, 103106]
[93, 95, 103, 105107]
[93, 96, 101, 104]
[29, 93, 96, 97, 99,
103, 107]
[3, 96, 104, 108, 109]

Naproxen

8000

1-5100

1-610

NA

[93, 104]

Ketoprofen

80-5700

20-1620

3.4-329

< 80

[93, 104]

Salicylic acid

340-8000

< 2098

< 302

6.5

[93, 95, 104]

Sulfamethoxazole

250-1300

3.8-2800

1.7-2000

1.4-410

[29, 93]

Ciprofloxacin

NA

40-3353

23-1300

NA

[93, 95]

Propranolol

NA

30-50

20

NA

[93]

840-2800*

< 1720

314

NA

[29, 93]

NA

110-200

55-635

NA

[110]

1-160
1-15

< 1-196
< 1-43

1-65
< 21.4-5

NA
NA

< 0.5-10
3.6-14
NA
3-450

0.4-30
<0.1-42
6-13
1-17

5-19
1.4-4.3
< 74
0.1-831

NA
0.1-0.5
NA
NA

[93, 104, 111-114]
[93, 111, 112, 114,
115]
[93, 112, 115]
[111, 113, 115]
[93]
[93]

NA

1.3-430

< 200

NA

57-2000

120-2000

< 248

0-4000

Pentachlorophenol

NA

NA

2000

NA

[116]

Hexachlorobenzene

7.5 - 319

NA

NA

NA

[117]

10-210

NA

NA

NA

[118]

Lindane

680-1380

NA

NA

NA

[119]

Dieldrin

23-94

NA

NA

NA

[120]

4.8-800

0.5-140

5-100

Diclofenac

Atenolol
Primidone
Steroid hormones
Estrone
17β-estradiol
Estriol
Ethinylestradiol
17α-estradiol
17α-ethinylestradiol
Pesticides
Atrazine
Clofibric acid

Aldrin

[110]
[93, 95, 110]

Industrial chemicals and their metabolites
Bisphenol A

60-600
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Compound

4-tert octylphenol
Nonylphenol
Methylparaben
Propylparaben
UV-Filters
Oxybenzone
Octocrylene

Raw
sewage

Level of contamination (ng/L)
Treatment
Surface
Ground
plant
water
water
effluent

Reference

80-3900
220-870
NA
NA

< 1000
< 4400
NA
< 28

NA
0.1-7300
< 1062
< 2142

NA
NA
NA
NA

[96]
[96, 104, 121, 122]
[108, 122]

1000-3100
87.5-100

1000-2800
60-120

NA
NA

NA
NA

[8]
[8]

581-2111
0.1-10
341-1688

0.1-48
< 0.6
< 18

1-74**
< 35
2-120

NA
NA
NA

[6, 84, 123]
[6, 84, 124]
[6, 84]

7-100,000

1.5-400

3-31
< 68
5*
13-41
< 40
< 41

2-1390
< 24
12
NA
< 1.8
< 19

Phytoestrogens
Enterolactone
Formononetin
Daidzein
N-nitrosamines
NDMA
NMOR
NDEA
NDPA
NPYR
NPIP
NDBA

5-125
20-275
8-40
<5
2-15
1-80
5-18

4400000#

<2
2-26
NA
NA
NA
2-8

[9, 11, 12, 100]
[12, 90, 100]
[12, 90, 100]
[12, 90, 100]
[90]
[12, 90, 100]
[12, 90, 100]

Note: * denotes the concentration in primary effluent, ** denotes enterolactone
concentration in sea water, # denotes NDMA concentration in California near rocket
engine testing facility.
2.3

Removal and fate of TrOCs during wastewater treatment
A wide range of TrOCs can be effectively removed during wastewater

treatment such as activated sludge treatment and membrane bioreactors. The efficacy
and the fate of TrOCs is dependent on operating parameters such as oxic/anoxic
conditions [22, 125, 126], nitrification/denitrification capacity, solids retention time
(SRT) [26, 28, 127], hydraulic retention time (HRT) [26, 127], temperature [23] and
mixed liquor pH [21, 128]. Compound specific parameters that have significant
influence on removal and fate during biological treatment include polarity, molecular
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structure and biodegradability [37, 129, 130]. Biodegradation, adsorption to
biosolids, photolysis and volatilization have been the main removal mechanisms of
TrOCs during biological wastewater treatment [19, 27, 29, 55, 99, 105]. This section
discusses the removal and fate of TrOCs during conventional wastewater treatment
processing. A detailed discussion on the fate and removal of TrOCs during MBR
treatment is given in Section 2.4.
2.3.1

Removal of TrOCs
Recently, increasing attention has been paid to the removal and fate of TrOCs

during wastewater treatment. Activated sludge treatment process (ASP) has been the
most widely used biological treatment technique for domestic wastewater treatment.
However, ASP is not specifically designed to remove TrOCs. As a result, TrOC
removal by ASP is generally low and often inadequate [27, 99]. The reported data
ranges from negligible to complete removal (Table 2.3). Ibuprofen is highly removed
during ASP (>97%) followed by estriol (>90%), lindane (80-90%), oxybenzone (6395%) and naproxen (58-90%). Diclofenac and carbamazepine are among the lowest
removed TrOCs (0-50%).
Biodegradation is a predominant removal mechanism of TrOCs removal
during ASP. Easily biodegradable TrOCs are effectively removed (>80%) during
ASP [105]. This includes most PhACs (e.g. ibuprofen, naproxen, ketoprofen and
gemfibrozil),

steroid

hormones,

phytoestrogens

(e.g.

enterolactone

and

formononetin) and UV filters (e.g. oxybenzone and benzophenone) (Table 2.3).
PhACs often have a complex structure with polarized ends [2], subsequently making
them soluble in water (log D > 3) and largely removed during ASP [19, 99, 105]. It
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has been showed that compounds with electron donating functional groups (e.g.
hydroxyl and methyl) are prone to aerobic biodegradation while compounds with
electron withdrawing groups (e.g. chloride and amide) are recalcitrant [37]. Steroid
hormones removal during ASP has been widely investigated and high removal
efficiency (>90%) has been observed (Table 2.3) [25, 125, 131]. A case study on
phytoestrogen removal by Kang et al. [6] reported more than 97% removal of
common phytoestrogens such as enterolactone, daidzein, and genistein.
Persistent TrOCs are negligibly or partially removed during conventional
wastewater treatment and include compounds such as diclofenac, clofibric acid,
carbamazepine, atrazine, and sulfamethoxazole (Table 2.3). These are also detected
at high levels in secondary effluents and in surface waters (Table 2.2). Washout of
slow growing/selective microorganisms due to low SRT, low organic retention time
due to inadequate retention mechanism and inclusion of electron withdrawing
functional groups in the molecular structure may significantly reduce the removal of
persistent contaminants during biological wastewater treatment [26, 37]
N-nitrosamines appear to be biodegradable under both aerobic and anaerobic
conditions. A number of studies have investigated their biodegradability in soils,
groundwater, river bed sludge and isolated microbial cultures [31-34]. Bradley et al.
[31] reported more than 54% biodegradation of NDMA in soil from a wastewater
reclamation facility under both oxic and anoxic conditions. Drewes et al. [32]
conducted a laboratory scale study of the removal of seven N-nitrosamines under
conditions relevant to groundwater recharge operations. Half-lives of these seven Nnitrosamines were in the range from 1.3-7 d. However, Drewes et al. [32] also noted
some variation in the biodegradation rate of N-nitrosamines and that complete
25

Chapter 2: Literature review
removal of N-nitrosamines would require the establishment of an adapted microbial
community over several weeks or months. Zhou et al. [34] monitored the fate and
transport of NDMA in groundwater being recharged with recycled water and
reported that up to 80% of the recharged mass of NDMA could be biodegraded. The
half-life of NDMA under recharge conditions was 69.4 days [34]. It is noteworthy
that only a few studies have reported the removal of N-nitrosamines from either
industrial or domestic wastewaters by the ASP [11, 12, 35, 36]. One of the most
comprehensive studies to date was by Krauss et al. [12] who examined the fate and
removal of N-nitrosamines in 21 full scale conventional wastewater treatment plants
in Switzerland. They showed that the removal efficiencies from the aqueous phase by
ASP were generally above 40% for NMOR and over 60% for all other Nnitrosamines. The authors also noted the high variation in the removal efficiency of
N-nitrosamines amongst the 21 full scale plants investigated [12].
2.3.2

Adsorption to biosolids
Adsorption of TrOCs onto sludge (hydrophobic or electrostatic interactions)

is also an important removal mechanism during biological wastewater treatment [19,
27, 132]. It is noteworthy that the presence of TrOCs in sludge is of concern
especially in terms of their agricultural applications. Agricultural usage accounts for
50% of the biosolids production in Europe. As a result, the European Union regulates
these organic compounds in sludge to secure the safety of agriculture and soil [7].
Therefore, it is crucial to understand the removal of TrOCs from both aqueous and
solid phases in wastewater treatment (Table 2.3).
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Sludge adsorption of a number of TrOCs during ASP has been reported
(Table 2.3). This includes, PhACs (e.g. diclofenac, ibuprofen, ketoprofen and
triclosan) [29, 104], steroid hormones [104], phenolic compounds (e.g. nonylphenol,
4-tert-octylphenol and pentachlorophenol) [104, 133], organochlorine pesticides
(dieldrin and DDT) [117], polybrominated diphenyl ethers [117], bisphenol A [134],
UV filters (octocrylene and oxybenzone) [8, 77]. A summary of TrOCs adsorption in
ASP is given in Table 2.3. Octocrylene was detected at the highest concentration
(9170 ng/g) followed by triclosan (1505 ng/g). Octylphenol (1180 ng/g) and
oxybenzone (1020 ng/g). Sludge adsorption of bisphenol, ibuprofen, and diclofenac
could be moderate or low. Concentration of estrone, estradiol and 17β-estradiol in
activated sludge is in the range of 0 to 49 ng/g, where 17β-estradiol has the highest
sludge adsorption [132]. Andersen et al. [132] reported that about 50–75% of total
estrogen removal during ASP could be due to sludge adsorption. Removal of
alkylphenols ( e.g. pentachlorophenol and nonylphenol) by adsorption to sludge is
also significant during ASP [133].
TrOCs removal during biological wastewater treatment (WWT) is a
combined process of adsorption to biosolids followed by biodegradation [26, 37,
133]. TrOCs removal by sludge phase mainly depends on solids retention time and
operating temperature of the process, specific endogenous decay rate of biomass,
hydrophobicity and persistency of the compound [26, 135, 136]. The higher the SRT,
the lower the amount of TrOCs expected to be adsorbed in the sludge [135, 136].
High SRT results in longer sludge age for microorganism to biodegrade TrOCs
attached to bioflocs. Removal of TrOCs by adsorption to sludge is a main removal
mechanism for bioreactors with low SRT because (i) a high biomass wastage rate
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increases the removal of TrOCs in the solid phase and (ii) at a low SRT, the ASP
process has high biomass washout, slow growing microorganisms exist within the
reactor and reduce the biodegradation and increase the TrOCs in the solid phase
[135, 136]. For example, Kipopoulou et al. 2004 studied lindane adsorption in
different sludge matrices during ASP. Primary sludge contained the highest TrOC
concentrations compared to secondary sludge [137]. Primary sludge with low SRT
exhibits least biodegradation (low biological activity) potential than secondary
sludge where adsorption is the main removal mechanism in primary sludge [137].
Other than low SRT, high organic content also is significant for high TrOC
adsorption to sludge. Kipopuolu et al. [137] demonstrated a linear relationship
between lindane adsorption and the organic content in the primary sludge of ASP.
On the other hand, low sludge adsorption could be expected in WWT systems with
extended SRT due to the reduced biomass activity (endogenous decay phase). In
comparison to ASP, TrOCs removal by sludge phase in membrane bioreactors which
operates at high SRT would be low. Detailed discussion of the fate of TrOCs during
MBR treatment is given in Section 2.4.2.
TrOCs removal by sludge phase also depends on the hydrophobicity and the
persistency of the compound. Hydrophobic compounds (log D >3.2) have high
affinity to soils/biosolids. Moderately hydrophobic but persistent compounds can
also adsorb to sludge. For example, considerable adsorption of diclofenac, which is a
persistent and moderately hydrophobic compound (log D

pH 7

= 1.77), to subsoil has

been reported [95]. By contrast, hydrophilic compounds do not show any substantial
adsorption to soils and biosolids. Clofibric acid (log D
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example. TrOCs adsorption to sludge could be a synergetic effect of hydrophobicity
and persistency of the compound.
Operating temperature also is an important parameter determining TrOC
adsorption to sludge. High temperature reduces the adsorption of TrOCs to sludge
[138]. It is contradicting the fact that smaller floc size provides larger surface area
which leads to higher adsorption. In biological treatment, at high temperature, small
bioflocs are formed [139, 140]. Large surface area increases the adsorption of TrOCs
to the biosolids which will increase the biodegradation resulting in low accumulation
in sludge.
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Table 2.3 : Summary of removal and adsorption in sludge of selected TrOCs during
aerobic wastewater treatment
Compound

Oxybenzone
Octocrylene
Bisphenol A

Removal
efficiency
(%)
63–95
70–80
10–96

Ibuprofen
Naproxen
Ketoprofen
Diclofenac

97–100
58–90
36.9–76.3
0–50

Reference

Concentration
in sludge (ng/g)

Reference

140–1900
270–9170
53–196

[7, 8, 77]
[7, 8]
[104]

100–747
8–53
0–336
50–381
0-25
0-100
0-150
0-50
0–135
1430–1581
0–67
<70

[29, 104]
[104]
[29, 99, 104]
[29, 99, 104,
105]
[29]
[29]
[29]
[29]
[104]
[104]
[29, 99, 104]
[29]

Sulfamethoxazole
Loratidine
Acetaminophen
Erythromycin
Clofibric acid
Triclosan
Carbamazepine
Atenolol

50–74
0–15
99
0–36
49
61
0–31
0–62

[8]
[8]
[26, 27,
104]
[29, 105]
[29, 105]
[29, 99]
[95, 99,
105]
[19, 29]
[29]
[29]
[19, 29]
[19]
[19]
[99, 105]
[19]

Gemfibrozil

0–65

[19, 29]

38–172

[29, 104]

17β-estradiol

20–80

<49

[132]

17α-ethinylestradiol
Estrone

<80
20–98

<17
<37

[132]
[104, 132]

Estriol

40–90

NA

NA

Lindane
Nonylphenol
4-tert octylphenol

80–90
60–89
27–100

[26, 105,
131]
[105]
[26, 105,
131]
[19, 26,
131]
[137]
[27, 133]
[27]

1.4%*
35–1307
74–2286

[137]
[104]
[104]

Note: * lindane concentration in sludge as a percentage of the influent amount.
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2.4

Membrane bioreactor for trace organic contaminant removal

2.4.1

Membrane bioreactor technology
Membrane bioreactor can be defined as a combined process of conventional

biological wastewater treatment and membrane separation where biomass is
separated from treated water by a membrane filtration unit [141]. MBRs are
classified into two categories according to the relative position of the membrane with
the bioreactor namely, submerged MBR, where the membrane is immersed in the
bioreactor and side stream MBR, where bioreactor sludge is pump to the membrane
kept outside the bioreactor (Figure 2.2). Micro-porous membranes such as
microfiltration or ultrafiltration membranes are commonly used in MBR systems
[141].
MBRs have been used for the domestic and industrial wastewater treatment
since the 1960s [141]. There also has been a concern on retrofitting MBRs to
conventional aerobic wastewater treatment systems [141]. Stringent effluent
standards, less land availability, water scarcities and high quality product water are
key drivers for wide application of MBR in wastewater treatment [141] There had
been more than 500 MBR plants established worldwide by the end of 20th century
[142]. In Japan over 250, in United States 24 and Canada nine MBR plants were
installed to treat both industrial and domestic wastewater [142]. Also, nearly 300
MBR plants for industrial wastewater treatment and 100 MBR plants for domestic
wastewater treatment were used by 2005 [143]. Some examples of full scale MBR
plants are given in Table 2.4.
MBR have several inherent advantages compared to conventional WWT.
This includes smaller foot print, more flexibility for scaled up or retrofit, high
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effluent quality with respect to the removal of suspended solids, pathogens, organics
and nutrients [141, 144]. Biomass washout in MBR system is negligible given the
high suspended solids retention by micro-porous membranes. In addition, sludge
separation is not dependent on the influent characteristics or the flocculation status of
the biofloc as the bioflocs are much larger than the membrane pores and totally
retained by the membrane [145]. MBRs can work at high organic loading rates with a
small foot print given that the biomass is confined within the system providing both
the control of a high biomass concentration and decoupling of solids retention time
and hydraulic retention time [144, 145].
Permeate
suction

Recirculation
Pump
Feed
Wastew
ater

Feed
Wastewater

Membrane

Membrane
Retentate
Aeration

Aeration

Biomass
Waste

Biomass
Waste

(a) Aerobic-submerged MBR

(b) Aerobic-side stream MBR

Biogas

Biogas

Figure 2.2: MembranePermeate
bioreactor configurations.
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Table 2.4: Examples of full scale aerobic and anaerobic MBR plants

Wastewater

Capacity
(m3/d)

Dairy industry
wastewater

4000

Palm Jumeirah WWTP Dubai

Domestic wastewater

18000

Al Ansab WWTPMuscat Oman

Domestic wastewater

76,000

Domestic wastewater

540

Ken s Foods of
Marlborough (USA

Salad dressing and
Sauce Manufacturing

530

Operate at 35 oC, 99.4% COD removal, World’s largest
AnMBR

[147, 148]

Shochu distillery (Japan)

Alcohol stillage

20

NA

[148]

Awamori Distilleries
(Japan)

Alcohol stillage

15

NA

[147]

Project

Remarks

Reference

Aerobic MBRs
Almarai project Saudi
Arabia

Picnic Bay Queensland
WWTP
Anaerobic MBRs

Submerged MBR. Organic loading of 1200 kg/d.
Effluent COD and TSS < 100 and 5 mg/L, respectively.
Water reuse for general washing and irrigation.
Submerged MBR , 18,000 m3/d capacity, 4500 kg/d
organic loading, Effluent COD < 30 mg/L, water reuse
for gardening and firefighting purposes.
Effluent BOD < 10 mg/L, TSS < 10 mg/L, NH4-N < 1
mg/L and NO3-N< 8 mg/L, water reuse for gardening
and firefighting.
Submerged MBR. Target was to protect the great barrier
reefs by reducing the pollution load.
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2.4.2

Removal and fate of TrOCs during MBR treatment

2.4.2.1 Removal of TrOCs
Considerable research effort has been devoted to investigate the TrOCs
removal by MBR treatment. MBRs can effectively remove most TrOCs compared to
conventional wastewater treatment (Table 2.5). Importantly, TrOCs that are
hydrophobic and/or readily biodegradable are effectively removed [24, 27, 37, 38].
The reported data ranged from negligible removal to complete removal. Excellent
MBR removal of ketoprofen (>99%) [149], followed by ibuprofen (98%) [28],
naproxen (84-89%) [28] and roxythromycin (57-77%) [28, 149] have been reported.
Appreciable MBR removal of natural steroid hormones and phenolic compounds
also has been reported in the literature [15-25, 149-154]. For example, Wintgens et
al. [154] reported effective removal of bisphenol A (73-99%) and nonylphenol
(>90%) in their study on MBR treating dumpsite leachate. More than 98% removal
of 4-tert octylphenol has been observed by Tadkaew et al. [37]. Clara et al. [26] has
reported more than 80% removal of estrone, estradiol, estriol and 17αethinylestradiol in full scale MBR plant treating domestic wastewater whereas 17αethinylestradiol was more challenging to remove compared to the other three
compounds.
Recalcitrant compounds like sulfamethoxazole, carbamazepine, nonylphenol,
bisphenol A, atrazine and diclofenac are more likely to be removed in MBR than in
conventional treatment plants [18, 151, 155, 156]. For example, 52– 64% removal of
sulfamethoxazole and <20% removal of carbamazepine have been reported by Hai et
al. [22] and Reif et al. [28] in their lab scale and pilot scale MBRs, respectively.
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Kimura et al. [153] reported that compounds with two or more aromatic rings (e.g.
ketoprofen, naproxen and mefenemic acid) were not removed by ASP but can be
considerably eliminated by MBR. Bouju et al. [157] reported better removal of
atrazine in anoxic–aerobic MBR compare to ASP.
Recent studies have highlighted the challenges of removing recalcitrant
TrOCs (e.g., carbamazepine, and diclofenac) by biological based treatment
processes, including MBRs [27, 29, 37]. For example, MBR removal of TrOCs such
as carbamazepine, diclofenac, clofibric acid, atrazine, DEET and dilantin is very low
and inconsistent. Kimura et al. [153] found inconsistency in the removal of complex
compounds with chloride in their structure (clofibric acid and dicloroprop), with
clofibric acid being relatively well removed by MBR while dicloroprop was
negligibly removed.
In comparison with the CAS treatment process, very little is known about the
efficiency of membrane bioreactor (MBR) for the removal of N–nitrosamines during
wastewater treatment. Hatzinger et al. [36] recently demonstrated a novel aerobic
laboratory scale propane-fed MBR for the removal of NDMA from artificial
groundwater. This appears to be the only study to date which has investigated the
removal of N–nitrosamines by MBR treatment. The authors reported over 99.9%
removal efficiency of NDMA. Given the unique configuration and operating
condition of their propane-fed MBR, the results reported by Hatzinger et al. [36] in
case of groundwater may not be representative of a typical MBR used for wastewater
treatment. Also, removal of UV filters (e.g. benzophenone and oxybenzone) and
phytoestrogens during MBR is indistinct.
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2.4.3

Fate of TrOCs
Biodegradation or biotransformation by microorganisms and adsorption to

sludge are important removal mechanisms during MBR treatment. There is, however,
a limited number of studies on removal mechanisms of TrOCs in MBR. Radjenovic´
et al. [29] investigated the fate and distribution of pharmaceuticals in the aqueous
and solid phases during the MBR treatment and identified that adsorption to sludge
as an important removal mechanism for several pharmaceutical compounds such as
mefenamic acid, propanolol and loritidine [29]. They also suggested that MBR
enabling higher biodegradation rates could reduce the TrOCs load in sludge. Clara et
al. [26, 27] and Reif et al. [28] showed that MBR treatment could enhance the
biodegradation of several groups of TrOCs (such as pharmaceuticals, fragrances and
endocrine disruptive compounds) compared to conventional activated sludge
treatment. Tadkaew et al. [37] further demonstrated that biodegradability of a TrOC
can be qualitatively assessed based on the presence of electron donating functional
groups (EDGs) or electron withdrawing functional groups (EWGs) in their molecular
structure. Fate of TrOCs during MBR treatment and the factors affecting it will be
further discussed below.
2.4.3.1 Factors affecting removal and fate of TrOCs during MBR treatment
The molecular structure and hydrophobicity of the TrOCs, operating SRT,
mixed liquor pH, temperature and microbial diversity are the key factors affecting
removal and fate of TrOCs during MBR treatment [18]. Tadkaew et al. [37] studied
the effect of hydrophobicity (measured by log D) and functional groups on the
removal of TrOCs. They proposed a qualitative predictive framework which
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stipulated that: (i) hydrophobic compounds (log D > 3.2) and compounds which are
hydrophilic (log D < 3.2) but possess only electron donating groups (EDGs) would
achieve high removal during MBR treatment, (ii) the removal efﬁciency of
hydrophilic compounds possessing only electron withdrawing groups (EWGs) would
be low, and (iii) hydrophilic compounds having both EWGs and EDGs would
achieve varying removal depending on the type of the functional group. In good
agreement with that it was found that MBR removal of TrOCs with a chloride
moiety, which is a strong electron withdrawing functional group (atrazine, clofibric
acid, dichloropop, linuron and diclofenac) is low or negligible [130, 153, 157].
Nevertheless, the negative effect of chroride could be curtailed with the
hydrophobicity of TrOCs where hydrophobic compounds with high halogen content
and hydrophilic compounds with low halogen content could be well removed during
MBR treatment [130]. Tambosi et al. [149] claimed lower removal of naproxen
(86%) than ketoprofen (99%) that have similar physicochemical properties would be
due to the naphthalene ring in naproxen. Given the diverse range of emerging TrOCs,
elucidation of the removal mechanisms and subsequent development of predictive
tools for the extent of the removal of specific TrOC groups is vital to avoid
continuous and expensive monitoring of the fate of each individual TrOC.
MBR is usually operated with a long solid retention time (SRT). Typical SRT
is about 25–80 days compared to the SRT of ASP (8–25 days) [141, 158]. High SRT
can affect the fate and removal of TrOCs mainly in three ways namely, (i) provide
extended contact time for adsorption onto sludge and subsequent biodegradation (ii)
provide sufficient time for microorganisms to acclimatize to the pollutant [18, 26,
159] and (iii) high SRT favours the proliferation of slowly growing bacteria (such as
37

Chapter 2: Literature review
nitrifying bacteria), thus improving the microbial diversity in the reactor and
achieving better biodegradation of TrOCs [19, 26-30]. It is suggested that the SRT of
the treatment process has to be chosen based on the persistency of the target
pollutant. Cirja et al. [18], has suggested 10–30 days SRT for most of the PhACs like
carbamazepine, diclofenac, benzafibrate, naproxen, estrone, estradiol, estriol and
17α–ethinylestradiol. Clara et al. [26] reported increased diclofenac removal from 20
to 60% with increasing SRT from 22 days to 40–80 days, three times higher removal
by increasing SRT 2 fold. Extended SRT also could negatively affect the removal of
TrOCs due to the low sludge withdrawal and high endogenous decay rate [137].
High MLSS concentration in MBR (typically about 10 g/L compared to 2 g/L
in ASP) and total biomass retention would increase TrOC removal by adsorption to
sludge and subsequent biodegradation/transformation. Some TrOCs are persistent to
biodegradation, but can be removed mainly by adsorption, which is facilitated by a
high biomass concentration in MBR [160-162]. The morphology of biomass in a
MBR system could also stimulate the effective removal of TrOCs. MBR has smaller
flocs than in conventional treatment processes, which enhance the diffusivity,
provide larger surface area, and prolong biodegradation. Floc size in MBR and
conventional treatment plants are 10–100 µm and 100– 500 µm, respectively [163],
Total biomass retention assures the rich microbial diversity of MBR. Free living
microorganisms and filamentous microorganisms which are easily washout in
conventional treatment processes can be retained by the membrane. This might
possibly be a reason for high removal of certain compounds (e.g. carbamazepine,
naproxen, and diclofenac) during MBR treatment [18]. Bouju et al. [157] reported
the highest removal of atrazine to date (approximately 40%) through a genetically
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modiﬁed bacterial strain. Also favourable removal of TrOCs by nitrifying bacterial
strains has been demonstrated (e.g. for natural and synthetic steroid hormones,
halogenated hydrocarbons and phenolic compounds) [15-17, 25].
The operating pH of the MBR can also affect the removal and fate of TrOCs
by either changing the microbial properties (both physiological properties and
biological activity) and/or changing the solubility of TrOCs. Trace organic
contaminants can be positively charged at low pH and neutral or negatively charged
around pH 7 (e.g sulfamethoxazole), thus adsorption would only be a significant
removal mechanism at low operating pH [149]. This could largely affect the removal
of such TrOCs since the sorption is a major removal mechanism in biological
removal process. Tadkaew, et al. [21] also revealed that removal of ionisable TrOCs
(e.g Sulfamethoxazole, ibuprofen, ketoprofen and diclofenac) are largely dependent
on reactor operating pH, whereas non-ionisable compounds (e.g. bisphenol A and
carbamazepine) are relatively independent of the reactor operating pH. Incorporating
MBR with an anaerobic hydrolytic process, which typically operates at pH about 4–5
would enhance the removal of ionisable TrOCs.
Oxic and anoxic conditions also are imperative for the removal of TrOCs
during MBR treatment. Anoxic conditions favour the removal of some contaminants
such as carbamazepine [22]. TrOC removal during anaerobic condition is scarcely
reported. Some TrOCs are unlikely to biodegrade under anaerobic conditions, (e.g.
steroid hormones, alkylphenols (octylphenols and t–nonylphenols) and alkylphenol
ethoxylates) [164]. Removal of alkylphenols and 17α–ethinylestradiol under
anaerobic conditions is extremely low [126, 164]. In fact, it appears that alkylphenol
ethoxylates are transformed into alkylphenols (e.g. 4–nonylphenol and t–
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nonylphenol) and estrone is transformed into 17α–ethinylestradiol [126]. Oxic
conditions are vital for liquid phase removal (biodegradation) of alkylphenols such as
t–nonylphenol [164]. A recent study by Monsalvo et al. [165] showed that only
hydrophobic compounds can be effectively removed by AnMBR. Adsorption to
sludge seems crucial in determining the fate of TrOCs during anaerobic wastewater
treatment. [133, 164]. It is suggested that TrOCs are largely adsorbed onto anaerobic
sludge due to their low biodegradability under these conditions. For example,
alkylphenols and estrogens significantly accumulate in AnMBR sludge compared to
ASP [126, 133, 164]. Abargues et al. [164] also demonstrated that accumulation of
phenolic TrOCs (octylphenols and t–nonylphenol) in anaerobic sludge can be
enhanced by using high SRT during MBR treatment.
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Table 2.5: Selected experimental studies of TrOC removal by membrane bioreactor
Study

Wastewater

T
(°C)

TrOCs

Feed TrOCs
concentration
(µg/L)

SRT
(days)

MLSS
(g/L)

Removal
efficiency
(%)

Remarks

Ref.

Nitrification &
Denitrification
MBR

Dumpsite
leachate

NA

Nonylphenol
Bisphenol A

NA

NA

22

>90

Ultrafiltration (UF),
tubular membrane, reactor
size180 m3

[154]

Aerobic
Submerged MBR

Synthetic
domestic
wastewater

NA

>93.7

Hollow fibre (HF)
microfiltration (MF)
membrane, 10 L reactor
size, HRT of 8 h

[151]

7±1

>97
-8 to 93
14
78
8

21 L. HRT of 14 h

[155]

11

64
< 20

PVDF/HF membrane,
HRT of 24 h, 7.8 pH, 9 L
reactor

[162]

> 85 #
40-70 ##
< 30 ###

HRT 24 h, pH of 7.5,
TOC and TN Removal
efficiency >98.5 and > 66
respectively

[40]

100

HRT of 9 h (at SRT
15day), 13 h (at SRT
30day), UF and HF
membrane
Naproxen, trimethoprim
and sulfamethoxazole,
removal values represent
the removal at SRT of 15
and 30 days

[149]

NA

Bisphenol A

Aerobic
submerged

Domestic
wastewater

NA

Naphthalene sulfonate
Napthalene disulfonates
EDTA
BTSA
Diclofenac

MBR submerged

Synthetic
domestic
wastewater

22

Sulfamethoxazole
Carbamazepine

MBR submerged

Synthetic
domestic
wastewater

20

15 hydrophobic compounds *
25 hydrophilic compounds**

0.1, 5 and 20
mg/L

3 of each

750 of each

2 of each

350

623

NA

70

8.6-10

Acetaminophen, ketoprofen
Naproxen
MBR submerged

Domestic
wastewater

15

Roxithromycin

86 - 89

15 and
50 of each

30

12

57 - 64

Sulfamethoxazole

55 - 64

Ttrimethoprim

86 - 64
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Study

Submerged MBR

Wastewater

Synthetic
domestic
wastewater

T
(°C)

1824

Submerged MBR,
Conventional
activated sludge
process

Domestic
wastewater

NA

Submerged MBR

Synthetic DWW

20

Submerged MBR

Synthetic
domestic
wastewater

22

TrOCs

Feed TrOCs
concentration
(µg/L)

SRT
(days)

MLSS
(g/L)

Removal
efficiency
(%)

Carbamazepine, diclofenac &
erythromycin

<9

Diazepam

26

Ibuprofen
Naproxen

10-20 of each

77-72

10
(as
VSS)

98
84

Roxithromycin

77

Sulfamethoxazole

52

Trimethoprim

36

Ketoprofen, Naproxen,
Ibuprofen, Diclofenac,
Clofibric acid, Dicloprop

15 hydrophobic compounds *
25 hydrophilic compounds**
Sulfamethoxazole, Bisphenol
A, Carbamazepine,
Diclofenac, Ibuprofen,
Ketoprofen

20-500 ng/L
each

NA

10 in
MBR
and
1.7 in
ASP

2 µg/L

70

NA

NA

>85*

2-20 µg/L of
each

42

70

NA

<20**
*** higher
removal of
Ionisable
compounds
at lower pH

Remarks

Ref.

Pilot scale study. 220 L
reactor, pH 7.5-8.5. HRT
12 h, HF/UF membrane.
Short operating time:
(2 months acclimatization
and 2 month operation);
Target compounds cover
PhACs and musk
fragrances

[28]

MF membrane HRT of 9
and 13 h in MBR and
ASP, respectively
Near total removal of
ketoprofen, naproxen and
ibuprofen. No
considerable removal of
diclofenac and dicloprop
in both. Better removal of
clofibric in MBR.
HF -UF membrane. 9 L
volume, DO of 2±1 mg/L,
24 h HRT.
HF/UF membrane. 9 L
working volume, DO of
2±1 mg/L, 14 min suction
1 min relation operating
cycle, 24 h HRT, 4.3
L/m2.h permeate flux, pH
5,6,7,8 and 9

[153]

[37]

[21]
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Study

Wastewater

T (°C)

TrOCs

Feed TrOCs
concentration
(µg/L)

SRT
(days)

ibuprofen, naproxen,
ofloxacin, acetaminophen,
External MBR

Domestic
wastewater

20

sulfamethoxazole, atenolol,
propranolol, bezafibrate,

12–14600 ng/L

NA

20-27

1-8
(HF/UF)
7-26
(FS/MF)

70-90
50-70

loratidine, carbamazepine

<30

Bisphenol A, estrone, estriol,
17β –estradiol, ibuprofen

80-100

bezafibrate

60-100

17 α –ethinylestradiol
NA

Removal
efficiency
(%)
>90

diclofenac, famotidine,

Submerged MBR

MLSS
(g/L)

diclofenac

20-100

20, 40 &
20-3250 ng/L
82

carbamazepine
DEET

-

0-60
< 20
0-75

Carbamazepine

0-32

Bayrepel-acid

88-99

Remarks

Ref.

Pilot scale (3.6 & 4.7 m3). HF/UF
(HRT 7.2 h) and Flat sheet/MF
(HRT 15 h). 29 TrOCs. TrOCs with
moderate or low removal in FS/MF
MBR is considerably higher than the
HF/UF MBR presumably to high
HRT of the first MBR.

[29]

Pilot scale (4.2 m3), with nitrification
and denitrification capacity.
Removal efficiencies of bisphenol,
estrone, estriol, 17β –estradiol,
ibuprofen and carbamazepine were
stable with SRT. Removal efficiency
of diclofenac increased with
increasing SRT

Note:
BTSA-Bensothiazole-2-sulfonate, EDTA - Ethylenediamine tetraacetic
* hydrophobic compounds (Log D >3)- linuron, clozapine, bisphenol A, testosterone, Estrone, amitriptyline, etiocholanolone, 17β-estradiol, simvasatatin, 17α-ethinylestradiol,
triclosan, t-octylphenol, triclocarban, Nonylphenol,
** Hydrophilic compounds (Log D<3)- enalapril, atenolol,sulfamethoxazole,ketoprofen,caffeine,naproxen,paracetamol,ibuprofen,primidone,Diclofenac, sim-hydroxy acid,
meprobamate, trimethoprim, gemfibrozil, triameterene, DEET, hydroxyzine, meprazole,dilantin,trazine,risperidone,carbamezapine,verapamil,androstenedione, estriol
# Removal efficiency >86% of 11 hydrophilic and 14 hydrophobic compounds
## 5 hydrophilic compounds (ketoprofen, caffeine &naproxen, sim-hydroxy acid and omeprazole
### 10 no of hydrophilic compounds
*** Ionisable compounds; Sulfamethoxazole, ibuprofen, ketoprofen show higher removal efficiency below pH 6 and higher removal of diclofenac at pH 5 and negligible removal at
pH 7
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2.5
2.5.1

Membrane distillation
Membrane distillation technology

N
Q

Permeate (Condensing channel)

Feed (evaporating channel)

Hydrophobic
membrane

Tf
T1
T2
Cf

C1
C2

Pf

TD

CD

PD

(a)

(b)

Figure 2.3: Direct contact membrane distillation (a) configuration (b) principle

MD is a low temperature distillation process that involves the transport of
water vapour from a feed solution through the pores of a micro-porous and
hydrophobic membrane to the distillate (product) side. Because mass transfer occurs
in a gaseous phase, MD offers complete rejection of all non-volatile solutes [43].
Direct contact membrane distillation (DCMD) is probably the most widely studied
MD system configuration due to its simple operation [43, 166]. The principles of
DCMD are illustrated in Figure 2.3. In DCMD, the feed solution is maintained at a
higher temperature than the distillate; thus, creating a vapour pressure difference
between the feed and distillate. Moderately elevated temperatures (45-80 °C) are
required to obtain sufficient driving force and typically, fluxes of 2-20 L/m2.h can be
obtained [43, 49, 166]. The membrane separates the liquid phase of the feed and
distillate streams but allows water vapour to transport freely through its dry micro
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porous pores. In MD, the membrane material must be hydrophobic to prevent
wetting of the pores by liquid feed or distillate under standard operating conditions.
The vapour pressure (P°) within the membrane can be determined by the Antoine
equation [166]:
B

Po = exp [ A- C+T]

2.1

Where P° is in Pa and T is the temperature (K). Values of A,B,C constants for
pure water are 23.1964, 3816.44 K and -46.13 K respectively; for non-ideal binary
solutions, the membrane pore vapour pressure can be corrected by considering the
solute and solvent molar fractions [43, 166]. In direct contact membrane distillation,
the mass transfer and the heat transfer take place simultaneously; the total heat
transfer and molar flux are described in Equation 2.2 and 2.3 respectively [166].
1

Q = [h +h
f

1

m +N∆HV

1

⁄∆Tm

-1

+ h ] ×∆Tm

2.2

p

𝑁 = 𝑘𝑓 ∆𝑃𝑜

2.3

Where hf, hm and hp are the heat transfer coefficients of the feed, membrane

and permeate respectively, while N, ΔHv , kf and Tm are the molar flux molar heat of
vapourization, mass transfer coefficient and temperature difference between feed and
distillate side of the membrane respectively.
Mass transfer coefficient is a function of temperature, pressure and membrane
composition and membrane structure [166]. Meanwhile, ΔP° is a function of
temperature at membrane surface and membrane surface composition but not the
bulk solution conditions, thus, heat transfer rate and mass flux are related. However,
in the MD process, it is assumed that the pressure on each side of the membrane is
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equal to the saturation pressure of water at the membrane surface and the equation
2.4 can be expressed as a function of temperature drop across the membrane as
follows [166].

N =

2.5.2

K

dPo
dT

∆Tm = K

Po ∆Hv
RT2

∆Tm

2.4

Factors affecting the membrane distillation
Both the operating conditions and the membrane characteristics have been

identified as crucial factors in MD performance. It has been shown that feed
temperature, concentration and circulation velocity/stirring rate, permeate inlet
temperature, temperature difference are the dominant operating conditions affecting
the MD performances [167]. In addition, membrane hydrophobicity/contact angle,
thickness, pore size, pore size distribution, tortuosity, surface chemistry and module
geometry are the critical membrane characteristics in MD [167, 168]. Exponential
increase of membrane distillation flux has been reported with increase of feed
temperature; due to exponential increase of vapour pressure of the feed. However,
feed temperature range of 40-80 °C and permeate temperature range of 5-30°C are
recommended for MD process [43, 166, 167].
High MD flux could be obtained with high feed and permeate velocities as a
result of increased heat transfer coefficient at the feed side of the membrane and
reduced temperature and concentration polarization outside [167]. Optimising the
feed flow velocity has been recommended to maintain turbulence flow conditions
and a lower hydrostatic pressure than the liquid entry pressure to avoid membrane
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pore wetting. As reviewed by Lawson and Lloyd [166], 0.3 - 0.9 m/s and 0.1 - 0.3
m/s of feed and permeate circulation rates, respectively are widely used.
Membrane wetting is a major limitation in MD process [43, 167]. Due to the
surface tension, a pressure drop across the vapour-liquid interface generates up to the
liquid entry penetration pressure (Equation 2.5), ΔPentry; once the ΔPinterface exceeds
the ΔPentry, the liquid will penetrate into and through the pores causing the membrane
wetting. Once the membrane is wetted, feed liquid can pass through the membrane
deteriorating the permeate quality, therefore, wetted membrane is required to dry
completely before the next use. Hydrophobic membranes made of polypropylene,
polyvinylidine fluoride and polytetrofluroethylene are recommended for MD
process. Following properties also recommended for MD membranes to minimise
membrane wetting such as low resistant to mass transfer, high liquid entry pressure
of water, low thermal conductivity, high thermal stability and chemical resistance.
Pliquid - Pvapour = ∆Pinterface < ∆Pentry =

-2BγL Cosθ
rmax

2.5

Where γL , θ, rmax and B are the liquid surface tension, liquid –membrane contact

angle, largest pore size of the membrane and geometric factor determined by the pore
size of the membrane respectively.
Membrane thickness is inversely related to MD flux and heat transfer across
the membrane. Optimum thickness value has been estimated as 30-60 µm [167, 169].
Pours composite membranes with very low thicknesses (< 5µm) are also reported
[167]. The higher the membrane porosity, the higher the flux observed in MD;
membrane porosity greater than 70% is recommended for effective MD process.
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Positive correlation with MD flux and membrane pore size have been reported [43,
167]. Membranes with pore size from 0.1 to 1 µm have been widely employed for
MD and the maximum pore size of 1.0-1.2 µm is recommended to avoid membrane
pore wetting [43, 167].
2.5.3

Membrane distillation for TrOCs removal
MD can offer complete rejection of all non-volatile solutes such as inorganic

salts and pathogenic micro-organisms because mass transfer can occur only in the
gas phase. As a result, to date, much of the effort in MD research has focused on
desalination applications [43, 170-172]. Unlike pressure driven membrane processes,
due to the absence of hydraulic pressure, MD is less susceptible to membrane fouling
[170, 173]. Even when membrane fouling does occur, it is expected to be a less
compacted layer that can be easily removed [170, 174, 175].
The low operating temperature of MD allows for the utilization of solar
thermal or low grade heat as the energy source [43, 48, 166, 176-179]. Given the
advantages of high separation efficiency, low fouling propensity, and potentially low
energy consumption (when low grade heat is readily available), MD can be used for
a range of applications beyond those for brackish and seawater desalination.
Several studies have explored the use of MD for food processing, such as
whey protein recovery in dairy processing [175], polyphenolic antioxidants recovery
from olive oil wastewater [180], and orange juice concentration [181], separation of
fermentation broth [182] as well as treatment of wastewater from the textile [183]
and petrochemical industries [48], and municipal water reuse [177, 184]. Despite the
growing interest in using MD for the treatment of a range of wastewaters, there is
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still a lack of understanding of the rejection mechanisms of trace organic compounds
(TrOCs) by MD.
Only a few studies have been conducted to elucidate the rejection of specific
organic compounds by MD. The available studies are mostly concerned with
industrial chemicals such as benzene [185] and trichloroethylene [186] at an elevated
feed concentration. There have been a limited number of studies of the application of
MD for wastewater treatment. Examples of these include the investigation by Cath et
al. [184] and Cartinella et al. [187] to treat urine and hygiene wastewater by MD for
water reuse in long term space missions and the novel membrane distillation
membrane bioreactor (MDBR) concept proposed by Phattaranawik et al. [177] and
Goh et al. [50].
2.6
2.6.1

Membrane distillation bioreactor
Membrane distillation bioreactor technology
Membrane distillation bioreactor (MDBR) is a high retention MBR process

that integrates the bioreactor with a MD membrane. There are two main MDBR
configurations namely submerged and side stream MDBR (Figure 2.4). The MD
membrane can act as a barrier against the permeation of biomass, non-volatile
contaminants, low molecular weight compounds and recalcitrant compounds. In the
MDBR process, the biological reactor can be operated under thermophilic conditions
to facilitate the integration of biological treatment with MD. A thermophilic
bioprocess which operates at elevated temperature is advantageous in wastewater
treatment because of the high organic biodegradation rate, low sludge yield and
enhanced biodegradation [139]. It is also acknowledged that thermophilic wastewater
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treatment can work at higher organic loading rates than mesophilic conditions, due to
the higher microbial growth rate at elevated temperatures [139, 188]. Lower sludge
yield at thermophilic conditions [189, 190] is also an advantage in aerobic
wastewater treatment considering the high cost incurred in sludge handling. Thus,
MD would effectively couple with thermophilic bioprocesses for wastewater
treatment.

Energy

Distillate
(Product Water)

Hydrophobic
membrane

Mixed liquor
(MD feed)

Distillate
(Product Water)
Hydrophobic
membrane

MD Unit

Concentrate

Energy

Wastewater
(MBR feed)

Wastewater
(MBR feed)

Bioreactor

Bioreactor

Energy

(b) Side stream MDBR

(a) Submerged MDBR

Figure 2.4: MDBR configurations (a) Submerged and (b) Side stream MDBR
2.6.2

MDBR for wastewater treatment
The feasibility of MDBR for wastewater treatment has been recognized

because of the excellent salt rejection, low operating pressure and moderate
operating temperature. MDBR coupling a thermophilic activated sludge process
(ASP) with MD has recently been investigated. High quality effluent has been
achieved [48, 49, 177] indicating the excellent rejection of non-volatile compounds
by MD. Phattaranawik et al. [177], introduced a novel submerged MDBR by
combining thermophilic bioreactor and MD for wastewater treatment. Khaing et al.
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[48] investigated the feasibility of petrochemical wastewater treatment and reuse
using a submerged MD-MBR,where the waste heat of the petrochemical wastewater
has been used as the heat source. Excellent quality effluent was achieved regardless
of the biological activity of the reactor [48].
Fouling reduction inorder to achieve sustainable flux has been the main focus
[50, 51, 191] of MDBR investigations. Phattaranawik et al. [49] has reported rapid
flux reduction in their submerged MDBR. They [49] obtained a stable permeate flux
of 5 L/m2.h which is low compared with the typical flux of conventional MBR.
Rapid fouling due to cake layer formation is thought to be due to the rapid flux
reduction and low stable flux. Gryta [192] suggested feed pre-treatment to avoid
fouling propensity. In submerged MDBR, the rapid fouling could be due to the direct
interaction of sludge with the MD module. Fouling could also be minimised in side
stream MDBR configuration, but all the reported studies have worked only using a
submerged MDBR [48, 49, 177].
MDBR for wastewater treatment is yet to be fully understood. Importantly,
TrOC removal during MDBR is scarcely reported. Recent studies have highlighted
the challenge of removing low molecular weight and recalcitrant TrOCs by
biological based treatment processes including MBRs due to the size exclusion
mechanism. This demands a high retention MBR process, consequently MDBR
could be a promising technology assuring complete retention of TrOCs.
2.7

Summary
The occurrence of TrOCs in the aquatic environment is of significant concern

to public health and the environment as a diverse range of potential adverse effects
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on living organisms caused by TrOCs has been identified: these may include
estrogenic, mutagenic, endocrine disruption and genotoxic effects. As a result, the
removal of TrOCs during wastewater treatment has been the subject of many recent
publications.
Given the number of TrOCs and the diversity in their molecular properties,
the efﬁciency of MBRs as a barrier for some TrOCs and their removal mechanisms
need to be investigated comprehensively. The literature has mainly focused on the
fate of TrOCs in the aqueous phase and little is known about the accumulation of
TrOCs in sludge.
MD is a low temperature distillation process that involves the transport of
water vapour from a feed solution through the pores of a microporous and
hydrophobic membrane to the distillate (product) side. Because mass transfer occurs
in a gaseous phase, MD offers complete rejection of all non-volatile solutes including
non-volatile TrOCs. Unlike pressure driven membrane processes, MD is less
susceptible to membrane fouling, due to the absence of hydraulic pressure. Thus MD
can successfully use as a post treatment to completely remove TrOCs. Membrane
distillation bioreactor (MDBR) is a high retention MBR process where the MD
membrane can act as a barrier against the permeation of low molecular weight
compounds and recalcitrant compounds. Consequently, MDBR could be a promising
technology assuring complete retention of TrOCs.
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CHAPTER 3
MATERIALS AND METHODS
3.1

Introduction
This chapter describes the materials, experimental set-ups, experimental

protocol and analytical methods used in this study. Physicochemical properties of the
trace organic contaminants (TrOCs) investigated are also discussed. Further details
of experimental protocols and physicochemical properties of the TrOCs are also
given in subsequent chapters where necessary.
3.2
3.2.1

Experimental Set-ups
Aerobic membrane bioreactor
A laboratory scale membrane bioreactor (MBR) was used. A schematic

diagram and a picture of the MBR system are shown in Figure 3.1. The MBR system
consisted of a 5 L glass reactor, water bath, an inﬂuent pump, a recirculation pump,
an efﬂuent pump and an external stainless steel membrane vessel that housed a
ceramic membrane module. A tubular multi-channel ceramic membrane module
(NGK, Japan) made of alumina with a nominal pore size of 1 µm and an effective
area of 0.09 m2 was used in this system. A water bath equipped with an immersion
PID controlled heating unit (Julabo, Germany) maintained a constant temperature in
the MBR. Peristaltic pumps (Masterﬂex L/S, USA) were employed for feeding,
recirculation, and efﬂuent extraction. The inﬂuent pump was continuously operated
to provide wastewater to the reactor. The efﬂuent pump was operated employing a 15
min on and 15 min off operating cycle to provide relaxation time to the membrane
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module. This represents a longer relaxation time than that used in a typical MBR in
order to maintain a stable HRT and avoid excessive membrane fouling. The inﬂuent
pump ﬂow rate was matched to that of the efﬂuent pump to maintain a constant
reactor volume. During the experiment, the MBR was covered with aluminium foil
to minimise any loss of TrOCs from photodegradation and evaporation. The
bioreactor was aerated with an air pump (Risheng RS 9801, China) connected to a
glass diffuser to obtain the desired dissolved oxygen concentration.

(a)

(b)
Figure 3.1: (a) Schematic diagram and (b) a picture of the MBR system
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3.2.2

Direct contact membrane distillation
The laboratory scale direct contact membrane distillation (DCMD) system

used in this study is shown in Figure 3.2. The system comprised a membrane cell, a
stainless steel feed tank, a glass distillate tank, two circulation pumps (Micropump
Inc., USA), a temperature controller (Coleparmer, USA), and a heating element
(Process Technology, USA). The membrane cell was made of acrylic glass, and a
flow channel was engraved in each of the two acrylic glass blocks that make up the
feed and permeate semi-cells. The length, width, and height of each channel were
145, 95, and 3 mm, respectively. The feed solution was circulated from a stainless
steel reservoir to the membrane cell and then returned back to the feed reservoir. A
temperature sensor was placed immediately before the feed inlet to the membrane
cell. The heating element and the temperature sensor were connected to a
temperature control unit that was used to regulate the temperature of the feed
solution. Another temperature sensor was installed immediately at the outlet of the
distillate semi-cell. The temperature of the distillate was regulated using a chiller
(AquaCooler, Australia) equipped with a stainless steel heat exchanging coil
immersed directly in the distillate reservoir. Excess water was allowed to overflow
from the distillate reservoir into a glass container, placed and continuously weighed
on an analytical balance (Mettler Toledo, Switzerland). All pipes used in the DCMD
test unit were covered with insulation foam to minimize heat loss. The feed and
distillate tanks were covered with aluminium foil to minimise evaporation loss
during the experiment. At the end of each experiment, the solution volume was
measured again and the total volume loss was found to be less than 6%.
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(a)

(b)
Figure 3.2: (a) Schematic diagram and (b) a picture of the DCMD system
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3.2.3

Membrane distillation bioreactor system

(a)

(b)
Figure 3.3: (a) Schematic diagram and (b) a picture of the novel MDBR
experimental system.
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A laboratory-scale MDBR system consisting of a glass bioreactor and an
external DCMD module was used. A schematic diagram and picture of MDBR
system are shown in Figure 3.3. A peristaltic pump (Masterflex L/S, USA) was used
to continuously transfer feed wastewater to the bioreactor. The bioreactor had an
active volume of 5 L and was submerged in a water bath equipped with an
immersion heating unit (Julabo, Germany) to keep the temperature at 40±0.1 ºC. It
was also covered with aluminium foil to avoid any exposure to sunlight and heat
loss. The bioreactor was aerated using an air pump (Risheng RS 9801, China)
connected to a glass diffuser, and an overhead mixer (Heidolph Instruments,
Germany) was used to maintain homogeneity within the bioreactor. The mixed liquor
of the bioreactor was used as the feed to the external DCMD module.
The DCMD module was made of acrylic glass to minimize heat loss to the
surroundings. The flow channels were engraved in each of two acrylic glass blocks
that made up the feed and distillate semi-cells. The length, width, and height of each
channel were 145, 95, and 3 mm, respectively. The total active membrane surface
area for mass transfer was 140 cm2. Feed to the MD system (mixed liquor from the
bioreactor) was continuously pumped to the membrane cell and recirculated back to
the bioreactor. The temperature of the feed solution entering the MD cell was
monitored using a temperature sensor connected to the feed line immediately outside
the inlet. The temperature of the distillate leaving the membrane cell was monitored
using another temperature sensor located immediately after the outlet of the distillate
semi-cell. The temperature of the distillate was kept at 14.0 ± 0.1 °C using a chiller
(Neslab RTE7, Thermo Scientific, USA) equipped with a stainless steel heat
exchanging coil, which was directly immersed in the distillate reservoir. A glass
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container was used as the distillate reservoir and was placed on a digital balance
(Mettler Toledo Inc, USA) to calculate the distillate flux. Excess distillate was
pumped out from the distillate reservoir intermittently and collected in a stainless
steel container for analysis. The MD feed and distillate flow rate were monitored
using two rotameters and maintained at 1 L/min (corresponding to a cross flow
velocity of 9 cm/s). Milli-Q water (2.25 L) was used as the initial distillate. The
MDBR system was covered with insulation foam to minimize heat loss.
3.3
3.3.1

Experimental protocols
Aerobic membrane bioreactor experiments
The MBR system was inoculated with sludge obtained from the biological

nutrient removal reactor of the Wollongong Wastewater Treatment Plant
(Wollongong, Australia). The system was operated at a longer HRT (24 h) than that
in a typical MBR to maintain a relatively low membrane ﬂux and to minimise
membrane fouling since the focus of the study was on the removal of trace organic
contaminants. Excess sludge was withdrawn regularly to maintain the mixed liquor
suspended solid (MLSS) concentration in the reactor at 5.0 ± 0.5 g/L. A synthetic
wastewater was used to simulate medium strength municipal wastewater and to
maintain stable operating conditions. The wastewater characteristics are given in
Section 3.6.1. Prior to the addition of the TrOCs to the inﬂuent, the MBR system was
acclimatised over a period of time under the operating conditions for each
experiment as discussed in Section 4.2.2, Section 5.2.1, Section 6.2.2 and Section
3.3.3.
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3.3.2

Direct contact membrane distillation experiments
One set of MD experiments was conducted using a synthetic feed solution

containing approximately 5 µg/L of each TrOC in Milli-Q water. The list of TrOCs
and their physicochemical properties are discussed elsewhere (Section 3.7.1). In
another set of experiments, effluent obtained from a thermophilic MBR system was
used as the feed solution to evaluate the feasibility of combining MD with MBR.
Further details of this MBR system are discussed in Section 3.2.1 and MBR
experimental conditions are discussed in Section 6.2.2.
In all MD experiments, the feed and distillate temperatures were 40 and 20
°C, respectively, and the cross flow velocity of the feed and distillate circulation flow
was 11.7 cm/s. The initial feed volume was 10 L. The experiment was concluded
once the water recovery had reached 70% at which stage the feed and distillate
samples were collected for TrOC analysis. At the beginning of each MD experiment,
3.35 L of Milli-Q water were used as the initial make-up water. Thus, TrOC
concentration in the distillate was corrected for dilution by taking into account the
initial volume of make-up water in the distillate.
3.3.3

Membrane distillation bioreactor experiments
Prior to the MDBR experiment, the bioreactor sludge was acclimatised at 40

°C by operating the system in an MBR mode using a ceramic microfiltration
membrane module (NGK, Japan). Detailed description of the MBR system is given
in Section 3.2.1. The bioreactor system was inoculated with activated sludge from
the Wollongong Wastewater Treatment Plant (Wollongong, Australia). A synthetic
wastewater (Section 3.6.1) was used to simulate medium strength domestic
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wastewater and to maintain stable operating conditions. During the acclimatisation
period, the bioreactor was operated at a hydraulic retention time (HRT) of 24 h and a
solids retention time (SRT) of 88 d. The temperature, dissolved oxygen (DO)
concentration and conductivity of the mixed liquor were 40 °C, 2.8±0.5 mg/L, and
425 µS/cm, respectively. The mixed liquor suspended solids (MLSS) concentration
was 5.3 g/L, and under these operating conditions the mixed liquor pH remained
stable at 7.6. After the bioreactor had been acclimatised for 75 d, the ceramic
microfiltration membrane module was removed and the bioreactor was connected to
the DCMD system as discussed in Section 3.2.3. TrOCs were then continuously
introduced to the influent at a concentration of approximately 5 µg/L of each
compound. The MDBR operation commenced at a temperature and DO
concentration of 40 °C and 2.8±0.5 mg/L, respectively, and operated for 38 d. The
HRT of the MDBR was 9.6 d due to the low distillate flux of the DCMD system.
3.4
3.4.1

Membranes and membrane modules
Ceramic membrane
A multi-channel ceramic membrane module (NGK, Japan) made of alumina

with nominal pore size of 1 µm was used in the aerobic MBR system. The effective
area of the membrane was 0.09 m2. The membrane module and the membrane
characteristics are shown in the Figure 3.4 and Table 3.1, respectively.
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Figure 3.4: Ceramic membrane module
Table 3.1: Characteristics of the ceramic membrane module
Description

Characteristics

Material

Al2O3

Membrane type

Microfiltration

Module configuration

Tubular (multi-channel)

Channel Number

37
0.09 m2

Effective surface area
Nominal pore size

1 µm

Channel opening diameter

3 mm
2 m3/m2.d (or 83.3 L/m2.h)

Maximum flux
Membrane dimensions
Diameter
Length
Configuration

30 mm
250 mm
Inside-out
300oC

Maximum operating temperature
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3.4.2

Polytetrafloroethylene (PTFE) membrane
A hydrophobic microporous PTFE membrane (GE, Minnetonka, MN) was

used in the membrane distillation experiments. The average pore size, porosity,
thickness and active layer thickness of this membrane were 0.22 µm, 70%, 175 µm
and 5 µm, respectively [193]. A photo of the virgin membrane and SEM images are
shown in Figure 3.5.

(a)

(b)

(c)

Figure 3.5: (a) Picture of the membrane and SEM image of (a) virgin membrane (c)
pore of the virgin membrane
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3.5

Ceramic membrane cleaning
The ceramic membrane was chemically cleaned once the TMP reached 90

kPa. A standard ceramic membrane cleaning procedure was followed [194]. First, tap
water was flushed through the membrane to remove any foulants deposited on the
membrane. Membrane module was flushed with a mixture of 2% w/w NaOH and
NaOCl solution (400 ppm) at 60 °C for 15 min, and the NaOH and NaOCl mixture
was left inside the module for 4 hr. After that membrane was back flushed with 2%
w/w NaOH and NaOCl solution (400 ppm) solution for 30 min. Membrane module
was then flushed with water (60 °C) until the pH was close to pH 7. The clean water
flux was measured with deionised water to confirm the cleaning was completed.
3.6
3.6.1

Synthetic wastewater
Aerobic membrane bioreactor and membrane distillation bioreactor systems
A synthetic wastewater was used to simulate medium strength municipal

wastewater and to maintain stable operating conditions. The synthetic wastewater
was prepared each day by diluting a concentrated stock with Milli-Q water to obtain
100 mg/L glucose, 100 mg/L peptone, 17.5 mg/L KH2PO4, 17.5 mg/L MgSO4, 10
mg/L FeSO4, 225 mg/L CH3COONa and 35 mg/L urea [45]. The concentrated stock
solution was prepared every week and kept at 4 °C. TOC, COD, TN, NH4-N, TP,
PO4-P of feed were 160 mg/L, 550 mg/L, 29 mg/L, 0.5 mg/L, 22 mg/L, and 13
mg/L, respectively.
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3.6.2

Direct contact membrane distillation system
One set of MD experiments was conducted using a synthetic feed solution

containing approximately 5 µg/L of each TrOC in Milli-Q water. In another set of
experiments, permeate from the thermophilic ceramic MBR was used as the feed
solution, further details are included in Section 6.2.2.
3.7
3.7.1

Target trace organic contaminants
Pharmaceuticals, steroid hormones phytoestrogens, UV-filters and pesticides
A set of 29 TrOCs was selected to represent pharmaceuticals, steroid

hormones, phytoestrogens, UV-filters (i.e., active ingredients of sunscreens) and
pesticides that occur ubiquitously in municipal wastewater [2, 3, 6-8]. Analytical
grade samples of these compounds were obtained from Sigma–Aldrich (Saint Louis,
MO, USA). A combined stock solution of all TrOCs was prepared in pure methanol
and kept at –18 ºC in the dark. Concentration of stock solution was 25 µg/mL. Once
the MBR had been acclimatised, these chemicals were continually introduced into
the synthetic wastewater to obtain approximately 5 µg/L of each compound which is
similar to their occurrence in municipal wastewater [3]. TrOC stock solution of 1 mL
was added to 5 L of synthetic feed solution and the mixed feed solution was
continuously pumped to the reactor at a flow rate of 3.47 mL/min. Physicochemical
properties of these compounds were obtained from the SciFinder Scholar database
(https://scifinder.cas.org/scifinder) and detailed in Table 3.2. The vapour pressure,
molecular weight (MW), and water solubility of each selected compound were used
to calculate the Henry’s law constant at 25 °C as: H (atm.m3/mol) = Vapour pressure
(atm) × molecular weight (g/mol) / water solubility (g/m3)
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(http://www.epa.gov/superfund/health/conmedia/soil/pdfs/part_5.pdf).

The

pKH

value presented in Table 3.2 is defined as pKH = -log10H. Vapour pressure values
represent that of pure compound, thus the actual vapour pressure of a compound in
the experiment could be slightly varied. Further details of the compounds’
physicochemical properties will be described in Section 6.2.3. Molecular structures
of the selected compounds are given in Figure 3.6.
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Table 3.2: Physicochemical properties of the selected TrOCs

Compound

Compound

Molecular
Formula

Molecular
Weight
(g/mol)

Log D
at
pH 8

Water
Solubility
at 25 °C & pH
8 (mg/L)

Vapour
Pressure at
25 °C
(mmHg)

Henry
Constant at
pH 8 & 25 °C
(atm.m3/mol)

pKH at
pH 8 &
25 °C

pka

Salicylic acid

C7H6O3

138.12

-1.14

1000000

4.45 ×10-5

8.09 × 10-12

11.09

3.01

Ketoprofen

C16H14O3

254.3

-0.55

310,000

3.32×10-8

3.58 × 10-14

13.45

4.23

120,000

3.01×10

-7

7.60 × 10

-13

12.12

4.84

-7

2.0 7× 10

-12

11.68

14.44

Naproxen

Pharmaceutical
and personal
care products

Steroid
Hormones

C14H14O3

230.3

-0.18

Metronidazole

C6H9N3O3

171.15

-0.14

29,000

2.67×10

Ibuprofen

C13H18O2

206.3

0.14

433,000

1.39 ×10-4

8.71 × 10-11

10.06

4.41

-11

1.16 × 10

-14

13.93

12.26

5.16 × 10

-12

11.29

4.18

Primidone

C12H14N2O2

218.25

0.83

1,500

6.08 ×10

-7

Diclofenac

C14H11Cl2NO2

296.15

1.06

12,000

1.59×10

Gemfibrozil

C15H22O3

250.3

1.18

83,000

6.13×10-7

2.43 × 10-12

11.61

4.75

Carbamazepine

C15H12N2O

236.27

1.89

1,100

5.78×10-7

1.63 × 10-10

9.79

13.97

-6

-9

8.99

9.18

Amitriptyline

C20 H23 N

277.4

3.21

530

1.50 ×10

Triclosan

C12H7Cl3O2

289.54

4.92

2.9

3.26×10-5

4.28 × 10-6

5.37

7.80

Estriol

C18H24O3

288.4

2.53

29

1.34 ×10-9

1.75 × 10-11

10.76

10.25

5.7

1.54 ×10

-8

9.61 × 10

-10

9.02

10.25

-9

3.74 × 10

-10

9.43

10.24

1.17 × 10-9

8.93

10.27

Estrone

C18H22O2

270.36

3.62

17 α – Ethinylestradiol

C20H24O2

296.48

4.11

3.9

3.74 ×10

17 β – Estradiol

C18H24O2

272.38

4.14

3

9.82 ×10-9
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Compound

Molecular
Formula

Molecular
Weight
(g/mol)

Log D
at
pH 8

Water
Solubility
at 25 °C & pH
8 (mg/L)

Vapour
Pressure at
25 °C
(mmHg)

Henry
Constant at
pH 8 & 25 °C
(atm.m3/mol)

pKH at
pH 8 &
25 °C

17 β – Estradiol- 17acetate

C20H26O3

314.42

5.11

1.9

9.88 ×10-9

2.15 × 10-9

8.67

Clofibric acid

C10H11ClO3

214.64

-1.29

100,000

1.03 ×10-4

2.91 × 10-10

9.54

3.18

Fenoprop

C9H7Cl3O3

269.51

-0.28

220,000

2.13×10-6

3.43 × 10-12

11.46

2.93

-4

4.22 × 10

-8

7.37

4.68

5.22 × 10

-8

7.28

2.27

Compound

Pesticides

Industrial
Chemicals
Phytoestrogens

Pentachlorophenol

C11H15NO3

266.38

2.19

2900

3.49×10

-5

pka

-

Atrazine

C6HCl5O

215.68

2.64

69

1.27 ×10

Propoxur

C8H14ClN5

209.24

1.54

800

1.53 ×10-3

5.26 × 10-7

6.28

12.28

Ametryn

C9 H17 N5 S

227.33

2.97

140

1.72 ×10-6

3.67 × 10-9

8.43

3.71

-6

5.12

10.13

150.22

3.39

950

0.0361

7.51 × 10

4-tert-octylphenol

(CH3)3CC6H4
O
C14H22O

206.33

5.18
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1.98 ×10-3

8.67 × 10-6

5.06

10.15

Formononetin

C16 H12 O4

268.26

1.81

0.99

8.17 ×10-10

2.91 × 10-10

9.54

6.99

160

-13

-16

15.09

9.93

-6

5.88

-

-9

8.39

7.56

-9

8.47

-

4-tert-butyphenol

Enterolactone

C18 H18 O4

Benzophenone

C13 H10 O

UV Filters

Oxybenzone
Octocrylene

C14 H12 O3
C24 H27 N

298.33

1.88

182.22

3.21

228.24

3.42

361.48

6.89

150
390
0.36

3.29 ×10

8.23 ×10

-4

5.26 ×10

-6

2.56 ×10

-9

8.07 × 10

1.32 × 10
4.05× 10

3.38 × 10

Note: Log D represents the n-octanol/ water partition coefficient which takes into account the compound intrinsic hydrophobicity, pKa
and pH of the solution.
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Electron withdrawing groups (EWG)

EWG

X,

O

O

C NR2 ,

C OH

Salicylic acid

Ketoprofen

Primidone

Diclofenac

Electron donating groups (EDG)
O
EDG

NH2,

OH,

OR,

C

R,

Naproxen

Metronidazole

Ibuprofen

Gemfibrozil

Carbamazepine

Triclosan

Amitriptyline
(a)
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Estriol

Estrone

17 α – Ethinylestradiol

17β – Estradiol

17 β – Estradiol- 17Acetate

(b)

Clofibric acid

Propoxur

Fenoprop

Atrazine

Pentachlorophenol

(c)

Ametryne

4Bisphenol A

4- tert octylphenol
(d)

tert butylphenol
(c)
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Oxybenzone

Octocrylene

Benzophenone

(e)
Note: molecular structures were drawn using ChemBioOffice.

Enterolactone

Formononetin
(f)

Figure 3.6: Molecular Structures of the selected trace organic contaminants (a) PhACs (b) steroid hormones (c) pesticides (d) industrial
chemicals (e) UV filters (f) phytoestrogens
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3.7.2

N-nitrosamines

Table 3.3: Physicochemical properties of the selected N-nitrosamines

Compound

Structure

Molecular
weight
(g/mol)

Log D at pH
7&
25 °C

Henry’s Law
constant at
25 °C
(atm m3/mol)

74.05

-0.5

1.2×10-6

88.06

0.01

1.44×10-6

100.06

-0.09

1.99×10-7

102.08

0.52

1.73×10-6

114.08

0.44

2.81×10-7

116.06

-0.59

2.13×10-10

130.11

1.54

3.46×10-6

158.14

2.54

9.96×10-6

O
N

NDMA

N

O
N

NMEA

N

O

N

NPYR

N

O

N
N

NDEA

N
N

it

di th
h l

i

O ND

(

N
N

NPIP

N

O
N

NMOR

N

O

O

NDPA

N
N

O

NDBA

N
N

i

NDBA

Note: Properties were adopted from Fujioka et al. [13].

72

Chapter 3: Materials and methods
Eight N-nitrosamines (namely NDMA, NMEA, NPYR, NPIP, NDEA,
NMOR, NDPA and NDBA) were selected for investigation based on their
widespread occurrence in wastewater and probable carcinogenic properties. These
compounds have low log D values (Table 3.3) and thus they can be classiﬁed as
being hydrophilic. In addition, because they do not possess ionisable functional
groups, these compounds can only exist in the aquatic environment as neutral
species. All N-nitrosamines used in this study were of analytical grade and were
purchased from Sigma–Aldrich (St Louis, MO, USA). A stock solution of all eight
N-nitrosamines was prepared in pure methanol and kept at -18 °C in the dark.
Deuterated standards (N-nitrosodimethylamine-d6, N-nitrosomethylethylamine-d3,
N-nitrosopyrrolidine-d8, N-nitros-opiperidine-d10, N-nitrosodiethylamine-d10, Nnitrosomorpholine-d8, N-nitrosodipropylamine-d14 and N-nitrosodi-n¬butylamined9) were purchased from CDN isotopes (Pointe-Claire, Quebec, Canada) and used as
surrogates. The surrogate stock solution was also prepared in methanol and kept at 18 °C in the dark.
3.8
3.8.1

Analytical methods
Basic water quality analysis

3.8.1.1 Total organic carbon and total nitrogen analysis
Total organic carbon (TOC) and total nitrogen (TN) concentrations in liquid
samples were analysed using a TOC/TN-VCSH analyser with an auto sampler (ASIV) (Shimadzu, Japan). TOC -VCSH analyser combined with TNM-1 unit measured
TOC and TN simultaneously. High purity air was used as the carrier gas. TOC
analysis was conducted in non purgeable organic carbon mode (NPOC) to avoid
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analytical error caused by the varied inorganic carbon concentrations in samples.
Samples were acidified to pH 2 to convert inorganic carbon species to CO2 and
sparged with the carrier gas to drive off the CO2. Total carbon combustion was at
680 °C. Total carbon in the sample oxidised to CO2 and detected using a nondispersive infrared detector (NDIR). TN measurement is a summation of all forms of
nitrogen present in liquid phase (organic, nitrite, nitrate and ammonia). For TN
measurements, sample combustion was undertaken at 720 °C. TN in the sample
decomposes to nitrogen monoxide and is detected by chemiluminescence. Potassium
dihydrogen phthalate (KHP) and potassium nitrate (KNO3) were used as the TOC
and TN standard solutions. Standard solutions were checked with an each sample
batch and TOC/TN concentrations were corrected according to the standard curves.
3.8.1.2 Nitrate (NO3-), nitrite (NO2-) and ammonium (NH4+) analysis
NO3- and NO2- concentrations in the liquid samples were analysed by ion
chromatography. An ion chromatograph (Shimadzu, Japan) was employed equipped
with conductivity detector (CDD-10A VP), degasser (DGU-20A3), liquid
chromatograph (LC-20AD), autosampler (SIL-20 AHT) and suppressor (Dionex
RFC-10). A high-capacity carbonate based anion-exchange column (IonPac AS23,
Dionex) was used. A mixture of 4.5 mM Sodium carbonate and 0.8 mM sodium
bicarbonate was used as the eluent. Potassium nitrate (KNO3) and potassium nitrite
(KNO2) were used as the standard solutions for NO3- and NO2-, respectively. NH4+
concentration was measured according to the phenate method in accordance with
standard methods for water and wastewater examinations [195]. Absorbance at 630

74

Chapter 3: Materials and methods
nm wave length was measured by a UV-visible spectrophotometer (Shimadzu UV
1700, Japan). NH4Cl solution was used as the standard solution.
3.8.1.3 Dissolved oxygen, pH, mixed liquor suspended solids and mixed liquor
volatile suspended solids
Dissolved oxygen (DO) concentration of the bioreactor mixed liquor was
measured using Professional plus YSI equipped with Pro 20 DO probe (YSI
incorporation, USA). The pH of the liquid samples was measured using a Orion 4
Star Plus portable pH and conductivity meter (Thermo Scientific, Waltham, MA).
Mixed liquor suspended solids (MLSS) and mixed liquor volatile suspended solids
(MLVSS) concentration of the mixed liquor were analysed in accordance with the
standard methods for water and wastewater examinations [195].
3.8.2

Solvent extraction method
To determine the TrOC concentrations in the sludge, a solvent extraction

method modified from Trinh et al. [196] was used (Figure 3.7). The sludge sample
was ﬁrst centrifuged and the solid pellet was freeze-dried for 4 h (-53 °C and 0.06
mbar) using an Alpha 1-2 LD plus Freeze Dryer (Christ GmbH, Germany). The dried
sludge was ground to powder and 0.5 g was transferred into a glass test tube.
Methanol (5 mL) was added to the test tube, thoroughly mixed using a vortex mixer
(VM1, Ratek, Australia) for 3 min and ultrasonicated for 10 min at 40 °C. The
sample was then centrifuged at 3270 x g for 10 min (Alleegra X-12R, Beckman
Coulter, USA) and the supernatant was collected in a glass beaker for further
analysis. Dichloromethane (5 mL) and methanol (5 mL) were added to the remaining
pellet. The whole process of mixing, ultrasonic extraction and centrifugation was
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then repeated. The supernatants from both steps were then mixed together; Milli-Q
water added up to a volume 50 mL and residual methanol and dichloromethane
purged using nitrogen gas. Finally, Milli-Q water was added to obtain an aqueous
sample (500 mL). This sample was then analysed using the analytical method
described in Section 3.8.3, and the TrOC concentration per gram of dry sludge was
calculated.
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Sludge pellet store
in a glass beaker

Centrifuge at 3500
rpm, 4 °C for 10 min

Freeze dried for 4 hr
at -53 °C & 0.06 mbar

Ground to powder

Weigh 0.5 g into 13 mL
glass tube

Add MeOH (5 mL),
Mix thoroughly using vortex mixer,
Ultrasonicate for 10 min at 40 °C, &
Centrifuge at 3500 rpm for 10 min
Supernatant: Store in a
cleaned 500 mL glass
beaker
Sludge pellet

Add DCM:MeOH (1:1, v/v) (5 mL),
Mix thoroughly using vortex mixer,
Ultrasonicate for 10 min at 40 °C, &
Centrifuge at 3500 rpm for 10 min

Supernatant

Add 50 mL of Milli-Q water and purge residual MeOH and DCM
with gentle stream of nitrogen and dilute to 500 mL, filter through
1µm followed by 0.7 µm glass fibre filter paper for SPE analysis
Figure 3.7: Procedure for solvent extraction
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3.8.3

Analysis of pharmaceuticals, steroid hormones phytoestrogens, UV-filters
and pesticides
TrOC concentrations in the aqueous samples were determined using an

analytical method previously reported by Hai et al. (2011c). Specific sampling
frequencies for the TrOC analysis are given in Chapter 4–7. This method consists of
a solid phase extraction procedure (SPE) (Figure 3.8) followed by gas
chromatography and quantitative determination by mass spectrometry with electron
ionisation. TrOC concentrations in liquid samples (500 mL each) were extracted
using 6 mL 200 mg Oasis HLB cartridges (Waters, Milford, MA, USA). First, the
cartridges were preconditioned with 7 mL dichloromethane (DCM) and methanol
(MeOH) mixture (1:1 v/v), 7 mL methanol followed by 7 mL reagent water
(synthetic feed wastewater excluding TrOCs). The samples were acidified to pH 2-3
(4 M H2SO4) and loaded onto the cartridges at a flow rate of 1-5 mL/min. Then, the
cartridges were rinsed with 20 mL Milli-Q water (6× 7mL) and dried in a stream of
nitrogen for 30 min. The extracted TrOCs were eluted from the cartridge using 7 mL
of methanol followed by dichloromethane and methanol mixture (1:1 v/v) at a flow
rate of 1-5 mL/min. Then the eluents were evaporated using a water bath (40 °C)
under a gentle stream of nitrogen. The extracts were dissolved with 200 uL methanol
which contained 5 µg bisphenol A-d16 and transferred into 1.5 mL vials, further
evaporated under a gentle stream of nitrogen. Finally, the extracts were derivatized
by

adding

100

µL

of

N,O-Bis(trimethylsilyl)trifluoroacetamide

(1%

trimethylchlorosilane) and pyridine (dried with KOH solid), then heated in a heating
block (60–70 ºC) for 30 min. The derivatives were cooled to room temperature and
analysed using GC–MS using a QP5000 (Shimadzu, Japan) equipped with a AOC20i
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auto-sampler

and

a

Phenomenex

Zebron

ZB-5

(5%

diphenyl–95%

dimethylpolysiloxane) capillary column (30 m × 0.25 mm ID, df = 0.25 µm). The
limit of detection of the selected TrOCs by this analytical method was 20 ng/L or
lower [23].
3.8.4

N-nitrosamines analysis
N-nitrosamine concentrations were determined using solid phase extraction

(SPE), gas chromatography (GC) and analysis by tandem mass spectrometry (MS–
MS) with electron ionization (EI) using a method previously reported by McDonald
et al. [197].
Prior to the SPE procedure (Figure 3.9) the surrogate stock solution was
added to the sample to obtain a concentration of 50 ng/L of each internal standard.
The samples were then extracted using the Supelclean™ Coconut Charcoal SPE
cartridges (2 g/mL, supplied by Supelco, St. Louis, MO, USA). Extracted
compounds were eluted from the cartridges using dichloromethane (4 X 3 mL) and
concentrated to 1 mL under a slight stream of high purity nitrogen in a Turbovap LV
evaporation system (Caliper Life Sciences, Hopkinton, MA, USA). A volume of 100
µL of toluene was added to the eluted sample to minimize compound evaporative
loss. Finally, concentrated samples were transferred to 2 mL GC vials for analysis.
Samples were analysed on an Agilent 7890A GC coupled with an Agilent 7000B
triple quadrupole tandem mass spectrometer (MS/MS). An injection volume of 1 µL
was used. Analytes were separated on an Agilent DB-1701P, (30 m × 0.25 mm, 0.25
µm film thickness) column using a 1.2 mL/min ultrahigh purity helium flow. The
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quantitative detection limit of this method was less than 4 ng/L for all Nnitrosamines investigated in this study.
Liquid samples at room temperature (500 mL)
Filter through 0.7 µm glass fibre filter
Acidified to pH 2-3 (4 M H2SO4)
Label the cartridges,
connect to the vacuum
manifold & set
vacuum at 15 mmHg

Precondition the cartridge with
1) DCM:MeOH mixture (7 mL)
2) MeOH (7 mL)
3) Reagent water (7mL)

Load samples onto the
cartridges (1-5 mL/min)
(Approximately 2.5 - 3 h to
extract 500 mL sample)

Rinse samples with Milli-Q
water (6 × 7 mL)
Dry cartridges in a gentle stream of nitrogen for 30 min
Store dried cartridges in freezer (-8 °C) in a nitrogen filled bag
until analysis
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Figure 3.8: Procedure for solid phase extraction for analysing pharmaceuticals,
steroid hormones, phytoestrogens, UV-filters and pesticides
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Liquid samples (200 mL) at room temperate
(Surrogate was added immediately after sampling)
Label the cartridges (make sure
cartridges are packed well), connect
to the vacuum manifold and set
vacuum at 15 mmHg

Precondition the cartridge with
1) DCM (2 × 3 mL)
2) MeOH (2 × 3 mL)
3) Milli-Q water (4 × 3mL)
Load cartridges onto the
vacuum manifold (5 mL/min)
(Approximately 1-2 h for
200mL sample)

Rinse sample with Milli-Q
water (3 mL)
Dry cartridges in a gentle stream of nitrogen until no
condensation is left on cartridges (approximately 1 h) and store
cartridges in freezer (- 8 °C) in a sealed bag until analysis

Figure 3.9: Procedure for solid phase extraction for analysing N-nitrosamines
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3.9

Summary
This chapter described the experimental procedure used to achieve the

objectives (examine the fate and removal of TrOCs during high retention MBR) of
the study. Four laboratory scale experimental set-ups such as aerobic MBR, DCMD,
MDBR and AnMBR were used. Relevant experimental protocols and analytical
methods also discussed. A set of 29 TrOCs with diverse physicochemical properties
was used to represent pharmaceuticals, steroid hormones, phytoestrogens, UV-filters
(i.e., active ingredients of sunscreens) and pesticides that occur ubiquitously in
municipal wastewater. Eight N-nitrosamines were also selected for investigation
based on their widespread occurrence in wastewater and probable carcinogenic
properties. A synthetic wastewater was used to simulate medium strength municipal
wastewater and to maintain a stable operating condition. TrOCs removal and their
fate during each process was systematically analysed and discussed in subsequent
chapters.
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CHAPTER 4
REMOVAL AND FATE OF PHARMACEUTICALS, STEROID HORMONES,
PHYTOESTROGENS, UV FILTERS AND PESTICIDES DURING MBR
TREATMENT
Corresponding publication: K.C. Wijekoon, F.I. Hai, J. Kang, W.E. Price, W. Guo,
H.H. Ngo, L.D. Nghiem, The fate of pharmaceuticals, steroid hormones,
phytoestrogens, UV-filters and pesticides during MBR treatment, Bioresource
Technology, 144 (2013) 247-254.
4.1

Introduction
A large number of trace organic contaminants (TrOCs) have been detected in

raw sewage, treated effluent and withdrawn sludge as well as sewage-affected water
bodies all over the world. These include steroid hormones, pharmaceuticals, personal
care products, surfactants, pesticides, and disinfection by products [2-5]. In recent
years, several studies have also highlighted the ubiquitous occurrence of UV ﬁlters
and phytoestrogens in municipal wastewater as a potential concern [6-8], although
little is known about their fate during wastewater treatment. The occurrence of
TrOCs in the aquatic environment is of signiﬁcant concern to public health and the
environment because of the potential adverse impact on living organisms caused by
TrOCs, which can include a range of oestrogenic, mutagenic, endocrine disrupting
and genotoxic effects [3, 4, 7]. As a result, the removal of TrOCs during wastewater
treatment has been the subject of many recent publications.
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Appreciable removal of certain TrOCs such as natural steroid hormones and
phenolic compounds by membrane bioreactor (MBR) treatment has been widely
reported in the literature [15-25]. MBR is usually operated with a long solid retention
time (SRT) which can improve the removal of some TrOCs via adsorption onto the
sludge and subsequent biodegradation. A long SRT can also favour the proliferation
of slowly growing bacteria (such as nitrifying bacteria), thus improving the microbial
diversity in the reactor and achieving better biodegradation of TrOCs [19, 26-30].
However, given the number of TrOCs and the diversity in their molecular properties,
the efﬁciency of MBRs as a barrier for some TrOCs and their removal mechanisms is
still poorly understood. In addition, studies available in the literature have focussed
mostly on the fate of TrOCs in the aqueous phase and little is known about the
accumulation of TrOCs in sludge.
Biodegradation and/or adsorption can govern the removal of TrOCs from the
aqueous phase during MBR treatment. Molecular structure is an important factor for
TrOC biodegradation. A previous study by Tadkaew et al. [37] revealed the effect of
physicochemical properties (namely log D) and functional groups on the removal of
TrOCs. They proposed a qualitative predictive framework which stipulates that: (i)
hydrophobic compounds (log D > 3.2) and compounds which are hydrophilic (log D
< 3.2) but possess only electron donating groups (EDGs) would achieve high
removal during MBR treatment, (ii) the removal efﬁciency of hydrophilic
compounds possessing only electron withdrawing groups (EWGs) would be low, and
(iii) hydrophilic compounds having both EWGs and EDGs would achieve varying
removal depending on the type of the functional group. EWGs (e.g. amide and
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chloro) impede initial electrophilic attack by oxygenases and electron-donating
groups EDGs (e.g hydroxyl and amine) promote electrophilic attack by oxygenases
[37]. As a result, TrOCs with EWGs are less biodegradable and TrOCs with EDGs
are readily biodegradable.
Given the diverse range of emerging TrOCs, elucidation of the removal
mechanisms and subsequent development of predictive tools for the extent of the
removal of specific groups is vital to avoid continuous and expensive monitoring of
the fate of each individual compound.
Adsorption of TrOCs onto sludge is an important removal mechanism during
MBR treatment. It is noteworthy that the presence of TrOCs in sludge is of concern
especially in terms of agricultural applications. Agricultural usage accounts for 50%
of the biosolids production in Europe. As a result, the European Union regulates
these organic compounds in sludge to secure the safety of agriculture and soil [7].
Therefore, it is crucial to understand the removal of TrOCs from both aqueous and
solid phases in wastewater treatment.
There are very few reported studies on removal mechanisms of TrOCs by
MBR. Radjenovic et al. [29] investigated the fate and distribution of pharmaceuticals
in the aqueous and solid phases during the conventional activated sludge and MBR
treatment. They have identiﬁed adsorption to sludge as a possible removal pathway
for several pharmaceutical compounds such as mefenamic acid, propanolol and
loritidine. Radjenovic et al. [29] suggested that MBR, yielding higher biodegradation
rate due to the application of a prolonged SRT, could reduce the TrOC load in
sludge. In addition, Clara et al. [26, 27] and Reif et al. [28]also illustrated that
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compared to the conventional activated sludge treatment, MBR treatment results in
enhanced biodegradation of several groups of TrOCs (such as pharmaceuticals,
fragrances and endocrine disruptive compounds) due to a longer SRT.
This study aimed to provide further insight to the fate of TrOCs during MBR
treatment. Aqueous phase and solid phase removal of 29 compounds representing
several groups of TrOCs and possessing diverse physicochemical properties were
examined. The effects of hydrophobicity and molecular structure on their removal
mechanisms were elucidated. Finally, a generalised framework for predicting the
removal mechanisms and fate of TrOCs during MBR treatment is proposed.
4.2
4.2.1

Materials and methods
Membrane bioreactor system
A laboratory scale aerobic MBR system was used. Detailed description of the

set-up is given in Section 3.2.1. During the experiment, the MBR was covered with
aluminium foil to minimise any loss of TrOCs from photodegradation and
evaporation.
4.2.2

Experimental protocol
The MBR system was inoculated with sludge obtained from the biological

nutrient removal reactor of the Wollongong Wastewater Treatment Plant
(Wollongong, Australia). Glucose and peptone based synthetic wastewater (Section
3.6.1) was used to simulate medium strength municipal wastewater and to maintain a
stable operating condition. The hydraulic retention time (HRT), temperature,
dissolved oxygen concentration (DO) and mixed liquor pH were 26 h, 26.0 ± 0.2 °C,
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2.4 ± 0.3 mg/L and 7.3 ± 0.3, respectively. The system was operated at a longer HRT
than that in a typical MBR to maintain a relatively low membrane ﬂux and to
minimise membrane fouling since the focus of the study is on the removal of trace
organic contaminants. Excess sludge was withdrawn every 3–4 days to maintain the
mixed liquor suspended solid (MLSS) concentration in the reactor at 5.0 ± 0.5 g/L,
resulting in an SRT of 88 days. Prior to the addition of the trace organic
contaminants to the inﬂuent, the MBR system was acclimatised for 125 days under
the above mentioned conditions.
4.2.3

Model compounds
A set of 29 emerging TrOCs (Table 3.2) was selected to represent

pharmaceuticals, steroid hormones, phytoestrogens, UV-ﬁlters and pesticides that
occur ubiquitously in municipal wastewater. A detail description of the selected
TrOCs is given in Section 3.7.1.
4.2.4

Analytical methods

4.2.4.1 Basic water quality parameters
Basic water quality parameters such as total organic carbon (TOC) and total
nitrogen (TN) were analysed using a TOC/TN-VCSH analyser (Shimadzu, Japan). All
other basic water quality parameters relevant to the MBR process were analysed
according to the standard methods for water and wastewater examination as reported
in a previous study.[23]. A detailed description of analysis of basic water quality
parameters is given in Section 3.8.1.
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4.2.4.2 Trace organic contaminant analysis
TrOC concentrations in the influent, sludge and effluent were determined.
Ultrasonic solvent extraction method was used to extract TrOC from sludge, a
detailed description is given in Section 3.8.2. Then, TrOC concentrations in liquid
samples were determined using a method consisting SPE and gas chromatography
followed by quantitative determination by mass spectrometry as previously reported
by Hai and co-workers. [23] (Section 3.8.3).
4.3
4.3.1

Results and discussion
Total organic carbon and total nitrogen removal performances
As noted earlier, the MBR system was acclimatised for 125 days before the

continuous operation using TrOC-laden feed solution. Basic performance parameters
including the concentrations of NO2-–N, NO3-–N, and NH4+–N in feed and permeate,
TOC and TN removal efficiency, permeate turbidity, DO, pH, mixed liquor volatile
suspended solid (MLVSS) and mixed liquor suspended solid (MLSS) in the mixed
liquor were continuously monitored to assess the operational stability of the MBR
system. NO2-–N, NO3- –N, and NH4+–N concentrations in permeate were found to be
stable at less than 0.5 ± 0.2 mg/L, 14 ± 2 mg/L and 4.3 ± 0.6 mg/L, respectively
throughout this study. The negligible NO2-–N concentration in permeate indicated a
good aerobic nitrification capacity of the MBR system and could possibly be
attributed to the nitrifying bacteria-rich sludge which was used to inoculate the
reactor (Section 0). In the MBR process, the membrane can effectively retain the
slow growing nitrifying microorganisms. In addition, the long SRT used in this study
was also conducive to maintenance of a nitrifying bacteria-rich sludge within the
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bioreactor. With 164 ± 8 mg/L of TOC and 30 ± 2 mg/L of TN in the feed solution,
TOC and TN removals were stable at 90 ± 1% and 33 ± 6%, respectively (Figure
4.1). The low TN removal efficiency can be attributed to the absence of an anoxic
chamber in our lab scale MBR which is necessary for effective denitrification. In this
study, the permeate turbidity was below 0.6 NTU and a MLVSS/MLSS ratio of
around 0.8 was consistently observed throughout this study.
Trace organic removal analysis
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Figure 4.1: Variation of (a) TOC and (b) TN removal performance of MBR : MBR
operating temperature, dissolved oxygen, pH, MLSS, HRT and SRT were
maintained at 26 ± 0.2 ºC, 2.4 ± 0.3 mg/L,7.5 and 5.0 ± 0.5 mg/L, 26 h and 88 d,
respectively.
4.3.2

Removal of trace organic contaminants from the aqueous phase
The removal efficiency of each TrOC from the aqueous phase was relatively

stable over the study period (Figure 4.2), although a signiﬁcant variation in removal
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between the TrOCs was observed. All eleven hydrophobic TrOCs (i.e., log DpH 8
>3.2) used showed more than 95% removal efficiency, with octocrylene being the
only exception (88%). On the other hand, the removal of hydrophilic TrOCs varied
from as low as 27% (diclofenac) to almost complete removal (ibuprofen). Since these
TrOCs possess diverse molecular structure and functional groups (Figure 3.7), it was
not surprising that their removal efficiencies varied signiﬁcantly. Of the 29
compounds selected in this study, four showed signiﬁcantly lower removal
efﬁciencies (60% or below). Diclofenac was removed with the lowest level of
removal (27%) followed by atrazine (36%), propoxur (58%) and carbamazepine
(58%). It is noteworthy that these four compounds are hydrophilic and possess strong
EWGs such as amide and chloride in their molecular structure (Figure 3.7). Thus, the
low removal efficiency could be attributed to their low hydrophobicity and more
importantly the occurrence of strong EWGs in their molecular structure, as
previously reported by Tadkaew et al. [37]. Among the UV-ﬁlters and
phytoestrogens

selected,

formononetin,

enterolactone,

benzophenone

and

oxybenzone were highly removed (>96%) due to the presence of EDGs (hydroxyl
and methyl) in their molecular structure (Figure 3.7). By contrast, the removal of
octocrylene, with a moderately strong EWG (cyano group), was lower (67–96%) in
comparison to the removal of other selected UV-ﬁlters and phytoestrogens. Similar
removal of octocrylene [8], benzophenone [99] and considerably lower removal of
the selected phytoestrogens[84] during conventional activated sludge treatment have
been previously reported. However, their removal during MBR treatment has been
rarely studied.
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Figure 4.2:Average removal efficiency of trace organic contaminants by MBR; error bars represent the standard deviation calculated
from duplicate samples taken once a week for five weeks. Operating conditions of MBR are presented in Section 4.2.2.
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In this study, a better removal of nitrogen bearing compounds (where
nitrogen is bound to the cyclic structure - atrazine, primidone, metranidazole,
carbamazapine, diclofenac and propoxur) was observed (Figure 4.2) in comparison
to several previous studies [37, 40]. For instance, a near-complete removal of
primidone was observed which was in contrast to the very low removal efficiency
(<13%) previously reported by Tadkaew et al. [37]. A higher removal of atrazine
(36%) than that reported (<5%) in Tadkaew et al. [37]. and Alturki et al. [40] was
also observed. Notably, Bouju et al. [157] reported the highest reported removal of
atrazine to date (approximately 40%) through a genetically modiﬁed bacterial strain.
Relatively high removal of diclofenac and carbamezapine was observed compared to
removal (<17%) reported by Alturki et al. [40] and Tadkaew et al. [37] (Figure 4.2).
However, amitriptylene, a nitrogen bearing compound where nitrogen is bound to the
aliphatic chain, showed similar removal efficiency (95%) to that reported by
Tadkaew et al. [37]. Major differences in experimental design between Alturki et al.
[40], Tadkaew et al. [37] and the current study are in the membrane type and the seed
sludge (Table 4.1). Because of the development of a cake layer over the membrane in
MBR, the effect of type of microﬁltration/ultraﬁltration membranes on TrOC
removal is negligible. On the other hand, in the current study, seed sludge was
obtained from a biological nutrient removal reactor of a full scale sewage treatment
plant, while the seed sludge for the previous studies by Alturki et al. [40] and
Tadkaew et al. [37] was from a conventional activated sludge treatment process.
Therefore, the signiﬁcant difference in the removal of atrazine and other nitrogen
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bearing compounds between our current and the previous studies could possibly be
attributed to the microbial composition of the seed sludge.
Table 4.1: Comparison of operating conditions of previous studies and the current
investigation
Parameter

Tadkaew et al. [37]

Current Study

20.0±0.1

26.0 ± 0.2

DO (mg/L)

2±1

2.4 ± 0.3

HRT (h)

24

26

SRT (days)

70

88

Synthetic wastewater simulating

Synthetic wastewater simulating

municipal wastewater

municipal wastewater

ZeeWeed

Ceramic

(Hollowfiber, ultrafiltration)

(Tubular, microfiltration)

Configuration

Submerged

External

Seed Sludge

Activated

Temperature (°C)

Feed

Membrane module

sludge

from

Nitrifiers-rich

sludge

nutrient

from

conventional organics removal

biological

removal

aerobic tank of a full scale plant.

reactor of a full scale plant.

MBR can prevent the washout of slow-growing microorganisms like nitrifiers
[27]. Enhanced removal of TrOCs (such as natural and synthetic steroid hormones,
halogenated hydrocarbons and phenolic compounds) by nitrifying bacterial strains
has been confirmed in previous studies [15-17, 25]. Furthermore, in the present work
the applied SRT (88 d) was sufficiently long, which facilitated the improved removal
of the nitrogenous TrOCs mentioned above. Noting further the distinct behaviour of
the nitrogenous TrOCs with the nitrogen containing moiety bound to the aliphatic
chain or the cyclic structure, it is possible that removal of nitrogen bearing
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compounds, where nitrogen is bound to the cyclic structure, is selectively enhanced
by the nitrifying microbial consortium. A detailed study on the effect of the location
of nitrogen molecules in nitrogenous TrOCS on their degradation by nitrifiers would
be required to substantiate this; however, it is beyond the scope of this study. More
importantly, in line with that from the available reports, our results point to the role
of nitrifiers in TrOC removal enhancement.
4.3.3

Fate of trace organic contaminants during membrane bioreactor treatment
Stable concentrations of most of the TrOC were observed in both the liquid

and solid (sludge) phases during MBR treatment (Figure 4.3), demonstrating the
stability of the TrOC removal performances of the MBR. Permeate concentrations of
almost all hydrophobic compounds were low with octocrylene being the only
exception. In contrast, the concentrations of hydrophilic compounds in permeate
varied over a wide range.
Among the selected TrOCs, traces of some compounds (carbamazepine,
diclofenac, fenoprop, ketoprofen, gemfibrozil, 4-tert butylphenol and octocrylene)
were detected in the inoculating sludge even before the TrOCs were introduced to the
synthetic feed. This is because the seeded sludge was obtained from a domestic
wastewater treatment plant. Various levels of adsorption of the TrOCs onto the
sludge were observed once the TrOCs had been introduced to the MBR system.
Immediately after introducing the TrOCs, all compounds were detected at higher
concentrations compared to their concentration in initial samples (Figure 4.4).
Subsequently, no clear relationship was observed with TrOC concentration in sludge
with time except for naproxen, diclofenac and amitriptyline. Concentration of
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naproxen in sludge gradually reduced over time whereas amitriptyline concentration
in sludge increased with time. This could be due to the hydrophilicity of naproxen
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Figure 4.3: Average concentration of trace organic contaminants in (a) feed and
permeate streams, and (b) sludge of MBR system. Error bars of the feed and
permeate data represent the standard deviation of duplicate samples taken once a
week for five weeks. Error bars of sludge data represent the standard deviation of
duplicate samples taken once a week for four weeks.
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Figure 4.4: Variation of trace organic contaminant concentration in sludge with time in MBR
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On the other hand, the variation of diclofenac concentration in sludge could
be attributed to the low biodegradability caused by the complex structure regardless
of the hydrophilicity (log DpH 8= 1.06) as discussed below. A significant amount of
salicylic acid, fenoprop, naproxen, diclofenac, carbamazepine, amitriptyline,
triclosan and octocrylene remained adsorbed to biosolids throughout the experiment.
Two factors may be responsible this, namely high hydrophobicity and low
biodegradability. Interestingly, despite the high hydrophobicity, most of the
hydrophobic compounds exhibited very low solid phase concentration. Among the
11 hydrophobic compounds studied, only triclosan, octocrylene and amitriptyline
were detected in sludge at significant concentrations. Triclosan was most abundant in
the solid phase (1277 ng/g) followed by octocrylene and amitriptyline. In contrast,
despite their low hydrophobicity (log DpH

8

< 3.2), a few persistent hydrophilic

compounds (fenoprop, diclofenac, and carbamazepine) were consistently detected at
high concentrations in biosolids. Our results indicated that biodegradability was an
important factor governing the residual amount of TrOCs in biosolids. It was also
noted that stable amounts of these compounds in sludge over the experimental period
could be due to the periodic discharge of sludge from the system.
These results confirm that the removal mechanisms and the fate of TrOCs
(Figure 4.5) are governed by their molecular properties. The concentration of the
TrOCs in the solid phase increased after they had been introduced into the synthetic
wastewater only if they contained EWGs and/or were hydrophobic. In fact, other
than triclosan and octocrylene, the solid phase concentrations of all nine compounds
with log D at pH 8 of above 3.2 but containing no EWGs in their molecular structure
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were negligible. On the other hand, higher concentrations of triclosan and
octocrylene in sludge were due to their very high log D (of 4.92 and 6.89 at pH 8,
respectively) and the presence of EWG (i.e. chloride and cyano group, respectively).
Notably, mass balance calculations revealed that adsorption onto solid phase
accounted for 50 and 26% the overall loading of triclosan and octocrylene,
respectively, during MBR treatment (Figure 4.5). This signifies that strong EWG
(chlorine atoms in triclosan) could cause compounds to accumulate in sludge more
than for compounds with moderate EWG in their structure (cyanide group in
octocrylene) even if the latter may be more hydrophobic (in this case, octocrylene
(log DpH 8 = 6.89) possesses more hydrophobicity than triclosan (log DpH 8 = 4.92).
This also demonstrated that adsorption facilitated the occurrence of biodegradation
of TrOCs during MBR operation where the long SRT of the MBR system enhanced
the biodegradation of hydrophobic compounds due to adsorption to the sludge [19,
27, 29]
During MBR treatment, the concentrations of persistent hydrophilic/or
moderately hydrophobic compounds (e.g. propoxur, diclofenac, carbamazepine, and
atrazine) in the solid phase were low and adsorption to sludge could only account for
a small fraction (5%) of their fate (except for carbamazepine) (Figure 4.5). Despite
being a very recalcitrant compound with moderate hydrophobicity (log D pH 8 =1.89)
due to the presence of an amide functional group [37], carbamazepine, could
significantly accumulate in sludge. Although the overall aqueous phase removal of
carbamazepine ranged between 47% to 70% (Figure 4.2), the actual extent of
biodegradation/transformation did not exceed 26% (Figure 4.5).
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Figure 4.5: Fate of the selected trace organic contaminants during MBR treatment. Operating conditions of MBR are given in Section
4.2.2.
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4.3.4

Removal mechanisms
Trace organic contaminants

Log D < 3.2

Persistent
(contain EWGs)

Low biodegradation (< 50%)
Negligible to low sludge accumulation
(< 20%)

Log D > 3.2

Non persistent
(contain EDGs)

High biodegradation (> 70%)
Negligible sludge accumulation (< 10%)

(< 20 %)
High removal
Low aqueous phase removal
Persistent
(contain EWGs)

Moderate biodegradation (< 70%)
High sludge accumulation (up to 50%)

High removal

Non persistent
(contain EDGs)

High biodegradation (> 75%)
Low sludge accumulation (< 20%)

High removal

Figure 4.6: TrOC removal mechanisms during MBR treatment. Percentages of
biodegradation and accumulation in sludge are with respect to the influent loading.
EWGs and EDGs represent the electron withdrawing functional groups and electron
donating functional groups, respectively.

Results from this study demonstrate a clear dependence of TrOC molecular
structure on their removal mechanism and their fate in aerobic MBR. It appeared that
the removal mechanisms and the fate of TrOCs were governed, in addition to
hydrophobicity (log D), by the presence of EWGs or EDGs in their structure. Thus,
the removal mechanism and the fate of TrOCs could be predicted by assessing the
presence of EWGs and/or EDGs in their structure and their log D. Based on the
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TrOC concentrations in aqueous and solid phases as well as the extent of their
biodegradation/transformation, a generalised framework to predict the removal
mechanisms of TrOCs during MBR treatment was proposed in Figure 4.6.
4.4

Conclusion
This study investigated both the solid (sludge) phase and aqueous phase

removal of TrOCs and their fate during MBR treatment. The fate of TrOCs during
MBR

treatment

was

governed

by

both

biodegradation

and

adsorption.

Biodegradation was the predominant removal mechanism of the hydrophilic TrOCs
from the aqueous phase. The removal of hydrophobic TrOCs from the aqueous phase
could occur via adsorption. However, readily biodegradable hydrophobic TrOCs did
not accumulate significantly in sludge. Additionally, recalcitrant TrOCs which are
moderately hydrophobic or even hydrophilic could accumulate significantly in the
sludge.
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CHAPTER 5
REMOVAL AND FATE OF N-NITROSAMINES DURING MBR
TREATMENT
Corresponding publication: K.C. Wijekoon, T. Fujioka, J.A. McDonald, S.J. Khan,
F.I. Hai, W.E. Price, L.D. Nghiem, Removal of N-nitrosamines by an aerobic
membrane bioreactor, Bioresource Technology, 141 (2013) 41-45.
5.1

Introduction
N-nitrosamines are an emerging class of trace organic contaminants of

signiﬁcant health concern. They have been widely detected at trace levels (of the
order of a few nanograms per litre) in several environmental matrices including raw
sewage, secondary treated effluent, and even drinking water [9-11]. In particular,
elevated concentrations of N-nitrosamines have been reported in some wastewater [9,
11, 12]. N-nitrosamines can originate from both industrial and domestic wastewater
discharges. They can be generated as by-products from a range of industrial
processes where amines are in contact with nitrite, nitrous acid and nitrogen oxides.
Consequently N-nitrosamines frequently occur in wastewater discharges from
industries such as tanneries, circuit board manufacturing, dye manufacturing, metal
casting, rubber manufacturing, metal working and food processing [88]. They may
also be present in commercial products such as antifreezes, pesticides, detergents,
processed meats, beverages, cigarette ﬁlters and cosmetics [12]. It is estimated that
up to several hundred micrograms per litre of N-nitrosamines can be found in either
untreated or treated industrial discharges from the above industries [11]. In addition
to industrial wastewater discharge, domestic wastewater also contributes to the Nnitrosamines load in wastewater [11]. The occurrence of N-nitrosamines in domestic
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wastewater can be attributed to the consumption of amines and nitrate rich food,
cosmetics as well as household detergents. Furthermore, chloramination or
chlorination of drinking water can also contribute to the elevated N-nitrosamines
concentration in domestic wastewater [11, 12].
Most N-nitrosamines have been classified as probable human carcinogens by
the US Environmental Protection Agency [13]. Their carcinogenic effects have been
detected even at several nanograms per litre (ng/L) [35]. Therefore, some Nnitrosamines have been regulated in both drinking water and recycling water
guidelines. For example, the Australian Guidelines for Water Recycling sets the
maximum value for N-nitrosodimethylamine (NDMA) and N-nitrosomorpholine
(NMOR) at 10 and 1 ng/L, respectively [13]. Other N-nitrosamines of concern to
water authorities include N-nitrosomethylethylamine (NMEA), N-nitrosopyrrolidine
(NPYR), N-nitrosodiethylamine (NDEA), N-nitrosodipropylamine (NDPA), Nnitrosopiperidine (NPIP), and N-nitrosodi-n-butylamine (NDBA). Considering the
probable adverse effects of the environmental occurrence of nitrosamines, their
removal from wastewater is of paramount importance for the protection of public
health and the environment.
N-nitrosamines appear to be biodegradable under both aerobic and anaerobic
conditions. A number of studies have investigated their biodegradability in soils,
groundwater, river bed sludge and isolated microbial cultures [31-34]. Bradley et al.
[31] reported more than 54% biodegradation of NDMA in soil from a wastewater
reclamation facility under both oxic and anoxic conditions. Drewes et al. [32]
conducted a laboratory scale study of the removal of seven N-nitrosamines under
conditions relevant to groundwater recharge operations. Half-lives of these seven Nnitrosamines were in the range from 1.3 to 7 days. However, Drewes et al. [32] also
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noted some variation in the biodegradation rate of N-nitrosamines and that complete
removal of N-nitrosamines would require the establishment of an adapted microbial
community over several weeks or months. In a more recent study, Zhou et al. [34]
monitored the fate and transport of NDMA in groundwater being recharged with
recycled water and reported that up to 80% of the recharged mass of NDMA could
be biodegraded. The half-life of NDMA under a recharge condition was 69.4 days
[34]. Notably, only a few studies have reported the removal of N-nitrosamines from
either industrial or domestic wastewaters by the conventional activated sludge (CAS)
treatment process [11, 12, 35, 36]. One of the most comprehensive studies to date, by
Krauss et al. [12], looked at the fate and removal of N-nitrosamines in 21 full scale
conventional wastewater treatment plants in Switzerland. They reported that the
removal efficiencies from the aqueous phase by activated sludge treatment were
generally above 40% for NMOR and over 60% for all other N-nitrosamines. The
authors also noted the high variation in the removal efficiency of N-nitrosamines
amongst the 21 full scale plants investigated [12]. In comparison to the CAS
treatment process, very little is known about the efficiency of membrane bioreactor
(MBR) for the removal of N-nitrosamines during wastewater treatment. An MBR
efficiently combines biodegradation and membrane filtration in a single step,
compact process, and offers flexibility in operation and expansion as compared to
CAS processes [144]. It is also potentially more suitable for water recycling
applications and the removal of trace organic compounds [24, 30, 37]. Hatzinger et
al. [36] recently reported a novel aerobic laboratory scale propane-fed MBR for the
removal of NDMA from artificial groundwater. This appears to be the only study,
which has investigated the removal of N-nitrosamines by MBR treatment to date.
These authors reported over 99.9% removal of NDMA. Given the unique

105

Chapter 5: Removal and fate of N-nitrosamines during MBR treatment
configuration and operating condition of their propane-fed MBR, the results by
Hatzinger et al. [36] in case of groundwater may not be representative for a typical
MBR used for wastewater treatment.
This study aims to increase our understanding of the removal of Nnitrosamines by MBR during wastewater treatment. The fate and removal of eight Nnitrosamines were systematically evaluated by a laboratory scale aerobic MBR by
monitoring their concentrations in both the aqueous and sludge phases. Removal
mechanisms of the selected N-nitrosamines were also elucidated by relating the
removal efficiencies to their molecular structures.
5.2
5.2.1

Materials and methods
Membrane bioreactor system
A laboratory scale MBR system was used in this study. Detailed description

of the MBR set-up is given in Section 3.2.1. During the entire experiment, the MBR
system was covered with aluminium foil to avoid any exposure to sunlight to prevent
any possible photolysis of the N-nitrosamines. The system was operated at constant
conditions. The hydraulic retention time (HRT), temperature, dissolved oxygen
concentration (DO) and mixed liquor pH were 24 h, 30 ± 0.1 °C, 2.68 ± 0.47 mg/L
and 7.3 ± 0.2, respectively. The mixed liquor suspended solid (MLSS) concentration
in the reactor was maintained at 5.0 ± 0.5 g/L by regular withdrawal of the excess
sludge every 4–5 days, resulting in a sludge retention time of approximately 175
days. The relatively low MLSS concentration and high HRT value used here were
necessary to avoid membrane fouling and ensure a stable operating condition
throughout the experiment.
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5.2.2

Target N-nitrosamine compounds
Eight N-nitrosamines (namely NDMA, NMEA, NPYR, NPIP, NDEA,

NMOR, NDPA and NDBA) were selected for investigation based on their
widespread occurrence in wastewater and probable carcinogenic properties. Detailed
description of the N-nitrosamines is given in the Section 3.7.2.
5.2.3

Synthetic wastewater
Glucose and peptone based synthetic wastewater was used in this study to

simulate medium strength domestic wastewater, the composition of which is given in
Section 3.6.1. The synthetic wastewater was prepared each day by diluting the
concentrated stock with Milli-Q water. A required volume of the N-nitrosamine
stock solution was added to prepare a synthetic wastewater with approximately 250
ng/L of each N-nitrosamine.
5.2.4

Analytical methods
TOC and TN were analysed using a TOC/TN-VCSH analyser (Shimadzu,

Japan) (Section 3.8.1). All other basic parameters of the MBR process were analysed
according to the standard methods for water and wastewater examination as reported
in a previous study [23] (Section 3.8.1).
5.2.5

N-nitrosamine analysis
Nitrosamines concentration in feed, permeate and sludge were analysed. N-

nitrosamines were extracted from sludge using a solvent extraction method discussed
in Section 3.8.2 and aliquot sample volume was 200 mL. N-nitrosamine
concentrations in aqueous aliquot samples were determined using solid phase
extraction (SPE), gas chromatography (GC) and analysis by tandem mass
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spectrometry (MS–MS) with electron ionization (EI) using a method previously
reported. [197] as discussed in Section 3.8.4.
5.3
5.3.1

Results and discussion
Biological performance of the membrane bioreactor system
Prior to the main experimental phase of the study, the MBR system was

acclimatised for four months under constant operating conditions. Synthetic feed
solution simulating domestic wastewater was used to ensure a consistent feed
composition. Throughout this acclimatisation period, the effluent quality was stable.
N-nitrosamines were introduced to the feed solution and the MBR system continued
to operate under the same conditions to maintain operational stability. TOC and TN
concentrations of the feed solution were 167.3 ± 8.0 mg/L and 29.8 ± 0.7 mg/L
respectively. Key operational parameters including DO and pH were continuously
examined to affirm the biological stability of the MBR. As expected, the
performance of the MBR system with respect to a range of basic performance
parameters, such as TOC removal, TN removal, permeate turbidity, DO and the ratio
of MLVSS/MLSS were stable throughout this study. Both TOC and TN removals
were stable at 88 ± 0.8% and 48.3 ± 4%, respectively. The low TN removal
efficiency observed here can be attributed to the absence of an anoxic chamber in our
lab scale MBR which is necessary for an effective denitrification process. Turbidity
of the MBR permeate was always below 0.7 NTU with an average of 0.46 ± 0.12
NTU. The MLSS concentration in the reactor was maintained at 5.0 ± 0.5 g/L by
withdrawing excess sludge every 4–5 days, resulting in a theoretical sludge retention
time of approximately 175 days. The MLVSS/MLSS ratio of the sludge was constant
at 0.79 ± 0.02 throughout this study. In addition, MBR system was operated at a
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transmembrane pressure below 90 kPa with no abnormal variation in transmembrane
pressure being observed throughout the entire study.
5.3.2

Fate and transport of N-nitrosamines during aerobic MBR treatment
Fate and transport of the eight N-nitrosamines investigated in this study by

MBR treatment are shown in Figure 5.1. Relatively constant concentrations of most
N-nitrosamines in the aqueous and solid (sludge) phase can be observed (Figure 5.1).
However, some variations were noted in the removal of NPYR and NPIP. Similar
temporal variations in the removal rate of NDMA and NMOR by conventional
wastewater treatment plants have also been reported in the literature [11, 12]. Given
the relatively stable operating conditions of the current study, the small temporal
variations described here could possibly be attributed to the sensitivity of Nnitrosamines removal in wastewater treatment.
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Figure 5.1: (a) Average concentration of the selected N-nitrosamines in feed and
permeate streams of MBR system; error bars represent the standard deviation of ten
consecutive measurements (b) Average concentration of the selected N-nitrosamines
in sludge over the experimental period; error bars represent the standard deviation of
four consecutive measurements. MBR operating temperature, dissolved oxygen, pH,
MLSS, HRT and SRT were maintained at 30 ±0.1 °C, 2.68 ± 0.47 mg/L, 7.3 ± 0.2
and 5.0 ± 0.5 mg/L, 24 h and 175 days respectively.
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Fate and transport of trace organic contaminants during MBR treatment can
be governed by biodegradation, adsorption, photolysis and volatilization. UV
oxidation or photolysis can be an important removal mechanism of N-nitrosamines
[9]. However, in this study, as described in Section 5.2.1, the MBR system was
covered with aluminium foil to prevent any accidental photolysis of N-nitrosamines.
In addition, all eight N-nitrosamines selected for this investigation have very low
Henry’s Law constants (Table 3.3). As a result, their volatilization due to aeration is
expected to be negligible. N-nitrosamines concentration in solid phase was
insignificant due to their hydrophilic nature which is reflected by their low log D
values (Table 3.3). In addition to its relatively low removal from the aqueous phase,
NMOR was detected in the solid phase at approximately 22 ng/g, which was slightly
higher than most of the other N-nitrosamines. This can be attributed to the
persistence of NMOR to biodegradation, which will be discussed further in the next
section. A signiﬁcant variation in the concentration of NDMA in the sludge phase
was also observed. However this is likely to be due to an error during sample
preparation and analysis. Overall, it is clear that biodegradation (or transformation)
governed the fate of all eight N-nitrosamines selected in this study during MBR
treatment (Figure 5.2).
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Figure 5.2: Overall fate of the N-nitrosamines during MBR treatment.
5.3.3

Removal mechanisms of N-nitrosamines during membrane bioreactor
treatment
The removal efficiencies of NDMA (94%), NMEA (87%), NDEA (88%),

NDPA (51%), NDBA (76%), NPYR (58%), NPIP (65%), and NMOR (24%)
obtained in this study are comparable with their removal efficiencies by the CAS
treatment process previously re-ported by Krauss et al. [12] Sedlak et al. [11]. In a
comprehensive survey of 21 full scale conventional wastewater treatment facilities,
Krauss et al. [12] reported that the removal efficiencies of most N-nitrosamines were
generally above 60%. They also singled out NMOR as a persistent compound
amongst the seven N-nitrosamines investigated in their study. However, their
reported removal efficiency of NMOR (40%) was higher than that obtained in this
study (24%).
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As discussed in Section 5.3.2, the removal of N-nitrosamines can be
attributed mainly to their biodegradability. It appears that biodegradation of Nnitrosamines can be qualitatively predicted based on their molecular structure
according to the framework proposed recently by Tadkaew et al. [37]. Indeed, the
removal efficiencies of N-nitrosamines reported here (Figure 5.3) are, in general, in
the order of acyclic (NDMA, NMEA, NDEA, NDPA, and NDBA) > alicyclic
(NPYR and NPIP) > morpholine (NMOR). According to Knackmuss [129], the
initial electrophilic attack by oxygenases of aerobic bacteria is often a rate-limiting
step and the first of a chain of reactions responsible for the biodegradation of many
organic compounds. As a result, the presence of electron withdrawing functional
groups (EWGs) generates an electron deficiency and thus renders the compounds
less susceptible to oxidative catabolism. Electron donating functional groups
(EDGs), on the other hand, render the molecules more prone to electrophilic attack
by oxygenases of aerobic bacteria. Thus, biodegradation of trace organic compounds
can be predicted based on the occurrence of EWGs or EDGs in their molecular
structure [37]. Organic compounds with strong EWGs (such as halogens and nitroso)
are more likely to be persistent to biodegradation. In contrast, organic compounds
with strong EDGs (such as hydroxyl and alkyl) are readily amenable to
biodegradation.
The molecular architecture of N-nitrosamines consists of both EWG (i.e.
nitroso) and EDG (i.e. amine or morpholine). Nitroso is a strong EWG while amine
is a strong EDG [198]. Thus, all N-nitrosamines except NMOR are quite amendable
to MBR treatment despite the presence of the nitroso functional group. In addition,
their removal efficiencies can be explained to some extent based on the strength of
their electron donating functional groups. The electron donating capacity of amines
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is influenced by the alkyl chains by the inductive effect [198]. The inductive effect is
weakened as the length of the aliphatic chain increases [198]. Similarly, acyclic alkyl
amines have a stronger electron donating capacity than that of alicyclic alkyl amines
[198]. As a result, NDMA with two methyl functional groups exhibited the highest
removal efficiency amongst all N-nitrosamines investigated here. Furthermore, in
general, acyclic N-nitrosamines were better removed by MBR treatment than their
aliphatic counterparts. The oxygen atom in the morpholine functional group
substantially reduces its electron donating capacity. As a result, NMOR removal is
dominated by the strong EWG nitroso. In good agreement to the qualitative
framework proposed by Tadkaew et al. [37], NMOR is persistent to biodegradation
and this compound exhibited the lowest removal efficiency by MBR treatment
amongst all eight N-nitrosamines studied here.
Better removal of acyclic N-nitrosamines in comparison to their alicyclic
counterparts is also consistent with their potential biodegradation pathways given in
the Biocatalysis/Biodegradation Pathway Database of the University of Minnesota
(https://umbbd.ethz.ch/predict/).

The

aerobic

biodegradation

of

acyclic

N-

nitrosamines (NMEA, NDEA and NDPA) is likely to be initiated by converting the
aliphatic backbone to an alcohol. In fact, demethylation has been identiﬁed as a key
metabolism pathway of NDMA in mammalian cells [33]. On the other hand, the
aerobic biodegradation of NMOR can possibly be initiated by converting the
unsubstituted cyclic ether to hydroxyl cyclic ether, which has a much higher energy
barrier than the demethylation process. This difference in the potential aerobic
biodegradation pathways could possibly explain for the reported lower removal of
NMOR compared to the other acyclic N-nitrosamines. In addition to the effect of
molecular structure on nitrosamines removal, the microbial population of the

114

Chapter 5: Removal and fate of N-nitrosamines during MBR treatment
biomass might also influence the removal of N-nitrosamines. Nevertheless, detailed
analysis of the microbial population diversity of the biomass is beyond the scope of
the current study.
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Figure 5.3: Average removal efficiency of selected N-nitrosamines by MBR; error
bars represent the standard deviation calculated from ten consecutive removal
efficiency measurements. MBR Operating conditions are given in Figure 5.1
5.4

Conclusion
Biodegradation is the predominant removal mechanism for N-nitrosamines.

Adsorption to sludge was negligible while photolysis and volatilization were not
expected to occur. N-nitrosamine removal efficiencies were dependent on their
molecular structure, and ranged from 24% to 94%. The results could be explained by
the presence of EWGs and EDGs (and their relative strength) in the N-nitrosamine
molecules. N-nitrosamines possessing strong EDGs such as dimethyl-amine and
diethyl-amine (e.g. NDMA and NDEA) are readily biodegradable during MBR
treatment. By contrast, NMOR which has the weak EDG morpholine was persistent
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to biodegradation and its removal efficiency by MBR treatment was correspondingly
the lowest.
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CHAPTER 6
REJECTION AND FATE OF TRACE ORGANIC CONTAMINANTS (TROC)
DURING MEMBRANE DISTILLATION
Corresponding publication: K. C. Wijekoon., F. I. Hai., J. Kang., W. E. Price., T. Y.
Cath., L. D. Nghiem. 2013. Rejection and fate of trace organic compounds (TrOCs)
during membrane distillation. Journal of Membrane Science, 453 (636-642).
6.1

Introduction
Membrane distillation (MD) is a low temperature distillation process that

involves the transport of water in the vapour phase from a feed solution through a
microporous and hydrophobic membrane to the distillate (product) side. Direct
contact membrane distillation (DCMD) is probably the most widely studied MD
system configuration due to its simplicity [43, 166]. In DCMD, the feed solution is
maintained at a higher temperature than the distillate, thus creating a vapour pressure
difference between the feed and distillate. The membrane separates the liquid phase
of the feed and distillate streams but allows water vapour to transport freely through
its dry micro porous pores. In MD, the membrane material must be hydrophobic to
prevent flooding of the pores by liquid feed or distillate under standard operating
conditions. Because mass transfer can occur only in the gas phase, MD can offer
complete rejection of all non-volatile solutes such as inorganic salts and pathogenic
micro-organisms. As a result, to date, much of the effort in MD research has focused
on desalination applications [43, 170-172].
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Unlike pressure driven membrane processes, MD is less susceptible to
membrane fouling, due to the absence of hydraulic pressure [170, 173]. Even when
membrane fouling does occur, it is expected to result in a less compacted layer that
can be easily removed [170, 174, 175]. The low operating temperature of MD allows
for the utilization of solar thermal or low grade heat as the energy source [43, 48,
166, 176-179]. Given the advantages of the high separation efficiency, low fouling
propensity, and potentially low energy consumption (when low grade heat is readily
available), MD can be used for a range of applications beyond those for brackish and
seawater desalination. Several studies have explored the use of MD for food
processing, such as whey protein recovery in dairy processing [175], polyphenolic
antioxidants recovery from olive oil wastewater [180], and orange juice
concentration [181], separation of fermentation broth [182] as well as treatment of
wastewater from the textile [183] and petrochemical industries [48], and municipal
water reuse [177, 184].
Despite the growing interest in using MD for treatment of a range of
wastewaters, there is still a lack of understanding of the rejection mechanisms of
trace organic contaminants (TrOCs) by MD. TrOCs have been frequently detected in
raw sewage and biologically treated effluent at concentrations ranging from several
ng/L to several µg/L [2, 3, 6-8]. As a result, the removal of these TrOCs from
secondary treated effluent by advanced treatment processes such as nanofiltration
(NF), reverse osmosis (RO), oxidation and activated carbon adsorption has been
extensively investigated in recent years [40, 42, 199-201]. Nevertheless, only a few
studies have been conducted to elucidate the rejection of specific organic compounds
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by MD. Moreover, the available studies are mostly concerned with industrial
chemicals such as benzene [185] and trichloroethylene [186] at an elevated feed
concentration.
Given the concerns associated with human and environmental exposure to
TrOCs, it is important to elucidate their fate and transport during MD, particularly in
water reuse applications. Examples of these include the investigation by Cath et al.
[184] and Cartinella et al. [187] to treat urine and hygiene wastewater by MD for
water reuse in long term space missions and the novel membrane distillation
membrane bioreactor (MDBR) concept proposed by Phattaranawik et al. [177] and
Goh et al. [50].
In this Chapter, the rejection of a broad range of TrOCs by MD was
investigated. The potential application of MD as a post treatment for thermophilic
MBR to enhance TrOC removal was also investigated. The transport and fate of
TrOCs during MD treatment are discussed with respect to compound hydrophobicity
and volatility (measured by the log D and the Henry’s law constant, respectively).
The results provide further insight with respect to TrOC rejection using MD, which
is critical for further development of this technology for wastewater reclamation
applications.
6.2
6.2.1

Materials and methods
Experimental system
The rejection of TrOCs by MD was evaluated using a hydrophobic

microporous polytetrafloroethylene (PTFE) membrane (GE, Minnetonka, MN) and a
laboratory-scale DCMD system. A detailed description of the DCMD system is
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given in Section 3.2.2. One set of MD experiments was conducted using a synthetic
feed solution containing approximately 5 µg/L of each TrOC in Milli-Q water. In
another series of experiments, effluent obtained from a thermophilic MBR system
was used as the feed solution to evaluate the feasibility of combining MD with MBR.
The MBR and MD experiments were conducted separately. Further details of the
MBR system are given in Section 3.2.1.
6.2.2

Experimental protocol
All MD experiments were carried out as discussed in Section 3.3.2. The

experiment was concluded once the water recovery had reached 70%, at which stage
the feed and distillate samples were collected for TrOC analysis. The MBR system
was operated under thermophilic conditions (40 °C) with an average dissolved
oxygen (DO) concentration of 2.9 mg/L, hydraulic retention time of 24 hr, and
average mixed liquor pH of 7.7. Excess sludge was withdrawn every week to
maintain the mixed liquor suspended solid (MLSS) concentration in the reactor at
5000 mg/L, resulting in a solids retention time (SRT) of 140 days.
Prior to the commencement of this study, the MBR system had been
acclimatized at 40 °C and operated for more than two months to produce constant
effluent quality (Figure 6.1). TrOCs were introduced to the MBR feed to obtain
approximately 5 µg/L of each compound and the MBR system was operated
continuously at similar operating conditions. Then, the effluent was collected and
used as MD feed. In good agreement with the previous studies [37, 39, 40] no
significant difference in the biological performances of the MBR was observed
following the introduction of TrOC. Key operational parameters including MLSS,
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mixed liquor volatile suspended solid (MLVSS), DO, total organic carbon (TOC),
and total nitrogen (TN) removal were periodically monitored to ensure the biological
stability of the MBR. The performance of the MBR system was stable throughout
this study with respect to these parameters. TOC and TN removal were stable at 91%
and 47%, respectively. The turbidity of the MBR permeate was always below 0.9
NTU. The MLVSS/MLSS ratio of the sludge remained constant at approximately
0.76 throughout the experimental period. In addition, the MBR system was operated
at a transmembrane pressure (TMP) below 90 kPa to maintain a constant permeate
flux, and no abnormal variation in TMP was observed over the entire study (Figure
6.2).
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Figure 6.1: Variation of TOC and TN removal of MBR during acclimatization to
thermophilic conditions (40 °C) and stable operation. Operated HRT, permeate flux,
mixed liquor DO concentration and pH were 24 h, 2.36 L/m2.h, 2.89 mg/L and 7.68,
respectively.
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Figure 6.2: TMP profile of the MBR during acclimatization to thermophilic
conditions (40 °C) and stable operation. HRT and permeate flux were 24 h and 2.36
L/m2.h (equivalent to 5 L/d), respectively.

TrOC removal or rejection (R) is defined as:
R = 100 × (1 −

CP
)
CF

6.1

where Cp and CF are the concentration of the specific compound in the
permeate and feed, respectively. The term ‘rejection’ was used for the MD process
while the term ‘removal’ was used for MBR. Taking the combined treatment of
MBR and MD into account, the term removal infers that TrOCs can also be
biologically degraded. Losses of TrOCs during the MD process were calculated by
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considering the mass balance of each compound in the feed, concentrate and
distillate as given below.
C F × VF = (C D × VD ) + (C C × VC ) + total loss

6.2

In Equation 6.2, CF, CD and CC are the concentration in the feed, distillate and
concentrate, respectively. Similarly, VF, VD and VC are the volume of the feed,
distillate and concentrate, respectively.
6.2.3

Trace organic contaminants
A set of 29 TrOCs (Table 6.1), was selected to represent pharmaceuticals,

steroid hormones, phytoestrogens, UV-filters (i.e., active ingredients of sunscreens),
industrial chemicals, and pesticides that occur ubiquitously in municipal wastewater
[2, 3, 6-8]. Log D values of these compounds were obtained from the SciFinder
Scholar database (https://scifinder.cas.org/scifinder) at pH 9 (Table 6.1). Vapour
pressure, molecular weight (MW), and water solubility of each selected compound
were also obtained from the SciFinder Scholar database (Supplementary Data Table
S1) to calculate the Henry’s law constant as: H (atm.m3/mol) = Vapour pressure ×
MW/water solubility. The pKH value presented in Table 6.1 is defined as pKH = log10H. It is important to note that because the water solubility used to calculate the
Henry’s law constant was obtained at 25 ºC, the actual pKH values at 40 ºC (which
was used during the MD experiment) could deviate slightly from those values
presented in the Table 6.1.
The pH of the synthetic feed solution was 8.5 and 8.6 at the beginning and the
end of the MD experiment. The initial pH value of the MBR effluent was 7.8 and it

124

Chapter 6: Rejection and fate of trace organic contaminants (TrOC) during
membrane distillation
increased to pH 9.1 at the end of the experiment. Accordingly, the log D and pKH
values of the TrOCs investigated in this study were obtained at pH 9 (Table 6.1).
6.2.4

Analytical methods

6.2.4.1 Basic water quality parameters
TOC and TN were analysed using a Shimadzu TOC/TN-VCSH analyser
(Shimadzu, Kyoto, Japan). Electrical conductivity and pH of the feed and distillate
were monitored using an Orion 4 Star Plus portable pH/conductivity meter (Thermo
Scientific, Waltham, MA). Analysis of basic water quality parameters is discussed in
Section 3.8.1.1.
6.2.4.2 Trace organic contaminant analysis
TrOC concentrations in influent, concentrate and distillate were determined
by a previously described method using solid phase extraction followed by gas
chromatography separation and quantitative determination using mass spectrometry
with electron ionization (Section 3.8.3)
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Table 6.1: Physicochemical properties of the selected contaminants
Compound

Chemical
Formula

Molecular
Weight (g/mol)

Log D at
pH 9

Water
Solubility at
25°C (mg/L)

Vapour
Pressure at
25°C (mmHg)

Henry Constant (H)
at pH 9 (atm.m3/mol)

pKH at
pH 9

Enterolactone

C18H18O4

298.33

1.89

200

3.29 ×10-13

6.46×10-16

15.19

Primidone

C12H14N2O2

218.25

0.83

1,500

6.08 ×10-11

1.16×10-14

13.93

Ketoprofen

C16H14O3

254.30

-0.84

554,000

3.32×10-8

2.00×10-14

13.70

Formononetin

C16H12O4

268.26

0.88

4800

8.17 ×10-10

6.01×10-14

13.22

Naproxen

C14H14O3

230.30

-0.73

435,000

3.01×10-7

2.10×10-13

12.68

Gemfibrozil

C15H22O3

250.30

0.67

263,000

6.13×10-7

7.68×10-13

12.11

Metronidazole

C6H9N3O3

171.15

-0.14

29,000

2.67×10-7

2.07×10-12

11.68

Diclofenac

C14H11Cl2NO2

296.15

0.83

20,000

1.59×10-7

3.10×10-12

11.51

Fenoprop

C9H7Cl3O3

269.51

-0.29

230,000

2.13×10-6

3.28×10-12

11.48

Estriol

C18H24O3

288.40

2.5

32

1.34 ×10-9

1.59×10-11

10.80

Ibuprofen

C13H18O2

206.30

-0.19

928,000

1.39 ×10-4

4.06×10-11

10.39

Clofibric acid

C10H11ClO3

214.64

-1.32

100,000

1.03 ×10-4

2.91×10-10

9.54

17 α – Ethinylestradiol

C20H24O2

296.48

4.08

3.9

3.74 ×10-9

3.74×10-10

9.43

Oxybenzone

C14H12O3

228.24

2.55

2700

5.26 ×10-6

5.85×10-10

9.23

Carbamazepine

C15H12N2O

236.27

1.89

220

5.78×10-7

8.17×10-10

9.09
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Compound

Chemical
Formula

Molecular
Weight (g/mol)

Log D at
pH 9

Water
Solubility at
25°C (mg/L)

Vapour
Pressure at
25°C (mmHg)

Henry Constant (H)
at pH 9 (atm.m3/mol)

pKH at
pH 9

Estrone

C18H22O2

270.36

3.6

5.9

1.54 ×10-8

9.29×10-10

9.03

17 β – Estradiol

C18H24O2

272.38

4.12

3

9.82 ×10-9

1.17×10-9

8.93

17 β – Estrodiol- 17- acetate

C20H26O3

314.42

5.11

1.9

9.88 ×10-9

2.15×10-9

8.67

Bisphenol A

C15H16O2

228.29

3.62

73

5.34 ×10-7

2.20×10-9

8.66

Octocrylene

C24H27N

361.48

6.89

0.36

2.56 ×10-9

3.38×10-9

8.47

Ametryn

C9H17N5S

227.33

2.97

140

1.72 ×10-6

3.67×10-9

8.43

Amitriptyline

C20H23N

277.40

4.01

83

1.50 ×10-6

6.60×10-9

8.18

Pentachlorophenol

C6HCl5O

266.38

1.99

4800

3.49×10-4

2.55×10-8

7.59

Atrazine

C8H14ClN5

215.68

2.64

69

1.27 ×10-5

5.22×10-8

7.28

Propoxur

C11H15NO3

209.24

1.54

800

1.53 ×10-3

5.26×10-7

6.28

Triclosan

C12H7Cl3O2

289.54

4.12

19

3.26×10-5

6.54×10-7

6.18

Benzophenone

C13H10O

182.22

3.21

150

8.23 ×10-4

1.32×10-6

5.88

4-tert-butyphenol

C10H14O

150.22

3.37

1000

0.0361

7.13×10-6

5.15

4-tert-octylphenol

C14H22O

206.33

5.18

62

1.98 ×10-3

8.67×10-6

5.06

Note: Molecular weight, log D, water solubility and vapour pressure data were obtained from Scifinder Scholar. Henry’s constant values were calculated as given in
Section 7.2.3.
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6.3

Results and discussion

6.3.1

Basic performance of the membrane distillation process

Table 6.2: MD and MBR-MD experimental conditions.
MD Experiment

MD experiment

with Milli-Q as

with MBR

feed

permeate as feed

MD feed

8.5

7.8

MD concentrate

8.6

9.1

Initial distillate

7.3

7.3

Final distillate

7.7

9.6

MD feed

18 ± 0.3

322 ± 2.0

Conductivity

MD concentrate

130 ± 17

1026 ± 46

(µS/cm)

Initial distillate

1.1 ± 0.1

1.3 ± 0.2

Final distillate

6.9 ± 0.4

9.3 ±0.1

Parameter

Phase

pH

Note: The standard deviation was calculated from duplicate experiments.

The MD experiments were analyzed considering the distillate flux, water
recovery, pH and conductivity variation (Table 6.2). The distillate flux was
continuously monitored to assess the stability (Figure 6.3). There was no notable
difference in the performance of the MD process with respect to the water flux and
conductivity rejection when either the synthetic solution or MBR effluent was used
as the feed. Both experiments achieved satisfactory water recovery at 70%. The
average TOC and TN concentrations of the MBR effluent were 15 ± 6 and 17 ± 4
mg/L, respectively. However, this high residual organic content in the MBR effluent
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did not exert any negative impact on the MD process. TOC and TN concentrations of
the distillate were consistently less than 1 mg/L. When either the synthetic solution
or the MBR effluent was used as the feed to the MD process, the water flux was
stable at approximately 17.5 L/m2.h and no flux decline was observed during the
entire experimental period (Figure 6.3). The conductivity of the distillate was always
less than 10 µS/cm regardless of the salinity level in the feed (Table 6.2).

(a) MD experiment

Flux (L/m2.h)

20
15
10

Test 1

Test 2

Test 1

Test 2

5
0

(b) MBR-MD experiment

Flux (L/m2.h)

20
15
10
5
0

200

400

600

800

1000

1200
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Figure 6.3: Permeate flux variation of MD and MBR–MD experiments: MD was
carried out at feed and distillate temperatures of 40 and 20 °C, respectively; and feed
and distillate circulation flow rate of 2 L/min (corresponding to 11.7 cm/s).
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6.3.2

Rejection and fate of trace organic contaminants during membrane
distillation

6.3.2.1 Trace organic contaminant rejection
Most of the 29 TrOCs investigated were effectively removed by MD (Figure
6.4). However, it is important to note that only a moderate rejection efficiency was
observed for several compounds. In particular, 4-tert-octylphenol showed the lowest
rejection (54%). In MD, mass transfer occurs only in the gas (vapour) phase. Thus,
the transport of TrOCs from the feed to the distillate solution depends on their
volatility. Not surprisingly, all TrOCs with pKH value higher than 9 (low volatility)
were well removed by the MD process. Oxybenzone is the only exception.
Compared to other TrOCs, the relatively lower rejection (81%) of oxybenzone in
relation to its pKH value as plotted in Figure 6.4 could be attributed to the strong
dependence of its pKH value on pH. pKH values at pH 9 have been plotted in Figure
6.4. However, it is noteworthy that the pKH value of oxybenzone changes from 9.23
to 8.39 when the solution pH decreases from 9 to 8 (Table 6.3). Because in this study
the feed solution pH was 8.5 and 8.6 at the beginning and the end of the MD
experiment, respectively, the interpolated pKH (8.6) value of oxybenzone is actually
below 9. The three TrOCs with the lowest rejection (i.e., 4-tert-octylphenol, 4-tertbutylphenol and benzophenone) also have the highest volatility (or lowest pKH)
amongst the 29 compounds studied. Low rejection of volatile organic compounds
such as benzene [185] and trichloroethylene [186] by MD have been previously
reported. However, in this study, there was no obvious correlation between rejection
efficiencies and pKH for TrOCs possessing a pKH value of less than 9. The data
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presented in Figure 6.4 suggest that in addition to volatility, other physicochemical
properties such as hydrophobicity (obtained from log D) may also influence the
transport of TrOCs during MD. In fact, octocrylene, which had the fourth lowest
rejection value of 81%, was also the most hydrophobic compound of the 29 TrOCs.
In addition, in this study most of the TrOCs with pKH of less than 9 were also
hydrophobic (i.e., log D>3), and their rejection efficiency varied widely from as low
as 54% (i.e., 4-tert-octylphenol) to near complete rejection. Significant adsorption of
hydrophobic organics to the MD membrane has been previously reported by Zuo and
Wang [202]. The results shown in Figure 6.4 suggest that the rejection of TrOCs may
be governed by the interplay between their volatility and hydrophobicity.
Table 6.3: pKH of oxybenzone at different pH values
pH

Log D*

Water Solubility

Vapour

at 25°C (mg/L)*

Pressure at 25°C

pKH

(mmHg)*
pH 8

3.42

390

5.26 ×10-6

8.39

pH 9

2.55

2700

5.26 ×10-6

9.23

Note : * Data from SciFinder Scholar.
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Figure 6.4: Rejection of the 29 TrOCs by DCMD and their log D and pKH values. Log D and pKH represent the values at pH 9. Error
bars represent the standard deviation from four replicate measurements. Synthetic solution containing approximately 5 µg/L of each
TrOC in Milli-Q water was used as the feed. The MD was carried out at the feed and distillate temperatures of 40 and 20 °C,
respectively. The feed and distillate circulation flow rate was 2 L/min (corresponding to 11.7 cm/s)
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6.3.2.2 Fate of trace organic contaminants during membrane distillation
The fate of TrOCs during the MD experiments is presented in Figure 6.5.
Considering each experiment as a closed system, any loss of TrOCs could be
attributed to either evaporation or adsorption to the membrane. The former is
governed by the volatility and the latter by the hydrophobicity. Both of these
physicochemical properties may be important in determining the fate of TrOCs
during MD (Figure 6.5). The results reveal that the hydrophilic TrOCs with low
volatility (pKH>9) can be concentrated in the feed. On the other hand, significant
losses through either evaporation or adsorption could be observed for moderately
volatile (i.e. pKH value < 9) and hydrophobic (i.e. log D > 3) compounds. As a result,
moderately volatile and hydrophobic compounds such as triclosan, propoxur,
amitryptyline, octocrylene and 17β–estradiol-17-acetate did not accumulate in the
feed. Indeed, concentrations of all three compounds (i.e. 4-tert-octylphenol, 4-tertbutylphenol and benzophenone) with the lowest pKH in the concentrate at the end of
the experiment were lower than the initial values (Table 6.4). In addition, the
rejection of these compounds by MD was also the lowest amongst the 29 TrOCs
investigated here (Figure 6.5).
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Figure 6.5: The fate of the 29 TrOCs in the DCMD process with their log D and pKH values. Log D and pKH illustrate the values at the
pH 9. Synthetic solution containing approximately 5 µg/L of each TrOC in Milli-Q water was used as the feed. The fate of each
compound was analyzed by mass balance considering the total input, mass in concentrate and permeate, and loss due to evaporation or
adsorption. Calculation of the fate of TrOCs during the MD process was based on the average value from four measurements (duplicate
samples from two replicate experiments)
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Table 6.4: Aqueous phase concentration of the selected TrOCs when tested in synthetic feed solution (in Milli-Q water)

Feed (ng/L)

Concentrate (ng/L)

Distillate (ng/L)

pKH at

Log D at

pH 9

pH 9

Mean

Error (±)

Mean

Error (±)

Mean

Error (±)

4-tert-Octylphenol

5.06

5.18

2292

828

585

110

631

109

4-tert-Butylphenol

5.15

3.37

1881

0

350

147

245

58

Benzophenone

5.88

3.21

666

0

274

26

128

44

Triclosan

6.19

4.12

3470

242

1019

232

115

26

Propoxur

6.28

1.54

1653

261

81

92

7

5

Atrazine

7.28

2.64

2462

89

10722

387

57

16

Pentachlorophenol

7.59

1.99

2924

459

8223

253

53

17

Amitriptyline

8.18

4.01

2465

455

1569

105

217

84

Ametryn

8.43

2.97

3133

117

10643

420

100

31

Octocrylene

8.47

6.89

888

229

371

76

95

49

Bisphenol A

8.66

3.62

3077

60

9070

266

283

56

17 β – Estrodiol- 17- acetate

8.67

5.11

3097

202

1192

278

76

62

17 β – Estradiol

8.93

4.12

3557

20

6944

603

38

24

Estrone

9.03

3.6

4163

34

9231

271

140

79

Carbamazapine

9.09

1.89

1806

105

6053

463

57

20

Oxybenzone

9.23

2.55

3531

333

2877

519

638

41

17 α – Ethinylestradiol

9.43

4.08

3276

145

4468

389

55

28

Clofibric acid

9.54

-1.32

3539

115

11594

72

22

14

Ibuprofen

10.39

-0.19

3555

288

13669

50

12

12

Compound
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Feed (ng/L)

Concentrate (ng/L)

Distillate (ng/L)

pKH at

Log D at

pH 9

pH 9

Mean

Error (±)

Mean

Error (±)

Mean

Error (±)

Estriol

10.80

2.5

3124

389

6866

1172

16

16

Fenoprop

11.48

-0.29

2330

42

7873

272

63

45

Diclofenac

11.51

0.83

3527

168

11633

414

123

132

Metronidazole

11.68

-0.14

742

156

3448

486

103

146

Gemifibrozil

12.11

0.67

3941

82

13514

191

34

16

Naproxen

12.68

-0.73

3794

199

13581

500

6

3

Formononetin

13.22

0.88

1432

297

5534

285

7

1

Ketoprofen

13.70

-0.84

3268

141

11493

180

24

2

Primidone
Enterolactone

13.93
15.19

0.83
1.89

1698
1213

121
274

7280
3076

88
933

5
2

4
2

Compound

Note: Error represents the standard deviation from four measurements (duplicate samples from two replicate experiments). MD was
carried out at the feed and distillate temperatures of 40 and 20 °C, respectively. The feed and distillate circulation flow rate was 2 L/min
(corresponding to 11.7 cm/s).
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6.3.3

Membrane bioreactor – membrane distillation (MBR-MD) system
MD can be operated with a feed temperature compatible to that in

thermophilic MBR. As discussed in Section 6.1, these two processes can be
combined with each other for enhanced TrOC removal. TrOC concentrations in the
feed and after each of these treatment steps are shown in Table 6.5. MBR treatment
effectively removed most of the 29 TrOCs investigated in this study. The high
removal of these compounds during MBR treatment has also been reported
elsewhere [24, 37, 39, 199]. However, several compounds including propoxur,
atrazine, ametryn, clofibric acid, diclofenac, carbamazepine, naproxen and fenoprop
were found to be persistent to MBR treatment, and their residual concentrations in
the MBR effluent were relatively high. This is consistent with several previous
studies [29, 37, 157]. It is noted that the removal efficiency of these compounds
under thermophilic conditions in this study was comparatively lower than that
observed in our previous study under mesophilic conditions [39]. The low removal of
most of the persistent compounds can be attributed to the disturbed metabolic
activity generally associated with the biological treatment at elevated temperatures
[23]. Nevertheless, as illustrated in Figure 6.6, all TrOCs including those that were
resistant to MBR treatment were effectively removed by the MD process. In this
study, complete or near complete (> 95%) removal efficiency of all 29 TrOCs was
achieved by the combined MBR-MD treatment.
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Table 6.5: Aqueous phase concentration of the selected TrOCs during the MBR-MD experiments with MBR permeate as the MD feed.
MBR feed (ng/L)

MBR Permeate (MD
feed) (ng/L)
Mean
Error
(±)
147
11

MD Concentrate
(ng/L)
Mean
Error
(±)
278
69

pKH at

Log D at

pH 9

pH 9

Mean

4-tert-Octylphenol

5.06

5.18

4683

Error
(±)
9

4-tert-Butylphenol

5.15

3.37

4240

45

112

19

116

Benzophenone

5.88

3.21

1568

166

205

35

Triclosan

6.19

4.12

4496

29

114

Propoxur

6.28

1.54

4445

68

Atrazine

7.28

2.64

2800

Pentachlorophenol

7.59

1.99

Amitriptyline

8.18

Ametryn

Compound

Distillate (ng/L)

96

Error
(±)
65

30

51

23

78

25

37

41

17

155

17

26

1

3011

278

164

53

39

14

107

3215

98

10034

1142

28

10

4588

150

441

70

1039

254

13

16

4.01

4143

484

149

42

40

3

36

30

8.43

2.97

4032

24

1655

121

4639

410

25

6

Octocrylene

8.47

6.89

1231

235

31

21

50

18

33

14

Bisphenol A

8.66

3.62

4919

854

56

1

756

17

178

13

17 β – Estrodiol- 17- acetate

8.67

5.11

3956

45

12

6

27

27

27

20

17 β – Estradiol

8.93

4.12

4359

22

5

5

0

0

0

0

Estrone

9.03

3.6

4654

26

31

2

40

5

21

17

Carbamazapine

9.09

1.89

3332

142

2093

93

8022

1332

32

12

Oxybenzone

9.23

2.55

5043

8

56

4

31

31

8

5

17 α – Ethinylestradiol

9.43

4.08

4131

339

236

22

125

91

80

11

Clofibric acid

9.54

-1.32

4230

63

2448

156

7245

1092

7

2

Ibuprofen

10.39

-0.19

4915

191

57

16

131

24

5

6
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MBR feed (ng/L)

pKH at

Log D at

pH 9

pH 9

Mean

Estriol

10.8

2.5

Fenoprop

11.48

Diclofenac

Compound

MBR Permeate (MD
Mean

3680

Error
(±)
387

-0.29

3940

11.51

0.83

Metronidazole

11.68

Gemifibrozil

MD Concentrate
Mean

88

Error
(±)
22

202

2071

3258

39

-0.14

851

12.11

0.67

Naproxen

12.68

Formononetin

Distillate (ng/L)
Mean

22

Error
(±)
22

16

Error
(±)
17

108

5203

600

25

18

3916

49

9993

645

19

5

86

127

2

282

86

5

5

4628

17

456

29

1473

183

6

1

-0.73

4746

196

2292

133

6749

296

2

2

13.22

0.88

1081

727

35

10

61

34

27

4

Ketoprofen

13.7

-0.84

4452

107

273

29

757

41

23

6

Primidone

13.93

0.83

2627

181

14

4

82

41

2

2

Enterolactone

15.19

1.89

5530

29

241

78

23

16

114

49

Note: Error represents the standard deviation from four measurements (duplicate samples from two replicate experiments)
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MBR
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Figure 6.6: Removal of TrOCs by the thermophilic MBR and by the MBR-MD as well as their log D and pKH values. Log D and pKH
illustrate the values at the pH 9. MBR permeate was used as the feed for MD. Error bars represent the standard deviation from two
replicate experiments.
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TrOC removal by MD as a post treatment step following MBR has not been
previously reported. On the other hand, the use of other post treatment processes
such as NF and RO desalination subsequent to MBR has been demonstrated [40, 199,
203, 204]. Tam et al. [203] reported near complete removal of estrogens and
disinfection by-products (trihalomethanes and halo-acetic acids) by a pilot MBR/RO
system. Alturki et al. [40] also showed the benefits of coupling MBR treatment and
NF/RO desalination for removing 40 TrOCs with a diverse range of physicochemical
properties. The current study suggests that an MBR-MD hybrid system could be as
effective as an MBR-NF/RO system for removing TrOCs. In addition, high removal
of TrOCs by a combination of MBR and MD treatment can be achieved regardless of
the diversity of their volatility, molecular structure, and hydrophobicity.
The results shed light on the prospective of integrating MD with MBR for
TrOC removal (e.g., MBR coupled MD (multi pass) system and MD bioreactor), and
the salinity affected complexities on removal performance would be vital to
investigate. However, it was not within the scope of the current study. Overall, the
high water flux, excellent distillate quality and the near complete removal of TrOCs
reported here suggests that MBR-MD system could be used to ensure safe water
reuse.
6.4

Conclusion
In this study the rejection of 29 trace organic contaminants (TrOCs) and their

fate in a membrane distillation (MD) system has been investigated. The results
suggest that rejection and fate and transport of TrOC during MD would be mainly
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governed by the volatility of the compound with additional effects due to its
hydrophobicity. All TrOCs with pKH > 9 (which can be classified as non-volatile)
were highly removed by MD. However, three compounds (i.e., 4-tert-octylphenol, 4tert-butylphenol and benzophenone) with pKH < 9 and thus classified as partially
volatile showed relatively low rejection efficiencies (i.e., 54, 73 and 66%,
respectively). The results also suggest that the rejection of TrOCs with pKH < 9 may
be controlled by the interplay between compound hydrophobicity and volatility. In
addition, the results show that hydrophilic TrOCs having negligible volatility were
concentrated in the feed, while hydrophobic compounds with moderate volatility
were substantially lost due to evaporation or adsorption to the membrane. Membrane
bioreactor followed by MD treatment resulted in near complete (> 95%) removal of
all 29 TrOCs despite their diverse physicochemical properties (i.e., hydrophobicity,
persistency and volatility).
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CHAPTER 7
A NOVEL MEMBRANE DISTILLATION – THERMOPHILIC
BIOREACTOR (MDBR) SYSTEM: BIOLOGICAL STABILITY AND TRACE
ORGANIC CONTAMINANT REMOVAL
Corresponding publication: K.C. Wijekoon., F.I. Hai., J. Kang., W. E. Price.,
W. Guo., H. N. Ngo., T. Y. Cath., L.D. Nghiem. 2014. A novel membrane distillation
– thermophilic bioreactor (MDBR) system: Biological stability and trace organic
compound removal. Bioresource Technology, 159 (334-341).
7.1

Introduction
Water reclamation is a pragmatic approach to address the scarcity of water

supplies in urban areas due to population growth and irregular climate pattern[1].
Through water reclamation, municipal wastewater can be a reliable alternative source
for clean water supply. However, development of advanced treatment processes is
necessary to ensure adequate removal of common contaminants (e.g., organics,
nutrients, and minerals) and especially trace organic contaminants (TrOCs) that
occur ubiquitously in municipal wastewater. These TrOCs include steroid hormones,
pharmaceuticals, personal care products, surfactants, pesticides, disinfection byproducts, and UV filters [4, 5] that have been widely detected in raw sewage and
reclaimed effluent from conventional wastewater treatment plants. Their occurrence
is of major health and environmental concern because of their potential adverse
impact on living organisms [205]. Thus, the removal of TrOCs during water
reclamation has been the subject of intensive research in recent years.
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Membrane bioreactor (MBR) is an efficient wastewater treatment technology,
capable of producing reuse standard effluent[14]. MBRs can effectively remove
TrOCs that are hydrophobic and/or readily biodegradable [24, 27, 37, 38]; however,
recent studies have highlighted the challenges of removing recalcitrant TrOCs (e.g.,
carbamazepine and diclofenac) by biological treatment processes, including MBRs
[27, 29, 37, 39].
Tadkaew et al.[37] suggested that biodegradability of a TrOC can be
qualitatively assessed based on the presence of electron donating functional groups
(EDGs) or electron withdrawing functional groups (EWGs) in their molecules. They
demonstrated that TrOCs with one or several EDGs can be well removed in an MBR,
whereas TrOCs with one or several EWGs (such as chloride and amide) in their
structure are usually poorly removed by MBRs. In a subsequent study, Wijekoon et
al. [39] have successfully extended this framework to elucidate the fate of TrOCs in
the aqueous and sludge phase during MBR treatment (Chapter 4). Given the
recalcitrant nature of some TrOCs to biodegradation, the use of post-treatment
processes to specifically target these recalcitrant TrOCs has also been explored.
Examples of these post-treatment processes subsequent to MBR treatment include
reverse osmosis [40], activated carbon adsorption [41], and ultraviolet oxidation [42].
Integration of a high retention membrane process such as nanofiltration[44], forward
osmosis [45-47], or membrane distillation (MD) [48-51] with a bioreactor constitutes
a so called high retention MBR, which can be an efficient means to achieve high
removal of pollutants. The working principles of these integrated processes have
been demonstrated in recent studies; however, except for Alturki et al.[45] and
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Hancock et al.[206], the removal of TrOCs using these novel high retention MBRs
has not been investigated.
MD is a low temperature distillation process that involves the transport of
water vapour from a feed solution through the pores of a microporous and
hydrophobic membrane to the distillate (product) side. Because mass transfer occurs
in a gaseous phase, MD offers complete rejection of all non-volatile solutes [43].
Membrane distillation bioreactor (MDBR) is a high retention MBR process where
MD membrane can act as a barrier against the permeation of low molecular weight
compounds and recalcitrant compounds. In the MDBR process, the biological reactor
can be operated at thermophilic conditions to facilitate the integration of biological
treatment with MD. In addition, the thermophilic bioreactor can also result in
enhanced biodegradation of organics and low sludge yield [139].
The main aim of this study was to evaluate the performance of a novel hybrid
MDBR process. Biological stability of the thermophilic bioreactor and the overall
performance in terms of basic water quality parameters, as well as the fate and
removal of TrOCs during MDBR treatment were elucidated.
7.2
7.2.1

Materials and methods
Experimental system
A laboratory-scale MDBR system consisting of a glass bioreactor and an

external direct contact membrane distillation (DCMD) module was used. A detailed
description of the system is given in Section 3.2.3.
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7.2.2

Experimental protocol
Prior to the MDBR experiment, the bioreactor sludge was acclimatized at 40

°C using an aerobic MBR as discussed in Section 3.3.3. After the bioreactor had
been acclimatised for 75 d, the ceramic membrane module was removed and the
bioreactor was connected to the DCMD system (Section 3.2.3). TrOCs were then
continuously introduced to the influent to maintain a feed concentration of
approximately 5 µg/L of each compound.
The basic biological performance of the MDBR in terms of total organic
carbon (TOC) and total nitrogen (TN) removal, conductivity/pH variation, and
MLSS concentration was continuously monitored. The mixed liquor was collected
weekly and centrifuged at 3270 × g for 10 min (Alleegra X-12R, Beckman Coulter,
USA) to obtain the supernatant and sludge pellets for further analysis. Feed and
distillate samples were collected for TrOC analysis on a weekly basis. The
concentration of TrOCs in the distillate was calculated by taking into account the
volume of Milli-Q water (2.25 L) used as the initial make up water.
TrOC removal by bioreactor (R1), MD (R2) and MDBR hybrid system (RT)
are defined as:

R 1 = 100 × (1 −

CS u
)
CF

R 2 = 100 × (1 −

R T = 100 × (1 −

7.1

CD
)
C Su

7.2

CD
)
CF

7.3
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where CF, CSu, and CD are the concentrations of the specific compound in the
bioreactor

feed,

bioreactor

supernatant,

and

distillate,

respectively.

Biodegradation/transformation of TrOCs during the treatment by the hybrid process
was calculated by considering the mass balance of each compound in the feed,
supernatant, sludge and distillate as given in Equation 7.4.
C F × VF = (C Su × VS ) + (C Sl × X Sl × VS ) + (C D × VD ) +

biodegradation/transformation
7.4

In Equation 7.4, CSl is the compound concentration in sludge and XSl denotes
the sludge (MLSS) concentration. Similarly VF, VD, and VS are the volume of the
bioreactor feed, distillate, and mixed liquor, respectively.
7.2.3

Trace organic contaminants
A set of 25 TrOCs, except for enterolactone, formononetin, Gemfibrozil,4-tert-

octylphenol listed in Table 3.2 was selected to represent pharmaceuticals and personal

care products, steroid hormones, UV-filters, and pesticides that occur ubiquitously in
municipal wastewater. A combined stock solution of all TrOCs was prepared in pure
methanol and kept at -18 ºC in the dark.
7.3

Analytical methods

7.3.1 Basic water quality parameters
TOC and TN were analysed using a TOC/TN-VCSH analyser (Shimadzu,
Japan) (Section 3.8.1). Electrical conductivity and pH of the feed and distillate were
monitored using an Orion 4 Star Plus portable pH/ conductivity meter (Thermo
Scientific, Waltham, MA).
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7.3.2

Trace organic contaminant analysis
TrOC concentration in solid phase (sludge) and liquid phase (feed, bioreactor

supernatant and distillate) were determined. An ultrasonic solvent extraction method
(Section 3.8.2) was used to extract the TrOCs from sludge. TrOC concentrations in
aliquot aqueous samples (feed, sludge, supernatant and distillate) were determined
using to a method employing solid phase extraction, gas chromatography separation
and quantitative determination using mass spectrometry with electron ionization
(Section 3.8.3)
7.4
7.4.1

Results and discussion
Biological performance
The basic performance of both the thermophilic bioreactor and MDBR

system was assessed in terms of the distillate flux and quality (i.e., conductivity,
TOC, and TN), mixed liquor characteristics (i.e., DO concentration, conductivity,
pH, MLSS, and MLVSS) and organics removal (i.e., TOC and TN). The main
performance parameters of the system are summarized in Figure 7.1. Water flux
through the MD membrane decreased from 4 to about 2 L/m2.h within the first three
days of operation, and after about 10 days of operation it became stable at
approximately 1.2±0.2 L/m2h (Figure 7.1a). This observed flux profile was
consistent with several previous studies [48, 49, 177]. The low water flux observed
could be attributed to the low cross flow velocity (i.e., 9 cm/s; see Section 3.2.3) in
the MD cell used in a laboratory scale system and can be improved by increasing the
circulation flow rate. In addition, the stable water flux after 10 days of operation
indicated that membrane wetting did not occur in this study, which was also
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evidenced by the low conductivity (<5 µS/cm) of the distillate (Figure 7.1b) during
the entire experiment. Changes in hydrophobicity as a result of membrane wetting
would lead to lower distillate quality (or an increase in distillate conductivity).
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Figure 7.1: (a) Distillate flux profile (b) Conductivity and pH variation of mixed
liquor/distillate of MDBR hybrid system during operation. The temperature
difference across the MD cell was 24 °C with feed temperature of 38 °C immediately
before the cell and distillate temperatures of 14 °C immediately after the cell. The
conductivity and pH of feed were 320±17 µS/cm and 7.5±0.1, respectively. The DO
concentration and temperature of bioreactor mixed liquor were 2.8±0.5 mg/L and 40
°C, respectively.
The mixed liquor salinity (measured by conductivity) increased continuously
as the experiment progressed (Figure 7.1b). It is noteworthy that the occasional slight
drop in the mixed liquor salinity was due to the collection of supernatant for
149

Chapter 7: A novel membrane distillation-thermophilic bioreactor (MDBR) system:
Biological stability and trace organic contaminant removal
sampling and replenishment with low salinity makeup wastewater. Salinity build-up
during MDBR operation was attributed to the complete rejection of salts by MD [48,
49, 207]. Moreover, there was a small increase in pH of the mixed liquor from 7.6 to
8.2, which was possibly due to the stripping of carbon dioxide at thermophilic
temperatures [50, 208].
TOC removal by the thermophilic bioreactor was stable at 94%, and the
supernatant TOC was always below 14 mg/L (Figure 7.2a). In addition, TOC
removal by thermophilic bioreactor before (Figure 7.3a) and after MDBR experiment
were almost identical. As most of the heterotrophic bacteria are subspecies of the
halophilic and halotolerent microbial community, heterotrophic bacteria are more
tolerant to salinity increase. Thus, the impact of salinity increase on TOC removal
was insignificant [191]. However, TN removal by the thermophilic bioreactor
significantly decreased from relatively stable removal at 51% (prior to MDBR
experiment) (Figure 7.3b) to almost zero after only about four days of integration of
the bioreactor with the MD unit (Figure 7.2b). The poor removal of TN probably
resulted from an increase of mixed liquor salinity which is toxic to nitrifying bacteria
[191]. LaPara and Alleman [139] also reported that thermophilic aerobic biological
treatment is more susceptible to environmental changes than a mesophilic process. A
gradual reduction in MLVSS concentration was noticed after starting MDBR
experiment (Figure 7.4 and Figure 7.5), and this can be attributed to salinity build-up
as reported by Alturki et al. [45] who explored a bioreactor integrated with a forward
osmosis unit. This is also consistent with the reported low sludge yield by
thermophilic aerobic biological treatment [139].
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Although the thermophilic conditions could exert some negative effects on
the performance of the bioreactor due to salinity build up, the overall TOC (> 99%)
and TN (> 96%) removals by the hybrid MDBR system were high and independent
of the biological stability of the reactor. Distillate TOC and TN concentrations were
below 1 mg/L throughout the experiment. These results confirmed that the high
performance of MD can offset the negative impact of salinity on the biological
treatment and produce a high quality final effluent.
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Figure 7.2: The variation of TOC and TN removal of the MDBR hybrid system. The
stable flux was 1.2 ±0.2 L/m2h. Operating conditions were as stated in Figure 7.1
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Figure 7.3: TOC and TN removal of thermophilic bioreactor during acclimatisation
period (i.e., prior to MDBR experiment). Bioreactor was acclimatised (increase
temperature to 40 °C and stable operation) at 40 °C by operating the system in an
MBR mode using a ceramic microfiltration membrane module.
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7.4.2

Trace organic contaminant removal
Biodegradation in the thermophilic bioreactor and rejection by the MD

membrane are the two removal mechanisms of TrOCs in the MDBR hybrid system.
The individual and total removals of the 25 investigated TrOCs are depicted in
Figure 7.6. Most TrOCs were moderately or highly removed during thermophilic
biological treatment. The results observed showed that salinity build-up did not
significantly affect the removal of readily biodegradable TrOCs, and their removal
efficiencies were stable over the entire experiment (Figure 7.7). The reason might be
that biodegradation of these TrOCs was mainly driven by heterotrophic bacteria,
which are tolerant to salinity changes [191]. All TrOCs containing EWGs (i.e.,
clofibric acid, fenoprop, diclofenac, carbamazepine, atrazine, and triclosan) were
poorly removed by the biological process in the thermophilic bioreactor, and their
removal efficiencies were in the range of zero to 53%. Moreover, the removal
efficiency of carbamazepine, atrazine, and triclosan continually deteriorated with
time (Figure 7.8), exhibiting the detrimental effect of salinity build up on the removal
of recalcitrant TrOCs by the bioreactor alone. It is notable that despite being a
hydrophobic compound, triclosan removal by the bioreactor was remarkably low
(53%) compared to the values previously reported in case of conventional MBR
treatment [19, 23, 37]. The biological removal efficiency of carbamazepine in this
study was also significantly lower than that by a thermophilic MBR operated at
similar temperature as reported by Hai et al. [23] and Wijekoon et al. [209]. Low
removal of Carbamazepine could be attributed to the low biological activity of
nitrifying bacteria caused by the salinity increase. Carbamazepine appears to be
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highly removed at anoxic condition compare to aerobic condition [23] and nitrifying
bacteria could mainly affect the biodegradation [209].
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Figure 7.6: TrOC removal by the hybrid MDBR system. Distillate flux was stable at 1.2 ±0.2 L/m2.h. The DO concentration and
temperature of the bioreactor mixed liquor were 2.8±0.5 mg/L and 40 °C, respectively. Removal efficiency represents the average value
of duplicate samples taken once a week for five weeks. Operating conditions are as described in Figure 7.1.
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The complexity associated with the dynamic salinity level could modify the
microbial community of MDBR as nitrifying bacteria are highly susceptible to
salinity changes [191]. As carbamazepine is a nitrogenous compound and more
likely to be removed by nitrifying bacteria [22, 39], it was substantially affected by
salinity increase in the bioreactor. It is noteworthy that this study was conducted over
a short period. For long term operation of the MDBR, the impact of salinity build-up
may become less critical due to selective microbial growth and natural adaptation of
the halophilic bacteria [191].
All TrOCs investigated were well removed (> 95%) by the integrated MDBR
system (Figure 7.6) despite the impact of salinity build-up on recalcitrant TrOC
removal by the bioreactor. TrOC removal by the MD process was investigated in a
previous study [209] (Chapter 6). Although TrOCs with low volatility (pKH> 9) were
well rejected, MD alone was not effective for removal of TrOCs such as 4-tert-butyl
phenol and oxybenzone which are moderately volatile (pKH< 9) [209]. Thus, the
results in the current study imply that MD can effectively complement the biological
treatment process to achieve high TrOC removal. In addition, the novel MDBR
system may offer a high effluent quality independent of the operating conditions of
the bioreactor.
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Figure 7.7: Biological removal of TrOCs as a function of time during MDBR treatment.
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Figure 7.8: Variation in the biological removal of recalcitrant TrOCs with time.
7.4.3

Fate and transport of trace organic contaminants
The concentration of TrOCs and their associated Log D and pKH values in the

solid and liquid phases of the different streams of the MDBR are summarized in
Figure 7.9. The concentration of most TrOCs in the aqueous (i.e., feed to the
bioreactor, supernatant, and distillate) and solid phases were stable during the
experiment. The accumulation of certain TrOCs in the supernatant (Figure 7.10) may
be ascribed to their low biological removal as discussed above. Triclosan was the
only TrOC that significantly accumulated in the sludge phase because it is a
hydrophobic

(log

DpH8

=

4.92)

and

recalcitrant

compound.

Biodegradation/transformation by the thermophilic bioreactor, adsorption to the
sludge phase, and rejection by the MD membrane could all contribute to the removal

159

Chapter 7: A novel membrane distillation-thermophilic bioreactor (MDBR) system:
Biological stability and trace organic contaminant removal
of TrOCs by the MDBR system. The mass balance of each TrOC was calculated
(Equations 7.1-7.4) based on the loading in the feed, supernatant, sludge, and
distillate

in

order

to

determine

the

relative

contribution

between

biodegradation/transformation, accumulation in supernatant, adsorption to sludge,
and volatilisation during MDBR treatment. Volatilisation during the MD process was
calculated by taking into account the compound concentration in the distillate.
Finally, the percentage of biodegradation/transformation was determined from the
difference of measured concentrations in the feed, the bioreactor supernatant, and the
distillate (Figure 7.11).
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Figure 7.9: Concentrations of the selected TrOC in (a) the aqueous phase and (b) the
sludge phase of the MDBR hybrid system. Operating conditions are given in Figure
7.6. Error bars represent the standard deviation of duplicate samples taken once a
week for five weeks. Error bars of sludge data represent the standard deviation of
duplicate samples taken once a week for four weeks.
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Figure 7.10: Variation in the supernatant concentration of recalcitrant TrOCs with
time.
Percentage biodegradation/transformation, adsorption to sludge, and rejection
by MD (accumulation in the supernatant) of TrOCs during MDBR treatment are
given in Figure 7.11. Volatilization to the distillate was insignificant considering the
low volatility (as denoted by low Henry’s constant or high pKH) and negligible
distillate concentrations of all TrOCs observed (Figure 7.9). The hydrophobicity
(measured by log D) and the presence of EDGs and EWGs could also govern the fate
and transport of TrOCs. Results revealed that readily biodegradable TrOCs were
mainly removed by biodegradation (>70%). As noted earlier, biodegradation of
recalcitrant TrOCs (possessing only EWGs) in this study, was considerably low
compared to their removal by a conventional MBR process as previously reported
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[19, 23, 29, 39, 209]. Biodegradation of triclosan, possessing strong EWG (i.e.,
chloro) was low (26%) compared to octocrylene (74%), which possesses weak
EWGs (i.e., cyano).
TrOC rejection by MD was the main removal mechanism of recalcitrant
compounds by the MDBR hybrid system. MD rejection accounted for the greater
portion of overall removal of six recalcitrant TrOCs, including triclosan (42%),
fenoprop (64%), atrazine (68%), clofibric acid (71%), diclofenac (75%), and
carbamazepine (94%). Accumulation in sludge greatly contributed to the aqueous
phase removal of hydrophobic recalcitrant compounds (i.e., triclosan and
octocrylene). Data from this study reveals that accumulation in sludge was governed
more by the strength of the EWG than the hydrophobicity of the compound. For
example, sludge adsorption of triclosan, which is less hydrophobic (log D pH 8 =4.92)
but possesses stronger EWGs (i.e., chloro), was higher (33%) compared to that of
octocrylene (22%), which is more hydrophobic (log D
weaker EWGs (i.e., cyano).
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7.5

Conclusion
The removal of 25 TrOCs by a novel hybrid MDBR system was investigated.

While most TrOCs were effectively removed by biological processes in the
thermophilic bioreactor, compounds containing EWGs in their molecular structure
were resistant to biological degradation. Salinity build-up occurred during MDBR
operation which negatively affected the performance of the biological processes in
the thermophilic bioreactor, lowering the removal of total nitrogen and recalcitrant
TrOCs. However, the overall performance of the MDBR system with respect to the
removal of all 25 TrOCs, TOC, and TN was high and independent of the
performance of the bioreactor.
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CHAPTER 8
CONCLUSIONS AND RECOMMENDATIONS
8.1

Conclusions
This thesis examined the removal and fate of trace organic contaminants

(TrOCs) during MBR treatment and proposed a framework to predict the removal
and fate of TrOCs by MBR treatment. Membrane distillation as a post treatment to
remove TrOCs during membrane bioreactor was also investigated. A novel
membrane distillation bioreactor system was evaluated to shed light on the
development of MDBR system for TrOC removal.
Chapter 4 examined the removal of TrOCs from both solid (sludge) and
aqueous phases as well as their fate during MBR treatment. The fate of TrOCs during
MBR

treatment

was

governed

by

both

biodegradation

and

adsorption.

Biodegradation was the predominant removal mechanism of the hydrophilic TrOCs
from the aqueous phase. The removal of hydrophobic TrOCs from the aqueous phase
could also occur via adsorption. However, readily biodegradable hydrophobic TrOCs
did not accumulate significantly in sludge. Additionally, recalcitrant TrOCs which
are moderately hydrophobic or even hydrophilic could accumulate significantly in
the sludge.
Results from Chapter 5 revealed that biodegradation was the predominant
removal mechanism for N-nitrosamines. Adsorption to sludge was negligible while
photolysis and volatilization were not expected to occur. N-nitrosamine removal
efﬁciencies were dependent on their molecular structure, and ranged from 24% to
94%. The results could be explained by the presence of EWGs and EDGs (and their
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relative strength) in the N-nitrosamine molecules. N-nitrosamines possessing strong
EDGs such as dimethyl-amine and diethyl-amine (e.g. NDMA and NDEA) are
readily biodegradable during MBR treatment. By contrast, NMOR which has the
weak EDG morpholine was persistent to biodegradation and its removal efﬁciency
by MBR treatment was correspondingly the lowest.
The rejection of 29 trace organic compounds (TrOCs) and their fate in a
membrane distillation (MD) system were investigated in Chapter 6. Results suggest
that rejection and fate and transport of TrOC during MD would be mainly governed
by the volatility and partially by the hydrophobicity of the compound. All TrOCs
with pKH > 9 (which can be classified as non-volatile) were highly removed by MD.
However,

three compounds

(i.e.

4-tert-octylphenol,

4-tert-butylphenol

and

benzophenone) with pKH < 9 and thus classified as partially volatile showed
relatively low rejection efficiencies (i.e. 54, 73 and 66%, respectively). The results
also suggest that the rejection of TrOCs with pKH < 9 may be governed by the
interplay between their hydrophobicity and volatility. In addition, the results showed
that hydrophilic TrOCs having negligible volatility were concentrated in the feed,
while hydrophobic compounds with moderate volatility were substantially lost due to
evaporation or adsorption to membrane. Membrane bioreactor followed by MD
treatment resulted in near complete (> 95%) removal of all 29 TrOCs despite their
diverse physicochemical properties (i.e. hydrophobicity, persistency and volatility).
In Chapter 7, the removal of 25 TrOCs by a novel hybrid MDBR system was
examined. While most TrOCs were well removed by biological processes in the
thermophilic bioreactor, compounds containing EWG groups in their molecular
structure were recalcitrant to biological degradation. Salinity build-up negatively
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affected the biological performances of the bioreactor, reducing the removal of total
nitrogen and recalcitrant TrOCs. However, impact of salinity increase on TOC
removal was insignificant as most of the heterotrophic bacteria are halotolerant.
Interestingly, MDBR overall performances with respect to the removal of all 25
TrOCs, TOC, and TN were high and independent of the bioreactor performances. .
8.2

Recommendations to future studies
Fate and removal of TrOCs during anaerobic MBR has been scarcely

reported previously. Sludge phase removal of TrOCs during anaerobic MBR could
be significant given the high adsorption potential of TrOCs to sludge. Therefore,
systematic investigation of the removal of TrOCs during AnMBR treatment is
recommended.
Membrane distillation bioreactor is an effective treatment which can produce
high quality product water. Basic removal performance and the TrOCs removal of
aerobic membrane distillation bioreactor are independent of the bioreactor
performance. Yet, AnMBR coupled membrane distillation hybrid process for
wastewater treatment has not been reported. Therefore, examining the feasibility of
AnMBR coupled membrane distillation hybrid process for TrOCs removal is
recommended.
Salinity build-up in MDBR treatment could adversely affect the membrane
characteristics and consequently affect the quality of the product water. Salinity
build-up may also affect the biological process with the selective growth of
microorganisms. Therefore, the removal mechanisms of TrOCs in long term
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operation may vary. Long term operation of MDBR should be investigated to
comprehensively understand the performance of this novel technology.
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